rntc/big-bigbio-ner · Datasets at Hugging Face

answer stringlengths 1 16.1k	id stringlengths 3 52	instruction stringlengths 106 72.6k	ner_tags listlengths 2 13.4k	text stringlengths 5 72.4k	tokens listlengths 2 13.4k	types listlengths 1 21
thrombocytopenia, haemolytic anaemia, ciprofloxacin	15375_2	Sentence: Severe thrombocytopenia and haemolytic anaemia associated with ciprofloxacin: a case report with fatal outcome. Instructions: please extract entity words from the input sentence	[ "O", "B-Disease", "O", "B-Disease", "I-Disease", "O", "O", "B-Chemical", "O", "O", "O", "O", "O", "O", "O", "O" ]	Severe thrombocytopenia and haemolytic anaemia associated with ciprofloxacin: a case report with fatal outcome.	[ "Severe", "thrombocytopenia", "and", "haemolytic", "anaemia", "associated", "with", "ciprofloxacin", ":", "a", "case", "report", "with", "fatal", "outcome", "." ]	[ "Disease", "Chemical" ]
Males is a Person, females is a Person, aged is a Person, > /= 50 years is a Value, No is a Negation, significant disease or drug use is a Scope, Absence of is a Negation, sign of dementia / cognitive impairment is a Scope, fulfils DSM - IV and NINCDS - ADRA criteria is a Scope, probable is a Mood, Alzheimers disease i...	NCT01009359_inc_0	Sentence: Able to give fully informed consent in writing Males or females aged >/= 50 years No significant disease or drug use Absence of any sign of dementia/cognitive impairment in neuropsychological examinationsPatients for brain imaging: Patient and designee capable of giving fully informed consent in writing ...	[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Person", "O", "B-Person", "B-Person", "B-Value", "I-Value", "I-Value", "I-Value", "O", "B-Negation", "B-Scope", "I-Scope", "I-Scope", "I-Scope", "I-Scope", "O", "B-Negation", "I-Negation", "O", "B-Scope", "I-Sc...	Able to give fully informed consent in writing Males or females aged >/= 50 years No significant disease or drug use Absence of any sign of dementia/cognitive impairment in neuropsychological examinationsPatients for brain imaging: Patient and designee capable of giving fully informed consent in writing Patient fu...	[ "Able", "to", "give", "fully", "informed", "consent", "in", "writing", "\n", "Males", "or", "females", "aged", ">", "/=", "50", "years", "\n", "No", "significant", "disease", "or", "drug", "use", "\n", "Absence", "of", "any", "sign", "of", "dementia", "/...	[ "Scope", "Procedure", "Condition", "Measurement", "Value", "Qualifier", "Negation", "Mood", "Person" ]
Males is a Person, females is a Person, aged is a Person, > /= 50 years is a Value, No is a Negation, significant disease or drug use is a Scope, Absence of is a Negation, sign of dementia / cognitive impairment is a Scope, fulfils DSM - IV and NINCDS - ADRA criteria is a Scope, probable is a Mood, Alzheimers disease i...	NCT01009359_inc_1	Sentence: Able to give fully informed consent in writing Males or females aged >/= 50 years No significant disease or drug use Absence of any sign of dementia/cognitive impairment in neuropsychological examinationsPatients for brain imaging: Patient and designee capable of giving fully informed consent in writing ...	[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Person", "O", "B-Person", "B-Person", "B-Value", "I-Value", "I-Value", "I-Value", "O", "B-Negation", "B-Scope", "I-Scope", "I-Scope", "I-Scope", "I-Scope", "O", "B-Negation", "I-Negation", "O", "B-Scope", "I-Sc...	Able to give fully informed consent in writing Males or females aged >/= 50 years No significant disease or drug use Absence of any sign of dementia/cognitive impairment in neuropsychological examinationsPatients for brain imaging: Patient and designee capable of giving fully informed consent in writing Patient fu...	[ "Able", "to", "give", "fully", "informed", "consent", "in", "writing", "\n", "Males", "or", "females", "aged", ">", "/=", "50", "years", "\n", "No", "significant", "disease", "or", "drug", "use", "\n", "Absence", "of", "any", "sign", "of", "dementia", "/...	[ "Scope", "Procedure", "Condition", "Measurement", "Value", "Qualifier", "Negation", "Mood", "Person" ]
Males, females, aged, > /= 50 years, No, significant disease or drug use, Absence of, sign of dementia / cognitive impairment, fulfils DSM - IV and NINCDS - ADRA criteria, probable, Alzheimers disease	NCT01009359_inc_2	Sentence: Able to give fully informed consent in writing Males or females aged >/= 50 years No significant disease or drug use Absence of any sign of dementia/cognitive impairment in neuropsychological examinationsPatients for brain imaging: Patient and designee capable of giving fully informed consent in writing ...	[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Person", "O", "B-Person", "B-Person", "B-Value", "I-Value", "I-Value", "I-Value", "O", "B-Negation", "B-Scope", "I-Scope", "I-Scope", "I-Scope", "I-Scope", "O", "B-Negation", "I-Negation", "O", "B-Scope", "I-Sc...	Able to give fully informed consent in writing Males or females aged >/= 50 years No significant disease or drug use Absence of any sign of dementia/cognitive impairment in neuropsychological examinationsPatients for brain imaging: Patient and designee capable of giving fully informed consent in writing Patient fu...	[ "Able", "to", "give", "fully", "informed", "consent", "in", "writing", "\n", "Males", "or", "females", "aged", ">", "/=", "50", "years", "\n", "No", "significant", "disease", "or", "drug", "use", "\n", "Absence", "of", "any", "sign", "of", "dementia", "/...	[ "Scope", "Procedure", "Condition", "Measurement", "Value", "Qualifier", "Negation", "Mood", "Person" ]
beta - casein is a Protein, STAT5 is a Protein, beta - casein is a Protein, promoter is a Entity, STAT ( signal transducer and activator of transcription)5 is a Protein, STAT5 is a Protein, PRL is a Protein, beta - casein is a Protein, beta - casein is a Protein, STAT5 is a Protein, beta - casein is a Protein, beta - c...	865_0	Sentence: Transcriptional regulation of the beta-casein gene by cytokines: cross-talk between STAT5 and other signaling molecules. The beta-casein promoter has been widely used to monitor the activation of STAT (signal transducer and activator of transcription)5 since STAT5 was originally found as a mediator of PRL-in...	[ "O", "O", "O", "O", "B-Protein", "I-Protein", "I-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "I-Protein", "I-Protein", "B-Entity", "O", "O", "O", "O", "O", "O", "O", "O", "O", "...	Transcriptional regulation of the beta-casein gene by cytokines: cross-talk between STAT5 and other signaling molecules. The beta-casein promoter has been widely used to monitor the activation of STAT (signal transducer and activator of transcription)5 since STAT5 was originally found as a mediator of PRL-inducible be...	[ "Transcriptional", "regulation", "of", "the", "beta", "-", "casein", "gene", "by", "cytokines", ":", "cross", "-", "talk", "between", "STAT5", "and", "other", "signaling", "molecules", ".", "\n", "The", "beta", "-", "casein", "promoter", "has", "been", "wide...	[ "Protein", "Entity" ]
beta - casein is a Protein, STAT5 is a Protein, beta - casein is a Protein, promoter is a Entity, STAT ( signal transducer and activator of transcription)5 is a Protein, STAT5 is a Protein, PRL is a Protein, beta - casein is a Protein, beta - casein is a Protein, STAT5 is a Protein, beta - casein is a Protein, beta - c...	865_1	Sentence: Transcriptional regulation of the beta-casein gene by cytokines: cross-talk between STAT5 and other signaling molecules. The beta-casein promoter has been widely used to monitor the activation of STAT (signal transducer and activator of transcription)5 since STAT5 was originally found as a mediator of PRL-in...	[ "O", "O", "O", "O", "B-Protein", "I-Protein", "I-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "I-Protein", "I-Protein", "B-Entity", "O", "O", "O", "O", "O", "O", "O", "O", "O", "...	Transcriptional regulation of the beta-casein gene by cytokines: cross-talk between STAT5 and other signaling molecules. The beta-casein promoter has been widely used to monitor the activation of STAT (signal transducer and activator of transcription)5 since STAT5 was originally found as a mediator of PRL-inducible be...	[ "Transcriptional", "regulation", "of", "the", "beta", "-", "casein", "gene", "by", "cytokines", ":", "cross", "-", "talk", "between", "STAT5", "and", "other", "signaling", "molecules", ".", "\n", "The", "beta", "-", "casein", "promoter", "has", "been", "wide...	[ "Protein", "Entity" ]
beta - casein, STAT5, beta - casein, promoter, STAT ( signal transducer and activator of transcription)5, STAT5, PRL, beta - casein, beta - casein, STAT5, beta - casein, beta - casein, interleukin-2, IL-2, STAT5, IL-4, STAT5, beta - casein, cytokine - inducible SH2-containing protein, CIS, oncostatin M, OSM, STAT6, IL-...	865_2	Sentence: Transcriptional regulation of the beta-casein gene by cytokines: cross-talk between STAT5 and other signaling molecules. The beta-casein promoter has been widely used to monitor the activation of STAT (signal transducer and activator of transcription)5 since STAT5 was originally found as a mediator of PRL-in...	[ "O", "O", "O", "O", "B-Protein", "I-Protein", "I-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "I-Protein", "I-Protein", "B-Entity", "O", "O", "O", "O", "O", "O", "O", "O", "O", "...	Transcriptional regulation of the beta-casein gene by cytokines: cross-talk between STAT5 and other signaling molecules. The beta-casein promoter has been widely used to monitor the activation of STAT (signal transducer and activator of transcription)5 since STAT5 was originally found as a mediator of PRL-inducible be...	[ "Transcriptional", "regulation", "of", "the", "beta", "-", "casein", "gene", "by", "cytokines", ":", "cross", "-", "talk", "between", "STAT5", "and", "other", "signaling", "molecules", ".", "\n", "The", "beta", "-", "casein", "promoter", "has", "been", "wide...	[ "Protein", "Entity" ]
DDB1 is a Protein, Ubiquitin is a Protein	397_0	Sentence: Targeting protein ubiquitylation: DDB1 takes its RING off. Ubiquitin E3 ligases of the RING and HECT families are distinct not only in their catalytic mechanisms but also in targeting substrates. Now it seems that one heterodimeric complex can target substrates to both types of E3 ligase. Instru...	[ "O", "O", "O", "O", "B-Protein", "O", "O", "O", "O", "O", "O", "B-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", ...	Targeting protein ubiquitylation: DDB1 takes its RING off. Ubiquitin E3 ligases of the RING and HECT families are distinct not only in their catalytic mechanisms but also in targeting substrates. Now it seems that one heterodimeric complex can target substrates to both types of E3 ligase.	[ "Targeting", "protein", "ubiquitylation", ":", "DDB1", "takes", "its", "RING", "off", ".", "\n", "Ubiquitin", "E3", "ligases", "of", "the", "RING", "and", "HECT", "families", "are", "distinct", "not", "only", "in", "their", "catalytic", "mechanisms", "but", ...	[ "Protein" ]
DDB1 is a Protein, Ubiquitin is a Protein	397_1	Sentence: Targeting protein ubiquitylation: DDB1 takes its RING off. Ubiquitin E3 ligases of the RING and HECT families are distinct not only in their catalytic mechanisms but also in targeting substrates. Now it seems that one heterodimeric complex can target substrates to both types of E3 ligase. Instru...	[ "O", "O", "O", "O", "B-Protein", "O", "O", "O", "O", "O", "O", "B-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", ...	Targeting protein ubiquitylation: DDB1 takes its RING off. Ubiquitin E3 ligases of the RING and HECT families are distinct not only in their catalytic mechanisms but also in targeting substrates. Now it seems that one heterodimeric complex can target substrates to both types of E3 ligase.	[ "Targeting", "protein", "ubiquitylation", ":", "DDB1", "takes", "its", "RING", "off", ".", "\n", "Ubiquitin", "E3", "ligases", "of", "the", "RING", "and", "HECT", "families", "are", "distinct", "not", "only", "in", "their", "catalytic", "mechanisms", "but", ...	[ "Protein" ]
DDB1, Ubiquitin	397_2	Sentence: Targeting protein ubiquitylation: DDB1 takes its RING off. Ubiquitin E3 ligases of the RING and HECT families are distinct not only in their catalytic mechanisms but also in targeting substrates. Now it seems that one heterodimeric complex can target substrates to both types of E3 ligase. Instru...	[ "O", "O", "O", "O", "B-Protein", "O", "O", "O", "O", "O", "O", "B-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", ...	Targeting protein ubiquitylation: DDB1 takes its RING off. Ubiquitin E3 ligases of the RING and HECT families are distinct not only in their catalytic mechanisms but also in targeting substrates. Now it seems that one heterodimeric complex can target substrates to both types of E3 ligase.	[ "Targeting", "protein", "ubiquitylation", ":", "DDB1", "takes", "its", "RING", "off", ".", "\n", "Ubiquitin", "E3", "ligases", "of", "the", "RING", "and", "HECT", "families", "are", "distinct", "not", "only", "in", "their", "catalytic", "mechanisms", "but", ...	[ "Protein" ]
exercises is an umlsterm, sports is an umlsterm, physical therapy is an umlsterm, manual is an umlsterm, therapy is an umlsterm, standard is an umlsterm, treatment is an umlsterm, program is an umlsterm, techniques is an umlsterm, therapy is an umlsterm, choice is an umlsterm, treatment is an umlsterm, muscle is an uml...	DerOrthopaede.70260981.eng.abstr_0	Sentence: Static stretching exercises have become very popular over the past fifteen years both in professional and amateur sports . In the fields of physical therapy and in manual therapy , in particular , static stretching has become part of a standard and successful treatment modality . Together with an appropriate ...	[ "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "B-umlsterm", "I-umlsterm", "O", "O", "B-umlsterm", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O"...	Static stretching exercises have become very popular over the past fifteen years both in professional and amateur sports . In the fields of physical therapy and in manual therapy , in particular , static stretching has become part of a standard and successful treatment modality . Together with an appropriate strengthen...	[ "Static", "stretching", "exercises", "have", "become", "very", "popular", "over", "the", "past", "fifteen", "years", "both", "in", "professional", "and", "amateur", "sports", ".", "In", "the", "fields", "of", "physical", "therapy", "and", "in", "manual", "ther...	[ "umlsterm" ]
exercises is an umlsterm, sports is an umlsterm, physical therapy is an umlsterm, manual is an umlsterm, therapy is an umlsterm, standard is an umlsterm, treatment is an umlsterm, program is an umlsterm, techniques is an umlsterm, therapy is an umlsterm, choice is an umlsterm, treatment is an umlsterm, muscle is an uml...	DerOrthopaede.70260981.eng.abstr_1	Sentence: Static stretching exercises have become very popular over the past fifteen years both in professional and amateur sports . In the fields of physical therapy and in manual therapy , in particular , static stretching has become part of a standard and successful treatment modality . Together with an appropriate ...	[ "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "B-umlsterm", "I-umlsterm", "O", "O", "B-umlsterm", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O"...	Static stretching exercises have become very popular over the past fifteen years both in professional and amateur sports . In the fields of physical therapy and in manual therapy , in particular , static stretching has become part of a standard and successful treatment modality . Together with an appropriate strengthen...	[ "Static", "stretching", "exercises", "have", "become", "very", "popular", "over", "the", "past", "fifteen", "years", "both", "in", "professional", "and", "amateur", "sports", ".", "In", "the", "fields", "of", "physical", "therapy", "and", "in", "manual", "ther...	[ "umlsterm" ]
exercises, sports, physical therapy, manual, therapy, standard, treatment, program, techniques, therapy, choice, treatment, muscle, musculoskeletal system, muscle, testing, procedures, muscle, muscle, techniques, techniques, exercises, methods, exercise, program, muscle	DerOrthopaede.70260981.eng.abstr_2	Sentence: Static stretching exercises have become very popular over the past fifteen years both in professional and amateur sports . In the fields of physical therapy and in manual therapy , in particular , static stretching has become part of a standard and successful treatment modality . Together with an appropriate ...	[ "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "B-umlsterm", "I-umlsterm", "O", "O", "B-umlsterm", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O"...	Static stretching exercises have become very popular over the past fifteen years both in professional and amateur sports . In the fields of physical therapy and in manual therapy , in particular , static stretching has become part of a standard and successful treatment modality . Together with an appropriate strengthen...	[ "Static", "stretching", "exercises", "have", "become", "very", "popular", "over", "the", "past", "fifteen", "years", "both", "in", "professional", "and", "amateur", "sports", ".", "In", "the", "fields", "of", "physical", "therapy", "and", "in", "manual", "ther...	[ "umlsterm" ]
staurosporine is a compound, 1,25-dihydroxy vitamin D is a compound, VDR is a protein, VDR is a protein	DS.d1450_0	Sentence: In the LNCaP prostate cancer cell line, induction of apoptosis and caspase-3/7 activities by staurosporine (STS) abolished ((3)H) 1,25-dihydroxy vitamin D (3) binding and VDR protein, suggesting that the VDR may be targeted for inactivation by caspases during apoptosis. Instructions: please extrac...	[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-compound", "O", "O", "O", "O", "O", "O", "O", "O", "B-compound", "I-compound", "I-compound", "O", "O", "O", "O", "O", "B-protein", "O", "O", "O", "O", "O", "B-pro...	In the LNCaP prostate cancer cell line, induction of apoptosis and caspase-3/7 activities by staurosporine (STS) abolished ((3)H) 1,25-dihydroxy vitamin D (3) binding and VDR protein, suggesting that the VDR may be targeted for inactivation by caspases during apoptosis.	[ "In", "the", "LNCaP", "prostate", "cancer", "cell", "line", ",", "induction", "of", "apoptosis", "and", "caspase-3/7", "activities", "by", "staurosporine", "(", "STS", ")", "abolished", "(", "(", "3)H", ")", "1,25-dihydroxy", "vitamin", "D", "(", "3", ")", ...	[ "compound", "protein" ]
staurosporine is a compound, 1,25-dihydroxy vitamin D is a compound, VDR is a protein, VDR is a protein	DS.d1450_1	Sentence: In the LNCaP prostate cancer cell line, induction of apoptosis and caspase-3/7 activities by staurosporine (STS) abolished ((3)H) 1,25-dihydroxy vitamin D (3) binding and VDR protein, suggesting that the VDR may be targeted for inactivation by caspases during apoptosis. Instructions: please typing...	[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-compound", "O", "O", "O", "O", "O", "O", "O", "O", "B-compound", "I-compound", "I-compound", "O", "O", "O", "O", "O", "B-protein", "O", "O", "O", "O", "O", "B-pro...	In the LNCaP prostate cancer cell line, induction of apoptosis and caspase-3/7 activities by staurosporine (STS) abolished ((3)H) 1,25-dihydroxy vitamin D (3) binding and VDR protein, suggesting that the VDR may be targeted for inactivation by caspases during apoptosis.	[ "In", "the", "LNCaP", "prostate", "cancer", "cell", "line", ",", "induction", "of", "apoptosis", "and", "caspase-3/7", "activities", "by", "staurosporine", "(", "STS", ")", "abolished", "(", "(", "3)H", ")", "1,25-dihydroxy", "vitamin", "D", "(", "3", ")", ...	[ "compound", "protein" ]
staurosporine, 1,25-dihydroxy vitamin D, VDR, VDR	DS.d1450_2	Sentence: In the LNCaP prostate cancer cell line, induction of apoptosis and caspase-3/7 activities by staurosporine (STS) abolished ((3)H) 1,25-dihydroxy vitamin D (3) binding and VDR protein, suggesting that the VDR may be targeted for inactivation by caspases during apoptosis. Instructions: please extrac...	[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-compound", "O", "O", "O", "O", "O", "O", "O", "O", "B-compound", "I-compound", "I-compound", "O", "O", "O", "O", "O", "B-protein", "O", "O", "O", "O", "O", "B-pro...	In the LNCaP prostate cancer cell line, induction of apoptosis and caspase-3/7 activities by staurosporine (STS) abolished ((3)H) 1,25-dihydroxy vitamin D (3) binding and VDR protein, suggesting that the VDR may be targeted for inactivation by caspases during apoptosis.	[ "In", "the", "LNCaP", "prostate", "cancer", "cell", "line", ",", "induction", "of", "apoptosis", "and", "caspase-3/7", "activities", "by", "staurosporine", "(", "STS", ")", "abolished", "(", "(", "3)H", ")", "1,25-dihydroxy", "vitamin", "D", "(", "3", ")", ...	[ "compound", "protein" ]
Laparoscopic cholecystectomy is an umlsterm, patients is an umlsterm, haemodynamic is an umlsterm, June is an umlsterm, cholecystectomies is an umlsterm, patients is an umlsterm, ASA is an umlsterm, cholecystectomies is an umlsterm, patients is an umlsterm, risk is an umlsterm, ASA is an umlsterm, patients is an umlste...	DerChirurg.80690061.eng.abstr_0	Sentence: Laparoscopic cholecystectomy offers many advantages , but cardiopulmonary impaired patients may be endangered by the haemodynamic and respiratory effects of the pneumoperitoneum . Between June 1990 and December 1995 , laparoscopic cholecystectomies were performed on 19 high-risk patients ( ASA IV ) and conven...	[ "B-umlsterm", "I-umlsterm", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O"...	Laparoscopic cholecystectomy offers many advantages , but cardiopulmonary impaired patients may be endangered by the haemodynamic and respiratory effects of the pneumoperitoneum . Between June 1990 and December 1995 , laparoscopic cholecystectomies were performed on 19 high-risk patients ( ASA IV ) and conventional cho...	[ "Laparoscopic", "cholecystectomy", "offers", "many", "advantages", ",", "but", "cardiopulmonary", "impaired", "patients", "may", "be", "endangered", "by", "the", "haemodynamic", "and", "respiratory", "effects", "of", "the", "pneumoperitoneum", ".", "Between", "June", ...	[ "umlsterm" ]
Laparoscopic cholecystectomy is an umlsterm, patients is an umlsterm, haemodynamic is an umlsterm, June is an umlsterm, cholecystectomies is an umlsterm, patients is an umlsterm, ASA is an umlsterm, cholecystectomies is an umlsterm, patients is an umlsterm, risk is an umlsterm, ASA is an umlsterm, patients is an umlste...	DerChirurg.80690061.eng.abstr_1	Sentence: Laparoscopic cholecystectomy offers many advantages , but cardiopulmonary impaired patients may be endangered by the haemodynamic and respiratory effects of the pneumoperitoneum . Between June 1990 and December 1995 , laparoscopic cholecystectomies were performed on 19 high-risk patients ( ASA IV ) and conven...	[ "B-umlsterm", "I-umlsterm", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O"...	Laparoscopic cholecystectomy offers many advantages , but cardiopulmonary impaired patients may be endangered by the haemodynamic and respiratory effects of the pneumoperitoneum . Between June 1990 and December 1995 , laparoscopic cholecystectomies were performed on 19 high-risk patients ( ASA IV ) and conventional cho...	[ "Laparoscopic", "cholecystectomy", "offers", "many", "advantages", ",", "but", "cardiopulmonary", "impaired", "patients", "may", "be", "endangered", "by", "the", "haemodynamic", "and", "respiratory", "effects", "of", "the", "pneumoperitoneum", ".", "Between", "June", ...	[ "umlsterm" ]
Laparoscopic cholecystectomy, patients, haemodynamic, June, cholecystectomies, patients, ASA, cholecystectomies, patients, risk, ASA, patients, complications, cholecystectomy, open, laparotomy, postoperative complications, patients, cholcystectomy, hospital, open, cholecystectomy, laparotomy, laparoscopy, classificatio...	DerChirurg.80690061.eng.abstr_2	Sentence: Laparoscopic cholecystectomy offers many advantages , but cardiopulmonary impaired patients may be endangered by the haemodynamic and respiratory effects of the pneumoperitoneum . Between June 1990 and December 1995 , laparoscopic cholecystectomies were performed on 19 high-risk patients ( ASA IV ) and conven...	[ "B-umlsterm", "I-umlsterm", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O"...	Laparoscopic cholecystectomy offers many advantages , but cardiopulmonary impaired patients may be endangered by the haemodynamic and respiratory effects of the pneumoperitoneum . Between June 1990 and December 1995 , laparoscopic cholecystectomies were performed on 19 high-risk patients ( ASA IV ) and conventional cho...	[ "Laparoscopic", "cholecystectomy", "offers", "many", "advantages", ",", "but", "cardiopulmonary", "impaired", "patients", "may", "be", "endangered", "by", "the", "haemodynamic", "and", "respiratory", "effects", "of", "the", "pneumoperitoneum", ".", "Between", "June", ...	[ "umlsterm" ]
Hospital is an umlsterm	DerOpthalmologe.80950820.eng.abstr_0	Sentence: In the years from 1995 to 1997 in the eyeclinic of Darmstadt and the eyeclinic of the St. Josef Hospital Hagen 261 dacryoendoscopies were done in a bicentrical study . Instructions: please extract entities and their types from the input sentence, all entity types are in options Options...	[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ]	In the years from 1995 to 1997 in the eyeclinic of Darmstadt and the eyeclinic of the St. Josef Hospital Hagen 261 dacryoendoscopies were done in a bicentrical study .	[ "In", "the", "years", "from", "1995", "to", "1997", "in", "the", "eyeclinic", "of", "Darmstadt", "and", "the", "eyeclinic", "of", "the", "St", ".", "Josef", "Hospital", "Hagen", "261", "dacryoendoscopies", "were", "done", "in", "a", "bicentrical", "study", ...	[ "umlsterm" ]
Hospital is an umlsterm	DerOpthalmologe.80950820.eng.abstr_1	Sentence: In the years from 1995 to 1997 in the eyeclinic of Darmstadt and the eyeclinic of the St. Josef Hospital Hagen 261 dacryoendoscopies were done in a bicentrical study . Instructions: please typing these entity words according to sentence: Hospital Options: umlsterm	[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ]	In the years from 1995 to 1997 in the eyeclinic of Darmstadt and the eyeclinic of the St. Josef Hospital Hagen 261 dacryoendoscopies were done in a bicentrical study .	[ "In", "the", "years", "from", "1995", "to", "1997", "in", "the", "eyeclinic", "of", "Darmstadt", "and", "the", "eyeclinic", "of", "the", "St", ".", "Josef", "Hospital", "Hagen", "261", "dacryoendoscopies", "were", "done", "in", "a", "bicentrical", "study", ...	[ "umlsterm" ]
Hospital	DerOpthalmologe.80950820.eng.abstr_2	Sentence: In the years from 1995 to 1997 in the eyeclinic of Darmstadt and the eyeclinic of the St. Josef Hospital Hagen 261 dacryoendoscopies were done in a bicentrical study . Instructions: please extract entity words from the input sentence	[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ]	In the years from 1995 to 1997 in the eyeclinic of Darmstadt and the eyeclinic of the St. Josef Hospital Hagen 261 dacryoendoscopies were done in a bicentrical study .	[ "In", "the", "years", "from", "1995", "to", "1997", "in", "the", "eyeclinic", "of", "Darmstadt", "and", "the", "eyeclinic", "of", "the", "St", ".", "Josef", "Hospital", "Hagen", "261", "dacryoendoscopies", "were", "done", "in", "a", "bicentrical", "study", ...	[ "umlsterm" ]
Angiitis is an umlsterm, Mann is an umlsterm, Lungenoberlappen is an umlsterm, Thymus is an umlsterm, Perikard is an umlsterm, Thymuskarzinom is an umlsterm, Thymus is an umlsterm, Lungenoberlappens is an umlsterm, Lymphknoten is an umlsterm, Diagnose is an umlsterm, Angiitis is an umlsterm, Differentialdiagnostik is a...	ZfuerHerzThoraxGefaesschirurgie.90130083.ger.abstr_0	Sentence: In der vorliegenden Kasuistik wird ueber eine ausgedehnte mediastinale Raumforderung berichtet , als deren Ursache sich eine allergische Granulomatose mit Angiitis ( Churg-Strauss ) herausstellte . Ein 24-jaehriger Mann wurde wegen einer grossen mediastinalen Raumforderung mit Infiltration von Mittellappen , ...	[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O",...	In der vorliegenden Kasuistik wird ueber eine ausgedehnte mediastinale Raumforderung berichtet , als deren Ursache sich eine allergische Granulomatose mit Angiitis ( Churg-Strauss ) herausstellte . Ein 24-jaehriger Mann wurde wegen einer grossen mediastinalen Raumforderung mit Infiltration von Mittellappen , rechtem Lu...	[ "In", "der", "vorliegenden", "Kasuistik", "wird", "ueber", "eine", "ausgedehnte", "mediastinale", "Raumforderung", "berichtet", ",", "als", "deren", "Ursache", "sich", "eine", "allergische", "Granulomatose", "mit", "Angiitis", "(", "Churg", "-", "Strauss", ")", "h...	[ "umlsterm" ]
Angiitis is an umlsterm, Mann is an umlsterm, Lungenoberlappen is an umlsterm, Thymus is an umlsterm, Perikard is an umlsterm, Thymuskarzinom is an umlsterm, Thymus is an umlsterm, Lungenoberlappens is an umlsterm, Lymphknoten is an umlsterm, Diagnose is an umlsterm, Angiitis is an umlsterm, Differentialdiagnostik is a...	ZfuerHerzThoraxGefaesschirurgie.90130083.ger.abstr_1	Sentence: In der vorliegenden Kasuistik wird ueber eine ausgedehnte mediastinale Raumforderung berichtet , als deren Ursache sich eine allergische Granulomatose mit Angiitis ( Churg-Strauss ) herausstellte . Ein 24-jaehriger Mann wurde wegen einer grossen mediastinalen Raumforderung mit Infiltration von Mittellappen , ...	[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O",...	In der vorliegenden Kasuistik wird ueber eine ausgedehnte mediastinale Raumforderung berichtet , als deren Ursache sich eine allergische Granulomatose mit Angiitis ( Churg-Strauss ) herausstellte . Ein 24-jaehriger Mann wurde wegen einer grossen mediastinalen Raumforderung mit Infiltration von Mittellappen , rechtem Lu...	[ "In", "der", "vorliegenden", "Kasuistik", "wird", "ueber", "eine", "ausgedehnte", "mediastinale", "Raumforderung", "berichtet", ",", "als", "deren", "Ursache", "sich", "eine", "allergische", "Granulomatose", "mit", "Angiitis", "(", "Churg", "-", "Strauss", ")", "h...	[ "umlsterm" ]
Angiitis, Mann, Lungenoberlappen, Thymus, Perikard, Thymuskarzinom, Thymus, Lungenoberlappens, Lymphknoten, Diagnose, Angiitis, Differentialdiagnostik, Churg - Strauss - Syndrom, Differentialdiagnose, Spezifitaet	ZfuerHerzThoraxGefaesschirurgie.90130083.ger.abstr_2	Sentence: In der vorliegenden Kasuistik wird ueber eine ausgedehnte mediastinale Raumforderung berichtet , als deren Ursache sich eine allergische Granulomatose mit Angiitis ( Churg-Strauss ) herausstellte . Ein 24-jaehriger Mann wurde wegen einer grossen mediastinalen Raumforderung mit Infiltration von Mittellappen , ...	[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O",...	In der vorliegenden Kasuistik wird ueber eine ausgedehnte mediastinale Raumforderung berichtet , als deren Ursache sich eine allergische Granulomatose mit Angiitis ( Churg-Strauss ) herausstellte . Ein 24-jaehriger Mann wurde wegen einer grossen mediastinalen Raumforderung mit Infiltration von Mittellappen , rechtem Lu...	[ "In", "der", "vorliegenden", "Kasuistik", "wird", "ueber", "eine", "ausgedehnte", "mediastinale", "Raumforderung", "berichtet", ",", "als", "deren", "Ursache", "sich", "eine", "allergische", "Granulomatose", "mit", "Angiitis", "(", "Churg", "-", "Strauss", ")", "h...	[ "umlsterm" ]
Folic acid - based intervention is a Intervention_Pharmacological, non - ST elevation acute coronary syndromes . is a Participant_Condition, vitamins B ( 6 ) and B ( 12 ) is a Intervention_Pharmacological, homocysteine levels is a Outcome_Physical, placebo - controlled is a Intervention_Control, folic acid - based supp...	40611_0	Sentence: Folic acid-based intervention in non-ST elevation acute coronary syndromes . Homocysteinemia is a risk factor for cardiovascular diseases . Folic acid combined with vitamins B ( 6 ) and B ( 12 ) is effective in lowering homocysteine levels . This randomized placebo-controlled study was designed to determine t...	[ "B-Intervention_Pharmacological", "I-Intervention_Pharmacological", "I-Intervention_Pharmacological", "I-Intervention_Pharmacological", "I-Intervention_Pharmacological", "O", "B-Participant_Condition", "I-Participant_Condition", "I-Participant_Condition", "I-Participant_Condition", "I-Participan...	Folic acid-based intervention in non-ST elevation acute coronary syndromes . Homocysteinemia is a risk factor for cardiovascular diseases . Folic acid combined with vitamins B ( 6 ) and B ( 12 ) is effective in lowering homocysteine levels . This randomized placebo-controlled study was designed to determine the effect ...	[ "Folic", "acid", "-", "based", "intervention", "in", "non", "-", "ST", "elevation", "acute", "coronary", "syndromes", ".", "Homocysteinemia", "is", "a", "risk", "factor", "for", "cardiovascular", "diseases", ".", "Folic", "acid", "combined", "with", "vitamins", ...	[ "Participant_Condition", "Outcome_Physical", "Intervention_Pharmacological", "Outcome_Other", "Intervention_Control", "Outcome_Mortality" ]
Folic acid - based intervention is a Intervention_Pharmacological, non - ST elevation acute coronary syndromes . is a Participant_Condition, vitamins B ( 6 ) and B ( 12 ) is a Intervention_Pharmacological, homocysteine levels is a Outcome_Physical, placebo - controlled is a Intervention_Control, folic acid - based supp...	40611_1	Sentence: Folic acid-based intervention in non-ST elevation acute coronary syndromes . Homocysteinemia is a risk factor for cardiovascular diseases . Folic acid combined with vitamins B ( 6 ) and B ( 12 ) is effective in lowering homocysteine levels . This randomized placebo-controlled study was designed to determine t...	[ "B-Intervention_Pharmacological", "I-Intervention_Pharmacological", "I-Intervention_Pharmacological", "I-Intervention_Pharmacological", "I-Intervention_Pharmacological", "O", "B-Participant_Condition", "I-Participant_Condition", "I-Participant_Condition", "I-Participant_Condition", "I-Participan...	Folic acid-based intervention in non-ST elevation acute coronary syndromes . Homocysteinemia is a risk factor for cardiovascular diseases . Folic acid combined with vitamins B ( 6 ) and B ( 12 ) is effective in lowering homocysteine levels . This randomized placebo-controlled study was designed to determine the effect ...	[ "Folic", "acid", "-", "based", "intervention", "in", "non", "-", "ST", "elevation", "acute", "coronary", "syndromes", ".", "Homocysteinemia", "is", "a", "risk", "factor", "for", "cardiovascular", "diseases", ".", "Folic", "acid", "combined", "with", "vitamins", ...	[ "Participant_Condition", "Outcome_Physical", "Intervention_Pharmacological", "Outcome_Other", "Intervention_Control", "Outcome_Mortality" ]
Folic acid - based intervention, non - ST elevation acute coronary syndromes ., vitamins B ( 6 ) and B ( 12 ), homocysteine levels, placebo - controlled, folic acid - based supplement, folate, placebo group, vitamin B ( 12 ), vitamin B ( 6 ), Clinical outcomes, death, nonfatal acute coronary syndrome, serious re - hosp...	40611_2	Sentence: Folic acid-based intervention in non-ST elevation acute coronary syndromes . Homocysteinemia is a risk factor for cardiovascular diseases . Folic acid combined with vitamins B ( 6 ) and B ( 12 ) is effective in lowering homocysteine levels . This randomized placebo-controlled study was designed to determine t...	[ "B-Intervention_Pharmacological", "I-Intervention_Pharmacological", "I-Intervention_Pharmacological", "I-Intervention_Pharmacological", "I-Intervention_Pharmacological", "O", "B-Participant_Condition", "I-Participant_Condition", "I-Participant_Condition", "I-Participant_Condition", "I-Participan...	Folic acid-based intervention in non-ST elevation acute coronary syndromes . Homocysteinemia is a risk factor for cardiovascular diseases . Folic acid combined with vitamins B ( 6 ) and B ( 12 ) is effective in lowering homocysteine levels . This randomized placebo-controlled study was designed to determine the effect ...	[ "Folic", "acid", "-", "based", "intervention", "in", "non", "-", "ST", "elevation", "acute", "coronary", "syndromes", ".", "Homocysteinemia", "is", "a", "risk", "factor", "for", "cardiovascular", "diseases", ".", "Folic", "acid", "combined", "with", "vitamins", ...	[ "Participant_Condition", "Outcome_Physical", "Intervention_Pharmacological", "Outcome_Other", "Intervention_Control", "Outcome_Mortality" ]
Sp1 site is a DNA, p53 is a protein, p53 is a protein, p53 is a protein, Sp1 mutant probe is an experimental-construct	1.0alpha7.train.1170_0	Sentence: Although mutation of the Sp1 site did not block p53 binding, it affected p53 binding in a significant manner, ranging from 50% to 25% of p53 bound to the Sp1 mutant probe relative to the native probe ( Fig. 1 E, lane 3). Instructions: please extract entities and their types from the inp...	[ "O", "O", "O", "O", "O", "O", "B-DNA", "I-DNA", "O", "O", "O", "O", "B-protein", "O", "O", "O", "O", "O", "B-protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-protein", "O", "O", "O",...	Although mutation of the Sp1 site did not block p53 binding, it affected p53 binding in a significant manner, ranging from 50% to 25% of p53 bound to the Sp1 mutant probe relative to the native probe ( Fig. 1 E, lane 3).	[ "Although", "mutation", " ", "of", "the", " ", "Sp1", "site", "did", "not", "block", " ", "p53", "binding", ",", "it", "affected", " ", "p53", "binding", "in", "a", " ", "significant", "manner", ",", "ranging", "from", "50", "%", " ", "to", "25", "%"...	[ "experimental-construct", "DNA", "protein" ]
Sp1 site is a DNA, p53 is a protein, p53 is a protein, p53 is a protein, Sp1 mutant probe is an experimental-construct	1.0alpha7.train.1170_1	Sentence: Although mutation of the Sp1 site did not block p53 binding, it affected p53 binding in a significant manner, ranging from 50% to 25% of p53 bound to the Sp1 mutant probe relative to the native probe ( Fig. 1 E, lane 3). Instructions: please typing these entity words according to senten...	[ "O", "O", "O", "O", "O", "O", "B-DNA", "I-DNA", "O", "O", "O", "O", "B-protein", "O", "O", "O", "O", "O", "B-protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-protein", "O", "O", "O",...	Although mutation of the Sp1 site did not block p53 binding, it affected p53 binding in a significant manner, ranging from 50% to 25% of p53 bound to the Sp1 mutant probe relative to the native probe ( Fig. 1 E, lane 3).	[ "Although", "mutation", " ", "of", "the", " ", "Sp1", "site", "did", "not", "block", " ", "p53", "binding", ",", "it", "affected", " ", "p53", "binding", "in", "a", " ", "significant", "manner", ",", "ranging", "from", "50", "%", " ", "to", "25", "%"...	[ "experimental-construct", "DNA", "protein" ]
Sp1 site, p53, p53, p53, Sp1 mutant probe	1.0alpha7.train.1170_2	Sentence: Although mutation of the Sp1 site did not block p53 binding, it affected p53 binding in a significant manner, ranging from 50% to 25% of p53 bound to the Sp1 mutant probe relative to the native probe ( Fig. 1 E, lane 3). Instructions: please extract entity words from the input sentence ...	[ "O", "O", "O", "O", "O", "O", "B-DNA", "I-DNA", "O", "O", "O", "O", "B-protein", "O", "O", "O", "O", "O", "B-protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-protein", "O", "O", "O",...	Although mutation of the Sp1 site did not block p53 binding, it affected p53 binding in a significant manner, ranging from 50% to 25% of p53 bound to the Sp1 mutant probe relative to the native probe ( Fig. 1 E, lane 3).	[ "Although", "mutation", " ", "of", "the", " ", "Sp1", "site", "did", "not", "block", " ", "p53", "binding", ",", "it", "affected", " ", "p53", "binding", "in", "a", " ", "significant", "manner", ",", "ranging", "from", "50", "%", " ", "to", "25", "%"...	[ "experimental-construct", "DNA", "protein" ]
perfusion is an umlsterm, shock is an umlsterm, mucosa is an umlsterm, oxygen is an umlsterm, vessels is an umlsterm, mucosa is an umlsterm, tip is an umlsterm, risk is an umlsterm, ischemia is an umlsterm, dysfunction is an umlsterm, bacteria is an umlsterm, toxins is an umlsterm, leukocytes is an umlsterm, cytokine i...	DerAnaesthesist.00490446.eng.abstr_0	Sentence: The splanchnic perfusion is reduced early in the course of any shock . The mucosa of the gut suffers most as it experiences a high oxygen demand even in the steady state . The specific arrangement of the micro vessels within the villus of the mucosa exposes the tip of the villus at the highest risk for ischem...	[ "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umls...	The splanchnic perfusion is reduced early in the course of any shock . The mucosa of the gut suffers most as it experiences a high oxygen demand even in the steady state . The specific arrangement of the micro vessels within the villus of the mucosa exposes the tip of the villus at the highest risk for ischemia , parti...	[ "The", "splanchnic", "perfusion", "is", "reduced", "early", "in", "the", "course", "of", "any", "shock", ".", "The", "mucosa", "of", "the", "gut", "suffers", "most", "as", "it", "experiences", "a", "high", "oxygen", "demand", "even", "in", "the", "steady",...	[ "umlsterm" ]
perfusion is an umlsterm, shock is an umlsterm, mucosa is an umlsterm, oxygen is an umlsterm, vessels is an umlsterm, mucosa is an umlsterm, tip is an umlsterm, risk is an umlsterm, ischemia is an umlsterm, dysfunction is an umlsterm, bacteria is an umlsterm, toxins is an umlsterm, leukocytes is an umlsterm, cytokine i...	DerAnaesthesist.00490446.eng.abstr_1	Sentence: The splanchnic perfusion is reduced early in the course of any shock . The mucosa of the gut suffers most as it experiences a high oxygen demand even in the steady state . The specific arrangement of the micro vessels within the villus of the mucosa exposes the tip of the villus at the highest risk for ischem...	[ "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umls...	The splanchnic perfusion is reduced early in the course of any shock . The mucosa of the gut suffers most as it experiences a high oxygen demand even in the steady state . The specific arrangement of the micro vessels within the villus of the mucosa exposes the tip of the villus at the highest risk for ischemia , parti...	[ "The", "splanchnic", "perfusion", "is", "reduced", "early", "in", "the", "course", "of", "any", "shock", ".", "The", "mucosa", "of", "the", "gut", "suffers", "most", "as", "it", "experiences", "a", "high", "oxygen", "demand", "even", "in", "the", "steady",...	[ "umlsterm" ]
perfusion, shock, mucosa, oxygen, vessels, mucosa, tip, risk, ischemia, dysfunction, bacteria, toxins, leukocytes, cytokine, syndrome, role, shock, dysfunction	DerAnaesthesist.00490446.eng.abstr_2	Sentence: The splanchnic perfusion is reduced early in the course of any shock . The mucosa of the gut suffers most as it experiences a high oxygen demand even in the steady state . The specific arrangement of the micro vessels within the villus of the mucosa exposes the tip of the villus at the highest risk for ischem...	[ "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umls...	The splanchnic perfusion is reduced early in the course of any shock . The mucosa of the gut suffers most as it experiences a high oxygen demand even in the steady state . The specific arrangement of the micro vessels within the villus of the mucosa exposes the tip of the villus at the highest risk for ischemia , parti...	[ "The", "splanchnic", "perfusion", "is", "reduced", "early", "in", "the", "course", "of", "any", "shock", ".", "The", "mucosa", "of", "the", "gut", "suffers", "most", "as", "it", "experiences", "a", "high", "oxygen", "demand", "even", "in", "the", "steady",...	[ "umlsterm" ]
HCC70 is a cellline	2778_0	Sentence: C Correlation plot between Cisplatin IC50 (half maximal inhibitory concentration) and H2AX protein level defined by western blots in BC cell lines (MCF7, BT474, MDA361, SKBr3, MDA453, MDA231, HCC70). Correlation coefficients σ and P-value are based on Spearman's rank correlation test. Instructions...	[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-cellline", "O", "O", "O", "O", "O", "O", ...	C Correlation plot between Cisplatin IC50 (half maximal inhibitory concentration) and H2AX protein level defined by western blots in BC cell lines (MCF7, BT474, MDA361, SKBr3, MDA453, MDA231, HCC70). Correlation coefficients σ and P-value are based on Spearman's rank correlation test.	[ "C", "Correlation", "plot", "between", "Cisplatin", "IC50", "(", "half", "maximal", "inhibitory", "concentration", ")", "and", "H2AX", "protein", "level", "defined", "by", "western", "blots", "in", "BC", "cell", "lines", "(", "MCF7", ",", "BT474", ",", "MDA3...	[ "cellline" ]
HCC70 is a cellline	2778_1	Sentence: C Correlation plot between Cisplatin IC50 (half maximal inhibitory concentration) and H2AX protein level defined by western blots in BC cell lines (MCF7, BT474, MDA361, SKBr3, MDA453, MDA231, HCC70). Correlation coefficients σ and P-value are based on Spearman's rank correlation test. Instructions...	[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-cellline", "O", "O", "O", "O", "O", "O", ...	C Correlation plot between Cisplatin IC50 (half maximal inhibitory concentration) and H2AX protein level defined by western blots in BC cell lines (MCF7, BT474, MDA361, SKBr3, MDA453, MDA231, HCC70). Correlation coefficients σ and P-value are based on Spearman's rank correlation test.	[ "C", "Correlation", "plot", "between", "Cisplatin", "IC50", "(", "half", "maximal", "inhibitory", "concentration", ")", "and", "H2AX", "protein", "level", "defined", "by", "western", "blots", "in", "BC", "cell", "lines", "(", "MCF7", ",", "BT474", ",", "MDA3...	[ "cellline" ]
HCC70	2778_2	Sentence: C Correlation plot between Cisplatin IC50 (half maximal inhibitory concentration) and H2AX protein level defined by western blots in BC cell lines (MCF7, BT474, MDA361, SKBr3, MDA453, MDA231, HCC70). Correlation coefficients σ and P-value are based on Spearman's rank correlation test. Instructions...	[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-cellline", "O", "O", "O", "O", "O", "O", ...	C Correlation plot between Cisplatin IC50 (half maximal inhibitory concentration) and H2AX protein level defined by western blots in BC cell lines (MCF7, BT474, MDA361, SKBr3, MDA453, MDA231, HCC70). Correlation coefficients σ and P-value are based on Spearman's rank correlation test.	[ "C", "Correlation", "plot", "between", "Cisplatin", "IC50", "(", "half", "maximal", "inhibitory", "concentration", ")", "and", "H2AX", "protein", "level", "defined", "by", "western", "blots", "in", "BC", "cell", "lines", "(", "MCF7", ",", "BT474", ",", "MDA3...	[ "cellline" ]
ROCK is a protein	10326_0	Sentence: (d) ROCK activity is increased upon starvation. Cell lines (HeLa and EJ) grown in control (+Glu) or starved with HBSS for 1 and 3 h were lysed, extracts normalized and ROCK kinase activity was measured by performing enzyme-linked immunosorbent assay. Graphs represent ROCK activity in starved cells plotted as ...	[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "...	(d) ROCK activity is increased upon starvation. Cell lines (HeLa and EJ) grown in control (+Glu) or starved with HBSS for 1 and 3 h were lysed, extracts normalized and ROCK kinase activity was measured by performing enzyme-linked immunosorbent assay. Graphs represent ROCK activity in starved cells plotted as percent of...	[ "(", "d", ")", "ROCK", "activity", "is", "increased", "upon", "starvation", ".", "Cell", "lines", "(", "HeLa", "and", "EJ", ")", "grown", "in", "control", "(", "+", "Glu", ")", "or", "starved", "with", "HBSS", "for", "1", "and", "3", "h", "were", "...	[ "protein" ]
ROCK is a protein	10326_1	Sentence: (d) ROCK activity is increased upon starvation. Cell lines (HeLa and EJ) grown in control (+Glu) or starved with HBSS for 1 and 3 h were lysed, extracts normalized and ROCK kinase activity was measured by performing enzyme-linked immunosorbent assay. Graphs represent ROCK activity in starved cells plotted as ...	[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "...	(d) ROCK activity is increased upon starvation. Cell lines (HeLa and EJ) grown in control (+Glu) or starved with HBSS for 1 and 3 h were lysed, extracts normalized and ROCK kinase activity was measured by performing enzyme-linked immunosorbent assay. Graphs represent ROCK activity in starved cells plotted as percent of...	[ "(", "d", ")", "ROCK", "activity", "is", "increased", "upon", "starvation", ".", "Cell", "lines", "(", "HeLa", "and", "EJ", ")", "grown", "in", "control", "(", "+", "Glu", ")", "or", "starved", "with", "HBSS", "for", "1", "and", "3", "h", "were", "...	[ "protein" ]
ROCK	10326_2	Sentence: (d) ROCK activity is increased upon starvation. Cell lines (HeLa and EJ) grown in control (+Glu) or starved with HBSS for 1 and 3 h were lysed, extracts normalized and ROCK kinase activity was measured by performing enzyme-linked immunosorbent assay. Graphs represent ROCK activity in starved cells plotted as ...	[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "...	(d) ROCK activity is increased upon starvation. Cell lines (HeLa and EJ) grown in control (+Glu) or starved with HBSS for 1 and 3 h were lysed, extracts normalized and ROCK kinase activity was measured by performing enzyme-linked immunosorbent assay. Graphs represent ROCK activity in starved cells plotted as percent of...	[ "(", "d", ")", "ROCK", "activity", "is", "increased", "upon", "starvation", ".", "Cell", "lines", "(", "HeLa", "and", "EJ", ")", "grown", "in", "control", "(", "+", "Glu", ")", "or", "starved", "with", "HBSS", "for", "1", "and", "3", "h", "were", "...	[ "protein" ]
Abstract is an umlsterm, cell is an umlsterm, non - Hodgkin lymphomas is an umlsterm, cell is an umlsterm, lymphomas is an umlsterm, diagnosis is an umlsterm, treatment is an umlsterm, antibiotics is an umlsterm, malignant is an umlsterm, non - Hodgkin lymphoma is an umlsterm, tumour is an umlsterm, lymphoid cells is a...	DerHautarzt.50460028.eng.abstr_0	Sentence: Abstract . Primary cutaneous large cell anaplastic non-Hodgkin lymphomas positive for Ki-1-antigen are rarely described . There are 100 published cases worldwide . Typically large cell anaplastic lymphomas have an inflammatory appearance , which often leads to false diagnosis and unsuccessful treatment with a...	[ "B-umlsterm", "O", "O", "O", "O", "B-umlsterm", "O", "B-umlsterm", "I-umlsterm", "I-umlsterm", "I-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "B-umlsterm", "O", "O", "O", "O", "O", ...	Abstract . Primary cutaneous large cell anaplastic non-Hodgkin lymphomas positive for Ki-1-antigen are rarely described . There are 100 published cases worldwide . Typically large cell anaplastic lymphomas have an inflammatory appearance , which often leads to false diagnosis and unsuccessful treatment with antibiotics...	[ "Abstract", ".", "Primary", "cutaneous", "large", "cell", "anaplastic", "non", "-", "Hodgkin", "lymphomas", "positive", "for", "Ki-1-antigen", "are", "rarely", "described", ".", "There", "are", "100", "published", "cases", "worldwide", ".", "Typically", "large", ...	[ "umlsterm" ]
Abstract is an umlsterm, cell is an umlsterm, non - Hodgkin lymphomas is an umlsterm, cell is an umlsterm, lymphomas is an umlsterm, diagnosis is an umlsterm, treatment is an umlsterm, antibiotics is an umlsterm, malignant is an umlsterm, non - Hodgkin lymphoma is an umlsterm, tumour is an umlsterm, lymphoid cells is a...	DerHautarzt.50460028.eng.abstr_1	Sentence: Abstract . Primary cutaneous large cell anaplastic non-Hodgkin lymphomas positive for Ki-1-antigen are rarely described . There are 100 published cases worldwide . Typically large cell anaplastic lymphomas have an inflammatory appearance , which often leads to false diagnosis and unsuccessful treatment with a...	[ "B-umlsterm", "O", "O", "O", "O", "B-umlsterm", "O", "B-umlsterm", "I-umlsterm", "I-umlsterm", "I-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "B-umlsterm", "O", "O", "O", "O", "O", ...	Abstract . Primary cutaneous large cell anaplastic non-Hodgkin lymphomas positive for Ki-1-antigen are rarely described . There are 100 published cases worldwide . Typically large cell anaplastic lymphomas have an inflammatory appearance , which often leads to false diagnosis and unsuccessful treatment with antibiotics...	[ "Abstract", ".", "Primary", "cutaneous", "large", "cell", "anaplastic", "non", "-", "Hodgkin", "lymphomas", "positive", "for", "Ki-1-antigen", "are", "rarely", "described", ".", "There", "are", "100", "published", "cases", "worldwide", ".", "Typically", "large", ...	[ "umlsterm" ]
Abstract, cell, non - Hodgkin lymphomas, cell, lymphomas, diagnosis, treatment, antibiotics, malignant, non - Hodgkin lymphoma, tumour, lymphoid cells, diagnosis, CD30 antigen, tumour, cells, lymphoma, Berlin, patients, diagnosis, cutaneous lymphoma, patient, lymph node, stage, tumour, stage, adjuvant, polychemotherapy...	DerHautarzt.50460028.eng.abstr_2	Sentence: Abstract . Primary cutaneous large cell anaplastic non-Hodgkin lymphomas positive for Ki-1-antigen are rarely described . There are 100 published cases worldwide . Typically large cell anaplastic lymphomas have an inflammatory appearance , which often leads to false diagnosis and unsuccessful treatment with a...	[ "B-umlsterm", "O", "O", "O", "O", "B-umlsterm", "O", "B-umlsterm", "I-umlsterm", "I-umlsterm", "I-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "B-umlsterm", "O", "O", "O", "O", "O", ...	Abstract . Primary cutaneous large cell anaplastic non-Hodgkin lymphomas positive for Ki-1-antigen are rarely described . There are 100 published cases worldwide . Typically large cell anaplastic lymphomas have an inflammatory appearance , which often leads to false diagnosis and unsuccessful treatment with antibiotics...	[ "Abstract", ".", "Primary", "cutaneous", "large", "cell", "anaplastic", "non", "-", "Hodgkin", "lymphomas", "positive", "for", "Ki-1-antigen", "are", "rarely", "described", ".", "There", "are", "100", "published", "cases", "worldwide", ".", "Typically", "large", ...	[ "umlsterm" ]
Zinc is a CHEMICAL, MTF-1 is a GENE-Y, ZnT4 is a GENE-Y, Slc30a4 is a GENE-Y	23368743_0	Sentence: Zinc-dependent lysosomal enlargement in TRPML1-deficient cells involves MTF-1 transcription factor and ZnT4 (Slc30a4) transporter. Instructions: please extract entities and their types from the input sentence, all entity types are in options Options: CHEMICAL, GENE-Y	[ "B-CHEMICAL", "O", "O", "O", "O", "O", "O", "O", "O", "B-GENE-Y", "O", "O", "O", "B-GENE-Y", "O", "B-GENE-Y", "O", "O", "O" ]	Zinc-dependent lysosomal enlargement in TRPML1-deficient cells involves MTF-1 transcription factor and ZnT4 (Slc30a4) transporter.	[ "Zinc", "-", "dependent", "lysosomal", "enlargement", "in", "TRPML1-deficient", "cells", "involves", "MTF-1", "transcription", "factor", "and", "ZnT4", "(", "Slc30a4", ")", "transporter", "." ]	[ "GENE-Y", "GENE-N", "CHEMICAL" ]
Zinc is a CHEMICAL, MTF-1 is a GENE-Y, ZnT4 is a GENE-Y, Slc30a4 is a GENE-Y	23368743_1	Sentence: Zinc-dependent lysosomal enlargement in TRPML1-deficient cells involves MTF-1 transcription factor and ZnT4 (Slc30a4) transporter. Instructions: please typing these entity words according to sentence: Zinc, MTF-1, ZnT4, Slc30a4 Options: CHEMICAL, GENE-Y	[ "B-CHEMICAL", "O", "O", "O", "O", "O", "O", "O", "O", "B-GENE-Y", "O", "O", "O", "B-GENE-Y", "O", "B-GENE-Y", "O", "O", "O" ]	Zinc-dependent lysosomal enlargement in TRPML1-deficient cells involves MTF-1 transcription factor and ZnT4 (Slc30a4) transporter.	[ "Zinc", "-", "dependent", "lysosomal", "enlargement", "in", "TRPML1-deficient", "cells", "involves", "MTF-1", "transcription", "factor", "and", "ZnT4", "(", "Slc30a4", ")", "transporter", "." ]	[ "GENE-Y", "GENE-N", "CHEMICAL" ]
Zinc, MTF-1, ZnT4, Slc30a4	23368743_2	Sentence: Zinc-dependent lysosomal enlargement in TRPML1-deficient cells involves MTF-1 transcription factor and ZnT4 (Slc30a4) transporter. Instructions: please extract entity words from the input sentence	[ "B-CHEMICAL", "O", "O", "O", "O", "O", "O", "O", "O", "B-GENE-Y", "O", "O", "O", "B-GENE-Y", "O", "B-GENE-Y", "O", "O", "O" ]	Zinc-dependent lysosomal enlargement in TRPML1-deficient cells involves MTF-1 transcription factor and ZnT4 (Slc30a4) transporter.	[ "Zinc", "-", "dependent", "lysosomal", "enlargement", "in", "TRPML1-deficient", "cells", "involves", "MTF-1", "transcription", "factor", "and", "ZnT4", "(", "Slc30a4", ")", "transporter", "." ]	[ "GENE-Y", "GENE-N", "CHEMICAL" ]
LC3 is a protein	18532_0	Sentence: (b) Immunofluorescence for LC3 in MOBs treated with vehicle or 18α glycyrrhetinic acid. Where indicated, chloroquine (CQ) was added to block lysosomal degradation. Bottom: Quantification of the average number of LC3-positive puncta per cell (n = 3 wells, 3 independent experiments, >30 cells per experiment). ...	[ "O", "O", "O", "O", "O", "B-protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", ...	(b) Immunofluorescence for LC3 in MOBs treated with vehicle or 18α glycyrrhetinic acid. Where indicated, chloroquine (CQ) was added to block lysosomal degradation. Bottom: Quantification of the average number of LC3-positive puncta per cell (n = 3 wells, 3 independent experiments, >30 cells per experiment).	[ "(", "b", ")", "Immunofluorescence", "for", "LC3", "in", "MOBs", "treated", "with", "vehicle", "or", "18α", "glycyrrhetinic", "acid", ".", "Where", "indicated", ",", "chloroquine", "(", "CQ", ")", "was", "added", "to", "block", "lysosomal", "degradation", "....	[ "protein" ]
LC3 is a protein	18532_1	Sentence: (b) Immunofluorescence for LC3 in MOBs treated with vehicle or 18α glycyrrhetinic acid. Where indicated, chloroquine (CQ) was added to block lysosomal degradation. Bottom: Quantification of the average number of LC3-positive puncta per cell (n = 3 wells, 3 independent experiments, >30 cells per experiment). ...	[ "O", "O", "O", "O", "O", "B-protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", ...	(b) Immunofluorescence for LC3 in MOBs treated with vehicle or 18α glycyrrhetinic acid. Where indicated, chloroquine (CQ) was added to block lysosomal degradation. Bottom: Quantification of the average number of LC3-positive puncta per cell (n = 3 wells, 3 independent experiments, >30 cells per experiment).	[ "(", "b", ")", "Immunofluorescence", "for", "LC3", "in", "MOBs", "treated", "with", "vehicle", "or", "18α", "glycyrrhetinic", "acid", ".", "Where", "indicated", ",", "chloroquine", "(", "CQ", ")", "was", "added", "to", "block", "lysosomal", "degradation", "....	[ "protein" ]
LC3	18532_2	Sentence: (b) Immunofluorescence for LC3 in MOBs treated with vehicle or 18α glycyrrhetinic acid. Where indicated, chloroquine (CQ) was added to block lysosomal degradation. Bottom: Quantification of the average number of LC3-positive puncta per cell (n = 3 wells, 3 independent experiments, >30 cells per experiment). ...	[ "O", "O", "O", "O", "O", "B-protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", ...	(b) Immunofluorescence for LC3 in MOBs treated with vehicle or 18α glycyrrhetinic acid. Where indicated, chloroquine (CQ) was added to block lysosomal degradation. Bottom: Quantification of the average number of LC3-positive puncta per cell (n = 3 wells, 3 independent experiments, >30 cells per experiment).	[ "(", "b", ")", "Immunofluorescence", "for", "LC3", "in", "MOBs", "treated", "with", "vehicle", "or", "18α", "glycyrrhetinic", "acid", ".", "Where", "indicated", ",", "chloroquine", "(", "CQ", ")", "was", "added", "to", "block", "lysosomal", "degradation", "....	[ "protein" ]
myc is a protein	32459_0	Sentence: F. Co-transfection of HEK293 cells with GADD34-Flag and different myc-tagged Nox4 constructs, followed by IP with an anti-myc antibody. GADD34 binds to full-length Nox4 (FL) and the Nox4 transmembrane domain (TD) but not the C-terminal domain (CD). Instructions: please extract entities and their t...	[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", ...	F. Co-transfection of HEK293 cells with GADD34-Flag and different myc-tagged Nox4 constructs, followed by IP with an anti-myc antibody. GADD34 binds to full-length Nox4 (FL) and the Nox4 transmembrane domain (TD) but not the C-terminal domain (CD).	[ "F.", "Co", "-", "transfection", "of", "HEK293", "cells", "with", "GADD34-Flag", "and", "different", "myc", "-", "tagged", "Nox4", "constructs", ",", "followed", "by", "IP", "with", "an", "anti", "-", "myc", "antibody", ".", "GADD34", "binds", "to", "full"...	[ "protein" ]
myc is a protein	32459_1	Sentence: F. Co-transfection of HEK293 cells with GADD34-Flag and different myc-tagged Nox4 constructs, followed by IP with an anti-myc antibody. GADD34 binds to full-length Nox4 (FL) and the Nox4 transmembrane domain (TD) but not the C-terminal domain (CD). Instructions: please typing these entity words ac...	[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", ...	F. Co-transfection of HEK293 cells with GADD34-Flag and different myc-tagged Nox4 constructs, followed by IP with an anti-myc antibody. GADD34 binds to full-length Nox4 (FL) and the Nox4 transmembrane domain (TD) but not the C-terminal domain (CD).	[ "F.", "Co", "-", "transfection", "of", "HEK293", "cells", "with", "GADD34-Flag", "and", "different", "myc", "-", "tagged", "Nox4", "constructs", ",", "followed", "by", "IP", "with", "an", "anti", "-", "myc", "antibody", ".", "GADD34", "binds", "to", "full"...	[ "protein" ]
myc	32459_2	Sentence: F. Co-transfection of HEK293 cells with GADD34-Flag and different myc-tagged Nox4 constructs, followed by IP with an anti-myc antibody. GADD34 binds to full-length Nox4 (FL) and the Nox4 transmembrane domain (TD) but not the C-terminal domain (CD). Instructions: please extract entity words from th...	[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", ...	F. Co-transfection of HEK293 cells with GADD34-Flag and different myc-tagged Nox4 constructs, followed by IP with an anti-myc antibody. GADD34 binds to full-length Nox4 (FL) and the Nox4 transmembrane domain (TD) but not the C-terminal domain (CD).	[ "F.", "Co", "-", "transfection", "of", "HEK293", "cells", "with", "GADD34-Flag", "and", "different", "myc", "-", "tagged", "Nox4", "constructs", ",", "followed", "by", "IP", "with", "an", "anti", "-", "myc", "antibody", ".", "GADD34", "binds", "to", "full"...	[ "protein" ]
alpha 2B - adrenoceptors is a GENE-Y, etomidate is a CHEMICAL	14508322_0	Sentence: Activation of alpha 2B-adrenoceptors mediates the cardiovascular effects of etomidate. Instructions: please extract entities and their types from the input sentence, all entity types are in options Options: CHEMICAL, GENE-Y	[ "O", "O", "B-GENE-Y", "I-GENE-Y", "I-GENE-Y", "I-GENE-Y", "O", "O", "O", "O", "O", "B-CHEMICAL", "O" ]	Activation of alpha 2B-adrenoceptors mediates the cardiovascular effects of etomidate.	[ "Activation", "of", "alpha", "2B", "-", "adrenoceptors", "mediates", "the", "cardiovascular", "effects", "of", "etomidate", "." ]	[ "GENE-N", "GENE-Y", "CHEMICAL" ]
alpha 2B - adrenoceptors is a GENE-Y, etomidate is a CHEMICAL	14508322_1	Sentence: Activation of alpha 2B-adrenoceptors mediates the cardiovascular effects of etomidate. Instructions: please typing these entity words according to sentence: alpha 2B - adrenoceptors, etomidate Options: CHEMICAL, GENE-Y	[ "O", "O", "B-GENE-Y", "I-GENE-Y", "I-GENE-Y", "I-GENE-Y", "O", "O", "O", "O", "O", "B-CHEMICAL", "O" ]	Activation of alpha 2B-adrenoceptors mediates the cardiovascular effects of etomidate.	[ "Activation", "of", "alpha", "2B", "-", "adrenoceptors", "mediates", "the", "cardiovascular", "effects", "of", "etomidate", "." ]	[ "GENE-N", "GENE-Y", "CHEMICAL" ]
alpha 2B - adrenoceptors, etomidate	14508322_2	Sentence: Activation of alpha 2B-adrenoceptors mediates the cardiovascular effects of etomidate. Instructions: please extract entity words from the input sentence	[ "O", "O", "B-GENE-Y", "I-GENE-Y", "I-GENE-Y", "I-GENE-Y", "O", "O", "O", "O", "O", "B-CHEMICAL", "O" ]	Activation of alpha 2B-adrenoceptors mediates the cardiovascular effects of etomidate.	[ "Activation", "of", "alpha", "2B", "-", "adrenoceptors", "mediates", "the", "cardiovascular", "effects", "of", "etomidate", "." ]	[ "GENE-N", "GENE-Y", "CHEMICAL" ]
IL-2 receptor alpha - chain is a Protein, protein kinase C - independent mechanism is a Entity, IL-2 is a Protein, IL-2R alpha is a Protein, IL-2R alpha is a Protein, IL-2R alpha is a Protein, IL-2R alpha is a Protein, IL-2R alpha is a Protein, IL-2R alpha is a Protein, IL-2R alpha is a Protein, IL-2R alpha is a Protei...	393_0	Sentence: Thapsigargin induces IL-2 receptor alpha-chain in human peripheral and Jurkat T cells via a protein kinase C-independent mechanism. Thapsigargin (TG), an inhibitor of Ca(2+)-ATPase, depletes intracellular Ca2+ stores and induces a sustained Ca2+ influx without altering phosphatidyl inositol levels. TG plus p...	[ "O", "O", "B-Protein", "I-Protein", "I-Protein", "I-Protein", "I-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Entity", "I-Entity", "I-Entity", "I-Entity", "I-Entity", "I-Entity", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O"...	Thapsigargin induces IL-2 receptor alpha-chain in human peripheral and Jurkat T cells via a protein kinase C-independent mechanism. Thapsigargin (TG), an inhibitor of Ca(2+)-ATPase, depletes intracellular Ca2+ stores and induces a sustained Ca2+ influx without altering phosphatidyl inositol levels. TG plus phorbol myr...	[ "Thapsigargin", "induces", "IL-2", "receptor", "alpha", "-", "chain", "in", "human", "peripheral", "and", "Jurkat", "T", "cells", "via", "a", "protein", "kinase", "C", "-", "independent", "mechanism", ".", "\n", "Thapsigargin", "(", "TG", ")", ",", "an", "...	[ "Entity", "Protein" ]
IL-2 receptor alpha - chain is a Protein, protein kinase C - independent mechanism is a Entity, IL-2 is a Protein, IL-2R alpha is a Protein, IL-2R alpha is a Protein, IL-2R alpha is a Protein, IL-2R alpha is a Protein, IL-2R alpha is a Protein, IL-2R alpha is a Protein, IL-2R alpha is a Protein, IL-2R alpha is a Protei...	393_1	Sentence: Thapsigargin induces IL-2 receptor alpha-chain in human peripheral and Jurkat T cells via a protein kinase C-independent mechanism. Thapsigargin (TG), an inhibitor of Ca(2+)-ATPase, depletes intracellular Ca2+ stores and induces a sustained Ca2+ influx without altering phosphatidyl inositol levels. TG plus p...	[ "O", "O", "B-Protein", "I-Protein", "I-Protein", "I-Protein", "I-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Entity", "I-Entity", "I-Entity", "I-Entity", "I-Entity", "I-Entity", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O"...	Thapsigargin induces IL-2 receptor alpha-chain in human peripheral and Jurkat T cells via a protein kinase C-independent mechanism. Thapsigargin (TG), an inhibitor of Ca(2+)-ATPase, depletes intracellular Ca2+ stores and induces a sustained Ca2+ influx without altering phosphatidyl inositol levels. TG plus phorbol myr...	[ "Thapsigargin", "induces", "IL-2", "receptor", "alpha", "-", "chain", "in", "human", "peripheral", "and", "Jurkat", "T", "cells", "via", "a", "protein", "kinase", "C", "-", "independent", "mechanism", ".", "\n", "Thapsigargin", "(", "TG", ")", ",", "an", "...	[ "Entity", "Protein" ]
IL-2 receptor alpha - chain, protein kinase C - independent mechanism, IL-2, IL-2R alpha, IL-2R alpha, IL-2R alpha, IL-2R alpha, IL-2R alpha, IL-2R alpha, IL-2R alpha, IL-2R alpha	393_2	Sentence: Thapsigargin induces IL-2 receptor alpha-chain in human peripheral and Jurkat T cells via a protein kinase C-independent mechanism. Thapsigargin (TG), an inhibitor of Ca(2+)-ATPase, depletes intracellular Ca2+ stores and induces a sustained Ca2+ influx without altering phosphatidyl inositol levels. TG plus p...	[ "O", "O", "B-Protein", "I-Protein", "I-Protein", "I-Protein", "I-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Entity", "I-Entity", "I-Entity", "I-Entity", "I-Entity", "I-Entity", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O"...	Thapsigargin induces IL-2 receptor alpha-chain in human peripheral and Jurkat T cells via a protein kinase C-independent mechanism. Thapsigargin (TG), an inhibitor of Ca(2+)-ATPase, depletes intracellular Ca2+ stores and induces a sustained Ca2+ influx without altering phosphatidyl inositol levels. TG plus phorbol myr...	[ "Thapsigargin", "induces", "IL-2", "receptor", "alpha", "-", "chain", "in", "human", "peripheral", "and", "Jurkat", "T", "cells", "via", "a", "protein", "kinase", "C", "-", "independent", "mechanism", ".", "\n", "Thapsigargin", "(", "TG", ")", ",", "an", "...	[ "Entity", "Protein" ]
mice is a species	10116_0	Sentence: Following injection of 20 mg/kg of RK-33, twice a week for 7 weeks, extensive histopathological examination was carried out following necropsy. Identical patterns were observed both in the control and in the treated mice (n = 2). Samples were stained with H&E. Scale bar is 50 μm. Instructions: ple...	[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-species", "O", "O", "O", "O", "O", ...	Following injection of 20 mg/kg of RK-33, twice a week for 7 weeks, extensive histopathological examination was carried out following necropsy. Identical patterns were observed both in the control and in the treated mice (n = 2). Samples were stained with H&E. Scale bar is 50 μm.	[ "Following", "injection", "of", "20", "mg", "/", "kg", "of", "RK-33", ",", "twice", "a", "week", "for", "7", "weeks", ",", "extensive", "histopathological", "examination", "was", "carried", "out", "following", "necropsy", ".", "Identical", "patterns", "were", ...	[ "species" ]
mice is a species	10116_1	Sentence: Following injection of 20 mg/kg of RK-33, twice a week for 7 weeks, extensive histopathological examination was carried out following necropsy. Identical patterns were observed both in the control and in the treated mice (n = 2). Samples were stained with H&E. Scale bar is 50 μm. Instructions: ple...	[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-species", "O", "O", "O", "O", "O", ...	Following injection of 20 mg/kg of RK-33, twice a week for 7 weeks, extensive histopathological examination was carried out following necropsy. Identical patterns were observed both in the control and in the treated mice (n = 2). Samples were stained with H&E. Scale bar is 50 μm.	[ "Following", "injection", "of", "20", "mg", "/", "kg", "of", "RK-33", ",", "twice", "a", "week", "for", "7", "weeks", ",", "extensive", "histopathological", "examination", "was", "carried", "out", "following", "necropsy", ".", "Identical", "patterns", "were", ...	[ "species" ]
mice	10116_2	Sentence: Following injection of 20 mg/kg of RK-33, twice a week for 7 weeks, extensive histopathological examination was carried out following necropsy. Identical patterns were observed both in the control and in the treated mice (n = 2). Samples were stained with H&E. Scale bar is 50 μm. Instructions: ple...	[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-species", "O", "O", "O", "O", "O", ...	Following injection of 20 mg/kg of RK-33, twice a week for 7 weeks, extensive histopathological examination was carried out following necropsy. Identical patterns were observed both in the control and in the treated mice (n = 2). Samples were stained with H&E. Scale bar is 50 μm.	[ "Following", "injection", "of", "20", "mg", "/", "kg", "of", "RK-33", ",", "twice", "a", "week", "for", "7", "weeks", ",", "extensive", "histopathological", "examination", "was", "carried", "out", "following", "necropsy", ".", "Identical", "patterns", "were", ...	[ "species" ]
triazole is a compound, gp120 is a protein, CD4 is a protein	DS.d254_0	Sentence: In this work, we identified a high affinity and potency metallocene-containing triazole peptide conjugate that suppresses the interactions of HIV-1 envelope gp120 at both its CD4 and co-receptor binding sites. Instructions: please extract entities and their types from the input sentence, all entit...	[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-compound", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-protein", "O", "O", "O", "B-protein", "O", "O", "O", "O", "O", "O", "O" ]	In this work, we identified a high affinity and potency metallocene-containing triazole peptide conjugate that suppresses the interactions of HIV-1 envelope gp120 at both its CD4 and co-receptor binding sites.	[ "In", "this", "work", ",", "we", "identified", "a", "high", "affinity", "and", "potency", "metallocene", "-", "containing", "triazole", "peptide", "conjugate", "that", "suppresses", "the", "interactions", "of", "HIV-1", "envelope", "gp120", "at", "both", "its", ...	[ "compound", "protein" ]
triazole is a compound, gp120 is a protein, CD4 is a protein	DS.d254_1	Sentence: In this work, we identified a high affinity and potency metallocene-containing triazole peptide conjugate that suppresses the interactions of HIV-1 envelope gp120 at both its CD4 and co-receptor binding sites. Instructions: please typing these entity words according to sentence: triazole, gp120, C...	[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-compound", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-protein", "O", "O", "O", "B-protein", "O", "O", "O", "O", "O", "O", "O" ]	In this work, we identified a high affinity and potency metallocene-containing triazole peptide conjugate that suppresses the interactions of HIV-1 envelope gp120 at both its CD4 and co-receptor binding sites.	[ "In", "this", "work", ",", "we", "identified", "a", "high", "affinity", "and", "potency", "metallocene", "-", "containing", "triazole", "peptide", "conjugate", "that", "suppresses", "the", "interactions", "of", "HIV-1", "envelope", "gp120", "at", "both", "its", ...	[ "compound", "protein" ]
triazole, gp120, CD4	DS.d254_2	Sentence: In this work, we identified a high affinity and potency metallocene-containing triazole peptide conjugate that suppresses the interactions of HIV-1 envelope gp120 at both its CD4 and co-receptor binding sites. Instructions: please extract entity words from the input sentence	[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-compound", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-protein", "O", "O", "O", "B-protein", "O", "O", "O", "O", "O", "O", "O" ]	In this work, we identified a high affinity and potency metallocene-containing triazole peptide conjugate that suppresses the interactions of HIV-1 envelope gp120 at both its CD4 and co-receptor binding sites.	[ "In", "this", "work", ",", "we", "identified", "a", "high", "affinity", "and", "potency", "metallocene", "-", "containing", "triazole", "peptide", "conjugate", "that", "suppresses", "the", "interactions", "of", "HIV-1", "envelope", "gp120", "at", "both", "its", ...	[ "compound", "protein" ]
technology is an umlsterm, sonography is an umlsterm, ultrasound is an umlsterm, developments is an umlsterm, ultrasound is an umlsterm, devices is an umlsterm, imaging is an umlsterm, communication is an umlsterm, standard is an umlsterm, control is an umlsterm, maintenance is an umlsterm, ultrasound is an umlsterm, d...	DerGynaekologe.00330187.eng.abstr_0	Sentence: Due to the basic digital technology of modern sonography , a large number of new features have become available . It is easy for the sonographer to employ an ultrasound improvement such as 3D , but other developments , like the networking of ultrasound devices , are less well known . The following application...	[ "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", ...	Due to the basic digital technology of modern sonography , a large number of new features have become available . It is easy for the sonographer to employ an ultrasound improvement such as 3D , but other developments , like the networking of ultrasound devices , are less well known . The following applications demonstr...	[ "Due", "to", "the", "basic", "digital", "technology", "of", "modern", "sonography", ",", "a", "large", "number", "of", "new", "features", "have", "become", "available", ".", "It", "is", "easy", "for", "the", "sonographer", "to", "employ", "an", "ultrasound",...	[ "umlsterm" ]
technology is an umlsterm, sonography is an umlsterm, ultrasound is an umlsterm, developments is an umlsterm, ultrasound is an umlsterm, devices is an umlsterm, imaging is an umlsterm, communication is an umlsterm, standard is an umlsterm, control is an umlsterm, maintenance is an umlsterm, ultrasound is an umlsterm, d...	DerGynaekologe.00330187.eng.abstr_1	Sentence: Due to the basic digital technology of modern sonography , a large number of new features have become available . It is easy for the sonographer to employ an ultrasound improvement such as 3D , but other developments , like the networking of ultrasound devices , are less well known . The following application...	[ "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", ...	Due to the basic digital technology of modern sonography , a large number of new features have become available . It is easy for the sonographer to employ an ultrasound improvement such as 3D , but other developments , like the networking of ultrasound devices , are less well known . The following applications demonstr...	[ "Due", "to", "the", "basic", "digital", "technology", "of", "modern", "sonography", ",", "a", "large", "number", "of", "new", "features", "have", "become", "available", ".", "It", "is", "easy", "for", "the", "sonographer", "to", "employ", "an", "ultrasound",...	[ "umlsterm" ]
technology, sonography, ultrasound, developments, ultrasound, devices, imaging, communication, standard, control, maintenance, ultrasound, devices, devices, hand, devices, future, ultrasound	DerGynaekologe.00330187.eng.abstr_2	Sentence: Due to the basic digital technology of modern sonography , a large number of new features have become available . It is easy for the sonographer to employ an ultrasound improvement such as 3D , but other developments , like the networking of ultrasound devices , are less well known . The following application...	[ "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", ...	Due to the basic digital technology of modern sonography , a large number of new features have become available . It is easy for the sonographer to employ an ultrasound improvement such as 3D , but other developments , like the networking of ultrasound devices , are less well known . The following applications demonstr...	[ "Due", "to", "the", "basic", "digital", "technology", "of", "modern", "sonography", ",", "a", "large", "number", "of", "new", "features", "have", "become", "available", ".", "It", "is", "easy", "for", "the", "sonographer", "to", "employ", "an", "ultrasound",...	[ "umlsterm" ]
serine palmitoyltransferase is a GENE-N	17559874_0	Sentence: The structure of serine palmitoyltransferase; gateway to sphingolipid biosynthesis. Instructions: please extract entities and their types from the input sentence, all entity types are in options Options: GENE-N	[ "O", "O", "O", "B-GENE-N", "I-GENE-N", "O", "O", "O", "O", "O", "O" ]	The structure of serine palmitoyltransferase; gateway to sphingolipid biosynthesis.	[ "The", "structure", "of", "serine", "palmitoyltransferase", ";", "gateway", "to", "sphingolipid", "biosynthesis", "." ]	[ "GENE-N", "CHEMICAL", "GENE-Y" ]
serine palmitoyltransferase is a GENE-N	17559874_1	Sentence: The structure of serine palmitoyltransferase; gateway to sphingolipid biosynthesis. Instructions: please typing these entity words according to sentence: serine palmitoyltransferase Options: GENE-N	[ "O", "O", "O", "B-GENE-N", "I-GENE-N", "O", "O", "O", "O", "O", "O" ]	The structure of serine palmitoyltransferase; gateway to sphingolipid biosynthesis.	[ "The", "structure", "of", "serine", "palmitoyltransferase", ";", "gateway", "to", "sphingolipid", "biosynthesis", "." ]	[ "GENE-N", "CHEMICAL", "GENE-Y" ]
serine palmitoyltransferase	17559874_2	Sentence: The structure of serine palmitoyltransferase; gateway to sphingolipid biosynthesis. Instructions: please extract entity words from the input sentence	[ "O", "O", "O", "B-GENE-N", "I-GENE-N", "O", "O", "O", "O", "O", "O" ]	The structure of serine palmitoyltransferase; gateway to sphingolipid biosynthesis.	[ "The", "structure", "of", "serine", "palmitoyltransferase", ";", "gateway", "to", "sphingolipid", "biosynthesis", "." ]	[ "GENE-N", "CHEMICAL", "GENE-Y" ]
Erythropoietin is a protein_molecule, tyrosine phosphorylation is an other_name, Jak2 is a protein_molecule, STAT5A is a protein_molecule, STAT5B is a protein_molecule, primary cultured human erythroid precursors is a cell_type	78479_0	Sentence: Erythropoietin induces tyrosine phosphorylation of Jak2, STAT5A, and STAT5B in primary cultured human erythroid precursors. Instructions: please extract entities and their types from the input sentence, all entity types are in options Options: cell_type, protein_molecule, other_name ...	[ "B-protein_molecule", "O", "B-other_name", "I-other_name", "O", "B-protein_molecule", "O", "B-protein_molecule", "O", "O", "B-protein_molecule", "O", "B-cell_type", "I-cell_type", "I-cell_type", "I-cell_type", "I-cell_type", "O" ]	Erythropoietin induces tyrosine phosphorylation of Jak2, STAT5A, and STAT5B in primary cultured human erythroid precursors.	[ "Erythropoietin", "induces", "tyrosine", "phosphorylation", "of", "Jak2", ",", "STAT5A", ",", "and", "STAT5B", "in", "primary", "cultured", "human", "erythroid", "precursors", "." ]	[ "cell_type", "other_name", "protein_molecule", "DNA_domain_or_region", "cell_line", "amino_acid_monomer" ]
Erythropoietin is a protein_molecule, tyrosine phosphorylation is an other_name, Jak2 is a protein_molecule, STAT5A is a protein_molecule, STAT5B is a protein_molecule, primary cultured human erythroid precursors is a cell_type	78479_1	Sentence: Erythropoietin induces tyrosine phosphorylation of Jak2, STAT5A, and STAT5B in primary cultured human erythroid precursors. Instructions: please typing these entity words according to sentence: Erythropoietin, tyrosine phosphorylation, Jak2, STAT5A, STAT5B, primary cultured human erythroid precurs...	[ "B-protein_molecule", "O", "B-other_name", "I-other_name", "O", "B-protein_molecule", "O", "B-protein_molecule", "O", "O", "B-protein_molecule", "O", "B-cell_type", "I-cell_type", "I-cell_type", "I-cell_type", "I-cell_type", "O" ]	Erythropoietin induces tyrosine phosphorylation of Jak2, STAT5A, and STAT5B in primary cultured human erythroid precursors.	[ "Erythropoietin", "induces", "tyrosine", "phosphorylation", "of", "Jak2", ",", "STAT5A", ",", "and", "STAT5B", "in", "primary", "cultured", "human", "erythroid", "precursors", "." ]	[ "cell_type", "other_name", "protein_molecule", "DNA_domain_or_region", "cell_line", "amino_acid_monomer" ]
Erythropoietin, tyrosine phosphorylation, Jak2, STAT5A, STAT5B, primary cultured human erythroid precursors	78479_2	Sentence: Erythropoietin induces tyrosine phosphorylation of Jak2, STAT5A, and STAT5B in primary cultured human erythroid precursors. Instructions: please extract entity words from the input sentence	[ "B-protein_molecule", "O", "B-other_name", "I-other_name", "O", "B-protein_molecule", "O", "B-protein_molecule", "O", "O", "B-protein_molecule", "O", "B-cell_type", "I-cell_type", "I-cell_type", "I-cell_type", "I-cell_type", "O" ]	Erythropoietin induces tyrosine phosphorylation of Jak2, STAT5A, and STAT5B in primary cultured human erythroid precursors.	[ "Erythropoietin", "induces", "tyrosine", "phosphorylation", "of", "Jak2", ",", "STAT5A", ",", "and", "STAT5B", "in", "primary", "cultured", "human", "erythroid", "precursors", "." ]	[ "cell_type", "other_name", "protein_molecule", "DNA_domain_or_region", "cell_line", "amino_acid_monomer" ]
THP1 is a cellline	34051_0	Sentence: (A) THP1 cells were infected with HSV-1 KOS or an ICP27-deficient mutant (ΔICP27) on KOS genetic background (MOI 3). Supernatants were harvested from untreated cultures or cells infected for 12 or 18 hours for measurement of type I IFN bioactivity. Instructions: please extract entities and their t...	[ "O", "O", "O", "B-cellline", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", ...	(A) THP1 cells were infected with HSV-1 KOS or an ICP27-deficient mutant (ΔICP27) on KOS genetic background (MOI 3). Supernatants were harvested from untreated cultures or cells infected for 12 or 18 hours for measurement of type I IFN bioactivity.	[ "(", "A", ")", "THP1", "cells", "were", "infected", "with", "HSV-1", "KOS", "or", "an", "ICP27-deficient", "mutant", "(", "ΔICP27", ")", "on", "KOS", "genetic", "background", "(", "MOI", "3", ")", ".", "Supernatants", "were", "harvested", "from", "untreate...	[ "cellline" ]
THP1 is a cellline	34051_1	Sentence: (A) THP1 cells were infected with HSV-1 KOS or an ICP27-deficient mutant (ΔICP27) on KOS genetic background (MOI 3). Supernatants were harvested from untreated cultures or cells infected for 12 or 18 hours for measurement of type I IFN bioactivity. Instructions: please typing these entity words ac...	[ "O", "O", "O", "B-cellline", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", ...	(A) THP1 cells were infected with HSV-1 KOS or an ICP27-deficient mutant (ΔICP27) on KOS genetic background (MOI 3). Supernatants were harvested from untreated cultures or cells infected for 12 or 18 hours for measurement of type I IFN bioactivity.	[ "(", "A", ")", "THP1", "cells", "were", "infected", "with", "HSV-1", "KOS", "or", "an", "ICP27-deficient", "mutant", "(", "ΔICP27", ")", "on", "KOS", "genetic", "background", "(", "MOI", "3", ")", ".", "Supernatants", "were", "harvested", "from", "untreate...	[ "cellline" ]
THP1	34051_2	Sentence: (A) THP1 cells were infected with HSV-1 KOS or an ICP27-deficient mutant (ΔICP27) on KOS genetic background (MOI 3). Supernatants were harvested from untreated cultures or cells infected for 12 or 18 hours for measurement of type I IFN bioactivity. Instructions: please extract entity words from th...	[ "O", "O", "O", "B-cellline", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", ...	(A) THP1 cells were infected with HSV-1 KOS or an ICP27-deficient mutant (ΔICP27) on KOS genetic background (MOI 3). Supernatants were harvested from untreated cultures or cells infected for 12 or 18 hours for measurement of type I IFN bioactivity.	[ "(", "A", ")", "THP1", "cells", "were", "infected", "with", "HSV-1", "KOS", "or", "an", "ICP27-deficient", "mutant", "(", "ΔICP27", ")", "on", "KOS", "genetic", "background", "(", "MOI", "3", ")", ".", "Supernatants", "were", "harvested", "from", "untreate...	[ "cellline" ]
sequence - specific HMG box is a DNA_domain_or_region, lymphocyte transcriptional activator is a protein_family_or_group, Sox-4 is a protein_molecule	100643_0	Sentence: Solution structure of the sequence-specific HMG box of the lymphocyte transcriptional activator Sox-4. Instructions: please extract entities and their types from the input sentence, all entity types are in options Options: protein_family_or_group, DNA_domain_or_region, protein_molecule...	[ "O", "O", "O", "O", "B-DNA_domain_or_region", "I-DNA_domain_or_region", "I-DNA_domain_or_region", "I-DNA_domain_or_region", "I-DNA_domain_or_region", "O", "O", "B-protein_family_or_group", "I-protein_family_or_group", "I-protein_family_or_group", "B-protein_molecule", "O" ]	Solution structure of the sequence-specific HMG box of the lymphocyte transcriptional activator Sox-4.	[ "Solution", "structure", "of", "the", "sequence", "-", "specific", "HMG", "box", "of", "the", "lymphocyte", "transcriptional", "activator", "Sox-4", "." ]	[ "protein_family_or_group", "DNA_domain_or_region", "protein_domain_or_region", "other_name", "protein_substructure", "peptide", "protein_molecule", "(AND protein_substructure protein_substructure)", "DNA_family_or_group", "DNA_substructure", "polynucleotide", "" ]
sequence - specific HMG box is a DNA_domain_or_region, lymphocyte transcriptional activator is a protein_family_or_group, Sox-4 is a protein_molecule	100643_1	Sentence: Solution structure of the sequence-specific HMG box of the lymphocyte transcriptional activator Sox-4. Instructions: please typing these entity words according to sentence: sequence - specific HMG box, lymphocyte transcriptional activator, Sox-4 Options: protein_family_or_group, DNA_do...	[ "O", "O", "O", "O", "B-DNA_domain_or_region", "I-DNA_domain_or_region", "I-DNA_domain_or_region", "I-DNA_domain_or_region", "I-DNA_domain_or_region", "O", "O", "B-protein_family_or_group", "I-protein_family_or_group", "I-protein_family_or_group", "B-protein_molecule", "O" ]	Solution structure of the sequence-specific HMG box of the lymphocyte transcriptional activator Sox-4.	[ "Solution", "structure", "of", "the", "sequence", "-", "specific", "HMG", "box", "of", "the", "lymphocyte", "transcriptional", "activator", "Sox-4", "." ]	[ "protein_family_or_group", "DNA_domain_or_region", "protein_domain_or_region", "other_name", "protein_substructure", "peptide", "protein_molecule", "(AND protein_substructure protein_substructure)", "DNA_family_or_group", "DNA_substructure", "polynucleotide", "" ]
sequence - specific HMG box, lymphocyte transcriptional activator, Sox-4	100643_2	Sentence: Solution structure of the sequence-specific HMG box of the lymphocyte transcriptional activator Sox-4. Instructions: please extract entity words from the input sentence	[ "O", "O", "O", "O", "B-DNA_domain_or_region", "I-DNA_domain_or_region", "I-DNA_domain_or_region", "I-DNA_domain_or_region", "I-DNA_domain_or_region", "O", "O", "B-protein_family_or_group", "I-protein_family_or_group", "I-protein_family_or_group", "B-protein_molecule", "O" ]	Solution structure of the sequence-specific HMG box of the lymphocyte transcriptional activator Sox-4.	[ "Solution", "structure", "of", "the", "sequence", "-", "specific", "HMG", "box", "of", "the", "lymphocyte", "transcriptional", "activator", "Sox-4", "." ]	[ "protein_family_or_group", "DNA_domain_or_region", "protein_domain_or_region", "other_name", "protein_substructure", "peptide", "protein_molecule", "(AND protein_substructure protein_substructure)", "DNA_family_or_group", "DNA_substructure", "polynucleotide", "" ]
hearing is an umlsterm, conductive hearing loss is an umlsterm, sensorineural hearing loss is an umlsterm, conductive hearing loss is an umlsterm, impedance is an umlsterm, middle ear is an umlsterm, impedance is an umlsterm, use is an umlsterm, patients is an umlsterm, electronic is an umlsterm, sensorineural hearing ...	HNO.70450758.eng.abstr_0	Sentence: Active hearing implants have been developed to varying degrees for conductive hearing loss as well as for sensorineural hearing loss . Implants for conductive hearing loss match impedance transformation by the middle ear . They will be referred to as ITI ( impedance transformation implants ) . Three partial I...	[ "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "I-umlsterm", "I-umlsterm", "O", "O", "O", "O", "B-umlsterm", "I-umlsterm", "I-umlsterm", "O", "O", "O", "B-umlsterm", "I-umlsterm", "I-umlsterm", "O", "B-umlsterm", "O", "O", "O", ...	Active hearing implants have been developed to varying degrees for conductive hearing loss as well as for sensorineural hearing loss . Implants for conductive hearing loss match impedance transformation by the middle ear . They will be referred to as ITI ( impedance transformation implants ) . Three partial ITIs have b...	[ "Active", "hearing", "implants", "have", "been", "developed", "to", "varying", "degrees", "for", "conductive", "hearing", "loss", "as", "well", "as", "for", "sensorineural", "hearing", "loss", ".", "Implants", "for", "conductive", "hearing", "loss", "match", "im...	[ "umlsterm" ]
hearing is an umlsterm, conductive hearing loss is an umlsterm, sensorineural hearing loss is an umlsterm, conductive hearing loss is an umlsterm, impedance is an umlsterm, middle ear is an umlsterm, impedance is an umlsterm, use is an umlsterm, patients is an umlsterm, electronic is an umlsterm, sensorineural hearing ...	HNO.70450758.eng.abstr_1	Sentence: Active hearing implants have been developed to varying degrees for conductive hearing loss as well as for sensorineural hearing loss . Implants for conductive hearing loss match impedance transformation by the middle ear . They will be referred to as ITI ( impedance transformation implants ) . Three partial I...	[ "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "I-umlsterm", "I-umlsterm", "O", "O", "O", "O", "B-umlsterm", "I-umlsterm", "I-umlsterm", "O", "O", "O", "B-umlsterm", "I-umlsterm", "I-umlsterm", "O", "B-umlsterm", "O", "O", "O", ...	Active hearing implants have been developed to varying degrees for conductive hearing loss as well as for sensorineural hearing loss . Implants for conductive hearing loss match impedance transformation by the middle ear . They will be referred to as ITI ( impedance transformation implants ) . Three partial ITIs have b...	[ "Active", "hearing", "implants", "have", "been", "developed", "to", "varying", "degrees", "for", "conductive", "hearing", "loss", "as", "well", "as", "for", "sensorineural", "hearing", "loss", ".", "Implants", "for", "conductive", "hearing", "loss", "match", "im...	[ "umlsterm" ]
hearing, conductive hearing loss, sensorineural hearing loss, conductive hearing loss, impedance, middle ear, impedance, use, patients, electronic, sensorineural hearing loss, function, cochlea, amplifier, CA, CAI, cochlea, amplifier, CAI, transducer, control, CAI, use, transducer, use, electromagnetic, transducers, tr...	HNO.70450758.eng.abstr_2	Sentence: Active hearing implants have been developed to varying degrees for conductive hearing loss as well as for sensorineural hearing loss . Implants for conductive hearing loss match impedance transformation by the middle ear . They will be referred to as ITI ( impedance transformation implants ) . Three partial I...	[ "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "I-umlsterm", "I-umlsterm", "O", "O", "O", "O", "B-umlsterm", "I-umlsterm", "I-umlsterm", "O", "O", "O", "B-umlsterm", "I-umlsterm", "I-umlsterm", "O", "B-umlsterm", "O", "O", "O", ...	Active hearing implants have been developed to varying degrees for conductive hearing loss as well as for sensorineural hearing loss . Implants for conductive hearing loss match impedance transformation by the middle ear . They will be referred to as ITI ( impedance transformation implants ) . Three partial ITIs have b...	[ "Active", "hearing", "implants", "have", "been", "developed", "to", "varying", "degrees", "for", "conductive", "hearing", "loss", "as", "well", "as", "for", "sensorineural", "hearing", "loss", ".", "Implants", "for", "conductive", "hearing", "loss", "match", "im...	[ "umlsterm" ]
STAMP2 is a gene	3637_0	Sentence: G LNCaP cells stably expressing either control or STAMP2 vector were treated in the same way as in (D). Cell lysates were prepared and subjected to Western blot analysis with the indicated antibodies. Instructions: please extract entities and their types from the input sentence, all entity types a...	[ "O", "O", "O", "O", "O", "O", "O", "O", "B-gene", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ]	G LNCaP cells stably expressing either control or STAMP2 vector were treated in the same way as in (D). Cell lysates were prepared and subjected to Western blot analysis with the indicated antibodies.	[ "G", "LNCaP", "cells", "stably", "expressing", "either", "control", "or", "STAMP2", "vector", "were", "treated", "in", "the", "same", "way", "as", "in", "(", "D", ")", ".", "Cell", "lysates", "were", "prepared", "and", "subjected", "to", "Western", "blot",...	[ "gene" ]
STAMP2 is a gene	3637_1	Sentence: G LNCaP cells stably expressing either control or STAMP2 vector were treated in the same way as in (D). Cell lysates were prepared and subjected to Western blot analysis with the indicated antibodies. Instructions: please typing these entity words according to sentence: STAMP2 Options:...	[ "O", "O", "O", "O", "O", "O", "O", "O", "B-gene", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ]	G LNCaP cells stably expressing either control or STAMP2 vector were treated in the same way as in (D). Cell lysates were prepared and subjected to Western blot analysis with the indicated antibodies.	[ "G", "LNCaP", "cells", "stably", "expressing", "either", "control", "or", "STAMP2", "vector", "were", "treated", "in", "the", "same", "way", "as", "in", "(", "D", ")", ".", "Cell", "lysates", "were", "prepared", "and", "subjected", "to", "Western", "blot",...	[ "gene" ]
STAMP2	3637_2	Sentence: G LNCaP cells stably expressing either control or STAMP2 vector were treated in the same way as in (D). Cell lysates were prepared and subjected to Western blot analysis with the indicated antibodies. Instructions: please extract entity words from the input sentence	[ "O", "O", "O", "O", "O", "O", "O", "O", "B-gene", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ]	G LNCaP cells stably expressing either control or STAMP2 vector were treated in the same way as in (D). Cell lysates were prepared and subjected to Western blot analysis with the indicated antibodies.	[ "G", "LNCaP", "cells", "stably", "expressing", "either", "control", "or", "STAMP2", "vector", "were", "treated", "in", "the", "same", "way", "as", "in", "(", "D", ")", ".", "Cell", "lysates", "were", "prepared", "and", "subjected", "to", "Western", "blot",...	[ "gene" ]
E2 is a chemical, DES is a chemical, estrogen is a chemical, alpha - fetoprotein is a protein, AFP is a protein, E2 is a chemical, DES is a chemical	1.0alpha7.train.518_0	Sentence: Complicating such studies is the fact that, in many perinatal rodents, E2 is much less potent than DES as an estrogen due to high serum concentrations of alpha-fetoprotein (AFP), which binds E2 but not DES with high affinity [ 17]. Instructions: please extract entities and their types from...	[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-chemical", "O", "O", "O", "O", "O", "B-chemical", "O", "O", "O", "B-chemical", "O", "O", "O", "O", "O", "O", "O", "B-protein", "I-protein", "I-protein", "O", ...	Complicating such studies is the fact that, in many perinatal rodents, E2 is much less potent than DES as an estrogen due to high serum concentrations of alpha-fetoprotein (AFP), which binds E2 but not DES with high affinity [ 17].	[ " ", "Complicating", "such", "studies", "is", "the", "fact", "that", ",", "in", "many", "perinatal", " ", "rodents", ",", " ", "E2", "is", "much", "less", "potent", "than", "DES", "as", "an", " ", "estrogen", "due", "to", "high", "serum", "concentrations...	[ "protein", "chemical" ]
E2 is a chemical, DES is a chemical, estrogen is a chemical, alpha - fetoprotein is a protein, AFP is a protein, E2 is a chemical, DES is a chemical	1.0alpha7.train.518_1	Sentence: Complicating such studies is the fact that, in many perinatal rodents, E2 is much less potent than DES as an estrogen due to high serum concentrations of alpha-fetoprotein (AFP), which binds E2 but not DES with high affinity [ 17]. Instructions: please typing these entity words according t...	[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-chemical", "O", "O", "O", "O", "O", "B-chemical", "O", "O", "O", "B-chemical", "O", "O", "O", "O", "O", "O", "O", "B-protein", "I-protein", "I-protein", "O", ...	Complicating such studies is the fact that, in many perinatal rodents, E2 is much less potent than DES as an estrogen due to high serum concentrations of alpha-fetoprotein (AFP), which binds E2 but not DES with high affinity [ 17].	[ " ", "Complicating", "such", "studies", "is", "the", "fact", "that", ",", "in", "many", "perinatal", " ", "rodents", ",", " ", "E2", "is", "much", "less", "potent", "than", "DES", "as", "an", " ", "estrogen", "due", "to", "high", "serum", "concentrations...	[ "protein", "chemical" ]
E2, DES, estrogen, alpha - fetoprotein, AFP, E2, DES	1.0alpha7.train.518_2	Sentence: Complicating such studies is the fact that, in many perinatal rodents, E2 is much less potent than DES as an estrogen due to high serum concentrations of alpha-fetoprotein (AFP), which binds E2 but not DES with high affinity [ 17]. Instructions: please extract entity words from the input s...	[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-chemical", "O", "O", "O", "O", "O", "B-chemical", "O", "O", "O", "B-chemical", "O", "O", "O", "O", "O", "O", "O", "B-protein", "I-protein", "I-protein", "O", ...	Complicating such studies is the fact that, in many perinatal rodents, E2 is much less potent than DES as an estrogen due to high serum concentrations of alpha-fetoprotein (AFP), which binds E2 but not DES with high affinity [ 17].	[ " ", "Complicating", "such", "studies", "is", "the", "fact", "that", ",", "in", "many", "perinatal", " ", "rodents", ",", " ", "E2", "is", "much", "less", "potent", "than", "DES", "as", "an", " ", "estrogen", "due", "to", "high", "serum", "concentrations...	[ "protein", "chemical" ]
nucleus is a gene	10152_0	Sentence: A β-catenin (red) and DDX3 (green) expression in H1299 cells. After overexpressing β-catenin, both DDX3 and β-catenin accumulate in the nucleus. Scale bar is 10 μm. Instructions: please extract entities and their types from the input sentence, all entity types are in options Options: g...	[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-gene", "O", "O", "O", "O", "O", "O", "O" ]	A β-catenin (red) and DDX3 (green) expression in H1299 cells. After overexpressing β-catenin, both DDX3 and β-catenin accumulate in the nucleus. Scale bar is 10 μm.	[ "A", "β", "-", "catenin", "(", "red", ")", "and", "DDX3", "(", "green", ")", "expression", "in", "H1299", "cells", ".", "After", "overexpressing", "β", "-", "catenin", ",", "both", "DDX3", "and", "β", "-", "catenin", "accumulate", "in", "the", "nucleus...	[ "gene" ]
nucleus is a gene	10152_1	Sentence: A β-catenin (red) and DDX3 (green) expression in H1299 cells. After overexpressing β-catenin, both DDX3 and β-catenin accumulate in the nucleus. Scale bar is 10 μm. Instructions: please typing these entity words according to sentence: nucleus Options: gene	[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-gene", "O", "O", "O", "O", "O", "O", "O" ]	A β-catenin (red) and DDX3 (green) expression in H1299 cells. After overexpressing β-catenin, both DDX3 and β-catenin accumulate in the nucleus. Scale bar is 10 μm.	[ "A", "β", "-", "catenin", "(", "red", ")", "and", "DDX3", "(", "green", ")", "expression", "in", "H1299", "cells", ".", "After", "overexpressing", "β", "-", "catenin", ",", "both", "DDX3", "and", "β", "-", "catenin", "accumulate", "in", "the", "nucleus...	[ "gene" ]
nucleus	10152_2	Sentence: A β-catenin (red) and DDX3 (green) expression in H1299 cells. After overexpressing β-catenin, both DDX3 and β-catenin accumulate in the nucleus. Scale bar is 10 μm. Instructions: please extract entity words from the input sentence	[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-gene", "O", "O", "O", "O", "O", "O", "O" ]	A β-catenin (red) and DDX3 (green) expression in H1299 cells. After overexpressing β-catenin, both DDX3 and β-catenin accumulate in the nucleus. Scale bar is 10 μm.	[ "A", "β", "-", "catenin", "(", "red", ")", "and", "DDX3", "(", "green", ")", "expression", "in", "H1299", "cells", ".", "After", "overexpressing", "β", "-", "catenin", ",", "both", "DDX3", "and", "β", "-", "catenin", "accumulate", "in", "the", "nucleus...	[ "gene" ]
Operationstechniken is an umlsterm, Nebennierenchirurgie is an umlsterm, Methoden is an umlsterm, Adrenalektomie is an umlsterm, hormonaktive is an umlsterm, Nebennierentumoren is an umlsterm, Hyperplasien is an umlsterm, Methoden is an umlsterm, Trokarzugaenge is an umlsterm, Methoden is an umlsterm, Orientierung is a...	DerChirurg.80690613.ger.abstr_0	Sentence: Zusammenfassung . Die minimal-invasiven Operationstechniken sind heute fester Bestandteil der Nebennierenchirurgie . Inzwischen kommen vier verschiedene Methoden zur Anwendung : laparoskopisch von vorne und von der Seite sowie retroperitoneoskopisch von hinten und von der Seite . Indikationen zur endoskopisch...	[ "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B...	Zusammenfassung . Die minimal-invasiven Operationstechniken sind heute fester Bestandteil der Nebennierenchirurgie . Inzwischen kommen vier verschiedene Methoden zur Anwendung : laparoskopisch von vorne und von der Seite sowie retroperitoneoskopisch von hinten und von der Seite . Indikationen zur endoskopischen Adrenal...	[ "Zusammenfassung", ".", "Die", "minimal", "-", "invasiven", "Operationstechniken", "sind", "heute", "fester", "Bestandteil", "der", "Nebennierenchirurgie", ".", "Inzwischen", "kommen", "vier", "verschiedene", "Methoden", "zur", "Anwendung", ":", "laparoskopisch", "von",...	[ "umlsterm" ]
Operationstechniken is an umlsterm, Nebennierenchirurgie is an umlsterm, Methoden is an umlsterm, Adrenalektomie is an umlsterm, hormonaktive is an umlsterm, Nebennierentumoren is an umlsterm, Hyperplasien is an umlsterm, Methoden is an umlsterm, Trokarzugaenge is an umlsterm, Methoden is an umlsterm, Orientierung is a...	DerChirurg.80690613.ger.abstr_1	Sentence: Zusammenfassung . Die minimal-invasiven Operationstechniken sind heute fester Bestandteil der Nebennierenchirurgie . Inzwischen kommen vier verschiedene Methoden zur Anwendung : laparoskopisch von vorne und von der Seite sowie retroperitoneoskopisch von hinten und von der Seite . Indikationen zur endoskopisch...	[ "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B...	Zusammenfassung . Die minimal-invasiven Operationstechniken sind heute fester Bestandteil der Nebennierenchirurgie . Inzwischen kommen vier verschiedene Methoden zur Anwendung : laparoskopisch von vorne und von der Seite sowie retroperitoneoskopisch von hinten und von der Seite . Indikationen zur endoskopischen Adrenal...	[ "Zusammenfassung", ".", "Die", "minimal", "-", "invasiven", "Operationstechniken", "sind", "heute", "fester", "Bestandteil", "der", "Nebennierenchirurgie", ".", "Inzwischen", "kommen", "vier", "verschiedene", "Methoden", "zur", "Anwendung", ":", "laparoskopisch", "von",...	[ "umlsterm" ]
Operationstechniken, Nebennierenchirurgie, Methoden, Adrenalektomie, hormonaktive, Nebennierentumoren, Hyperplasien, Methoden, Trokarzugaenge, Methoden, Orientierung, Nebenniere, Chirurgie, Methodik	DerChirurg.80690613.ger.abstr_2	Sentence: Zusammenfassung . Die minimal-invasiven Operationstechniken sind heute fester Bestandteil der Nebennierenchirurgie . Inzwischen kommen vier verschiedene Methoden zur Anwendung : laparoskopisch von vorne und von der Seite sowie retroperitoneoskopisch von hinten und von der Seite . Indikationen zur endoskopisch...	[ "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B...	Zusammenfassung . Die minimal-invasiven Operationstechniken sind heute fester Bestandteil der Nebennierenchirurgie . Inzwischen kommen vier verschiedene Methoden zur Anwendung : laparoskopisch von vorne und von der Seite sowie retroperitoneoskopisch von hinten und von der Seite . Indikationen zur endoskopischen Adrenal...	[ "Zusammenfassung", ".", "Die", "minimal", "-", "invasiven", "Operationstechniken", "sind", "heute", "fester", "Bestandteil", "der", "Nebennierenchirurgie", ".", "Inzwischen", "kommen", "vier", "verschiedene", "Methoden", "zur", "Anwendung", ":", "laparoskopisch", "von",...	[ "umlsterm" ]
activin is a protein-complex, ActRII is a protein, ActRIIB is a protein, activin type IB receptor is a protein, ALK4 is a protein, ActRI is a protein, ALK2 is a protein	1.0alpha7.train.1362_0	Sentence: Similarly, activin binds to either ActRII or ActRIIB, with activin type IB receptor (ALK4) or possibly ActRI (ALK2) then joining the complex ( 14-19). Instructions: please extract entities and their types from the input sentence, all entity types are in options Options: protein-co...	[ "O", "O", "O", "B-protein-complex", "O", "O", "O", "O", "B-protein", "O", "O", "B-protein", "O", "O", "O", "B-protein", "I-protein", "I-protein", "I-protein", "O", "B-protein", "O", "O", "O", "O", "B-protein", "O", "B-protein", "O", "O", "O", "O", "O",...	Similarly, activin binds to either ActRII or ActRIIB, with activin type IB receptor (ALK4) or possibly ActRI (ALK2) then joining the complex ( 14-19).	[ "Similarly", ",", " ", "activin", "binds", "to", "either", " ", "ActRII", "or", " ", "ActRIIB", ",", "with", " ", "activin", "type", "IB", "receptor", "(", "ALK4", ")", "or", "possibly", " ", "ActRI", "(", "ALK2", ")", "then", "joining", "the", "comple...	[ "protein", "protein-complex" ]
activin is a protein-complex, ActRII is a protein, ActRIIB is a protein, activin type IB receptor is a protein, ALK4 is a protein, ActRI is a protein, ALK2 is a protein	1.0alpha7.train.1362_1	Sentence: Similarly, activin binds to either ActRII or ActRIIB, with activin type IB receptor (ALK4) or possibly ActRI (ALK2) then joining the complex ( 14-19). Instructions: please typing these entity words according to sentence: activin, ActRII, ActRIIB, activin type IB receptor, ALK4, ActRI, ALK2 ...	[ "O", "O", "O", "B-protein-complex", "O", "O", "O", "O", "B-protein", "O", "O", "B-protein", "O", "O", "O", "B-protein", "I-protein", "I-protein", "I-protein", "O", "B-protein", "O", "O", "O", "O", "B-protein", "O", "B-protein", "O", "O", "O", "O", "O",...	Similarly, activin binds to either ActRII or ActRIIB, with activin type IB receptor (ALK4) or possibly ActRI (ALK2) then joining the complex ( 14-19).	[ "Similarly", ",", " ", "activin", "binds", "to", "either", " ", "ActRII", "or", " ", "ActRIIB", ",", "with", " ", "activin", "type", "IB", "receptor", "(", "ALK4", ")", "or", "possibly", " ", "ActRI", "(", "ALK2", ")", "then", "joining", "the", "comple...	[ "protein", "protein-complex" ]
activin, ActRII, ActRIIB, activin type IB receptor, ALK4, ActRI, ALK2	1.0alpha7.train.1362_2	Sentence: Similarly, activin binds to either ActRII or ActRIIB, with activin type IB receptor (ALK4) or possibly ActRI (ALK2) then joining the complex ( 14-19). Instructions: please extract entity words from the input sentence	[ "O", "O", "O", "B-protein-complex", "O", "O", "O", "O", "B-protein", "O", "O", "B-protein", "O", "O", "O", "B-protein", "I-protein", "I-protein", "I-protein", "O", "B-protein", "O", "O", "O", "O", "B-protein", "O", "B-protein", "O", "O", "O", "O", "O",...	Similarly, activin binds to either ActRII or ActRIIB, with activin type IB receptor (ALK4) or possibly ActRI (ALK2) then joining the complex ( 14-19).	[ "Similarly", ",", " ", "activin", "binds", "to", "either", " ", "ActRII", "or", " ", "ActRIIB", ",", "with", " ", "activin", "type", "IB", "receptor", "(", "ALK4", ")", "or", "possibly", " ", "ActRI", "(", "ALK2", ")", "then", "joining", "the", "comple...	[ "protein", "protein-complex" ]
MCF7 is a cellline	39788_0	Sentence: e, Log2(H:L) heat map of class 1A candidates from PANC-1 and MCF7 cells. CQ, chloroquine. Instructions: please extract entities and their types from the input sentence, all entity types are in options Options: cellline	[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-cellline", "O", "O", "O", "O", "O", "O" ]	e, Log2(H:L) heat map of class 1A candidates from PANC-1 and MCF7 cells. CQ, chloroquine.	[ "e", ",", "Log2(H", ":", "L", ")", "heat", "map", "of", "class", "1A", "candidates", "from", "PANC-1", "and", "MCF7", "cells", ".", "CQ", ",", "chloroquine", "." ]	[ "cellline" ]
MCF7 is a cellline	39788_1	Sentence: e, Log2(H:L) heat map of class 1A candidates from PANC-1 and MCF7 cells. CQ, chloroquine. Instructions: please typing these entity words according to sentence: MCF7 Options: cellline	[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-cellline", "O", "O", "O", "O", "O", "O" ]	e, Log2(H:L) heat map of class 1A candidates from PANC-1 and MCF7 cells. CQ, chloroquine.	[ "e", ",", "Log2(H", ":", "L", ")", "heat", "map", "of", "class", "1A", "candidates", "from", "PANC-1", "and", "MCF7", "cells", ".", "CQ", ",", "chloroquine", "." ]	[ "cellline" ]
MCF7	39788_2	Sentence: e, Log2(H:L) heat map of class 1A candidates from PANC-1 and MCF7 cells. CQ, chloroquine. Instructions: please extract entity words from the input sentence	[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-cellline", "O", "O", "O", "O", "O", "O" ]	e, Log2(H:L) heat map of class 1A candidates from PANC-1 and MCF7 cells. CQ, chloroquine.	[ "e", ",", "Log2(H", ":", "L", ")", "heat", "map", "of", "class", "1A", "candidates", "from", "PANC-1", "and", "MCF7", "cells", ".", "CQ", ",", "chloroquine", "." ]	[ "cellline" ]

thrombocytopenia, haemolytic anaemia, ciprofloxacin

15375_2

Sentence: Severe thrombocytopenia and haemolytic anaemia associated with ciprofloxacin: a case report with fatal outcome. Instructions: please extract entity words from the input sentence

[ "O", "B-Disease", "O", "B-Disease", "I-Disease", "O", "O", "B-Chemical", "O", "O", "O", "O", "O", "O", "O", "O" ]

Severe thrombocytopenia and haemolytic anaemia associated with ciprofloxacin: a case report with fatal outcome.

[ "Severe", "thrombocytopenia", "and", "haemolytic", "anaemia", "associated", "with", "ciprofloxacin", ":", "a", "case", "report", "with", "fatal", "outcome", "." ]

[ "Disease", "Chemical" ]

Males is a Person, females is a Person, aged is a Person, > /= 50 years is a Value, No is a Negation, significant disease or drug use is a Scope, Absence of is a Negation, sign of dementia / cognitive impairment is a Scope, fulfils DSM - IV and NINCDS - ADRA criteria is a Scope, probable is a Mood, Alzheimers disease i...

NCT01009359_inc_0

Sentence: Able to give fully informed consent in writing Males or females aged >/= 50 years No significant disease or drug use Absence of any sign of dementia/cognitive impairment in neuropsychological examinationsPatients for brain imaging: Patient and designee capable of giving fully informed consent in writing ...

[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Person", "O", "B-Person", "B-Person", "B-Value", "I-Value", "I-Value", "I-Value", "O", "B-Negation", "B-Scope", "I-Scope", "I-Scope", "I-Scope", "I-Scope", "O", "B-Negation", "I-Negation", "O", "B-Scope", "I-Sc...

Able to give fully informed consent in writing Males or females aged >/= 50 years No significant disease or drug use Absence of any sign of dementia/cognitive impairment in neuropsychological examinationsPatients for brain imaging: Patient and designee capable of giving fully informed consent in writing Patient fu...

[ "Able", "to", "give", "fully", "informed", "consent", "in", "writing", "\n", "Males", "or", "females", "aged", ">", "/=", "50", "years", "\n", "No", "significant", "disease", "or", "drug", "use", "\n", "Absence", "of", "any", "sign", "of", "dementia", "/...

[ "Scope", "Procedure", "Condition", "Measurement", "Value", "Qualifier", "Negation", "Mood", "Person" ]

Males is a Person, females is a Person, aged is a Person, > /= 50 years is a Value, No is a Negation, significant disease or drug use is a Scope, Absence of is a Negation, sign of dementia / cognitive impairment is a Scope, fulfils DSM - IV and NINCDS - ADRA criteria is a Scope, probable is a Mood, Alzheimers disease i...

NCT01009359_inc_1

Sentence: Able to give fully informed consent in writing Males or females aged >/= 50 years No significant disease or drug use Absence of any sign of dementia/cognitive impairment in neuropsychological examinationsPatients for brain imaging: Patient and designee capable of giving fully informed consent in writing ...

[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Person", "O", "B-Person", "B-Person", "B-Value", "I-Value", "I-Value", "I-Value", "O", "B-Negation", "B-Scope", "I-Scope", "I-Scope", "I-Scope", "I-Scope", "O", "B-Negation", "I-Negation", "O", "B-Scope", "I-Sc...

Able to give fully informed consent in writing Males or females aged >/= 50 years No significant disease or drug use Absence of any sign of dementia/cognitive impairment in neuropsychological examinationsPatients for brain imaging: Patient and designee capable of giving fully informed consent in writing Patient fu...

[ "Able", "to", "give", "fully", "informed", "consent", "in", "writing", "\n", "Males", "or", "females", "aged", ">", "/=", "50", "years", "\n", "No", "significant", "disease", "or", "drug", "use", "\n", "Absence", "of", "any", "sign", "of", "dementia", "/...

[ "Scope", "Procedure", "Condition", "Measurement", "Value", "Qualifier", "Negation", "Mood", "Person" ]

Males, females, aged, > /= 50 years, No, significant disease or drug use, Absence of, sign of dementia / cognitive impairment, fulfils DSM - IV and NINCDS - ADRA criteria, probable, Alzheimers disease

NCT01009359_inc_2

Sentence: Able to give fully informed consent in writing Males or females aged >/= 50 years No significant disease or drug use Absence of any sign of dementia/cognitive impairment in neuropsychological examinationsPatients for brain imaging: Patient and designee capable of giving fully informed consent in writing ...

[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Person", "O", "B-Person", "B-Person", "B-Value", "I-Value", "I-Value", "I-Value", "O", "B-Negation", "B-Scope", "I-Scope", "I-Scope", "I-Scope", "I-Scope", "O", "B-Negation", "I-Negation", "O", "B-Scope", "I-Sc...

Able to give fully informed consent in writing Males or females aged >/= 50 years No significant disease or drug use Absence of any sign of dementia/cognitive impairment in neuropsychological examinationsPatients for brain imaging: Patient and designee capable of giving fully informed consent in writing Patient fu...

[ "Able", "to", "give", "fully", "informed", "consent", "in", "writing", "\n", "Males", "or", "females", "aged", ">", "/=", "50", "years", "\n", "No", "significant", "disease", "or", "drug", "use", "\n", "Absence", "of", "any", "sign", "of", "dementia", "/...

[ "Scope", "Procedure", "Condition", "Measurement", "Value", "Qualifier", "Negation", "Mood", "Person" ]

beta - casein is a Protein, STAT5 is a Protein, beta - casein is a Protein, promoter is a Entity, STAT ( signal transducer and activator of transcription)5 is a Protein, STAT5 is a Protein, PRL is a Protein, beta - casein is a Protein, beta - casein is a Protein, STAT5 is a Protein, beta - casein is a Protein, beta - c...

865_0

Sentence: Transcriptional regulation of the beta-casein gene by cytokines: cross-talk between STAT5 and other signaling molecules. The beta-casein promoter has been widely used to monitor the activation of STAT (signal transducer and activator of transcription)5 since STAT5 was originally found as a mediator of PRL-in...

[ "O", "O", "O", "O", "B-Protein", "I-Protein", "I-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "I-Protein", "I-Protein", "B-Entity", "O", "O", "O", "O", "O", "O", "O", "O", "O", "...

Transcriptional regulation of the beta-casein gene by cytokines: cross-talk between STAT5 and other signaling molecules. The beta-casein promoter has been widely used to monitor the activation of STAT (signal transducer and activator of transcription)5 since STAT5 was originally found as a mediator of PRL-inducible be...

[ "Transcriptional", "regulation", "of", "the", "beta", "-", "casein", "gene", "by", "cytokines", ":", "cross", "-", "talk", "between", "STAT5", "and", "other", "signaling", "molecules", ".", "\n", "The", "beta", "-", "casein", "promoter", "has", "been", "wide...

[ "Protein", "Entity" ]

beta - casein is a Protein, STAT5 is a Protein, beta - casein is a Protein, promoter is a Entity, STAT ( signal transducer and activator of transcription)5 is a Protein, STAT5 is a Protein, PRL is a Protein, beta - casein is a Protein, beta - casein is a Protein, STAT5 is a Protein, beta - casein is a Protein, beta - c...

865_1

Sentence: Transcriptional regulation of the beta-casein gene by cytokines: cross-talk between STAT5 and other signaling molecules. The beta-casein promoter has been widely used to monitor the activation of STAT (signal transducer and activator of transcription)5 since STAT5 was originally found as a mediator of PRL-in...

[ "O", "O", "O", "O", "B-Protein", "I-Protein", "I-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "I-Protein", "I-Protein", "B-Entity", "O", "O", "O", "O", "O", "O", "O", "O", "O", "...

Transcriptional regulation of the beta-casein gene by cytokines: cross-talk between STAT5 and other signaling molecules. The beta-casein promoter has been widely used to monitor the activation of STAT (signal transducer and activator of transcription)5 since STAT5 was originally found as a mediator of PRL-inducible be...

[ "Transcriptional", "regulation", "of", "the", "beta", "-", "casein", "gene", "by", "cytokines", ":", "cross", "-", "talk", "between", "STAT5", "and", "other", "signaling", "molecules", ".", "\n", "The", "beta", "-", "casein", "promoter", "has", "been", "wide...

[ "Protein", "Entity" ]

beta - casein, STAT5, beta - casein, promoter, STAT ( signal transducer and activator of transcription)5, STAT5, PRL, beta - casein, beta - casein, STAT5, beta - casein, beta - casein, interleukin-2, IL-2, STAT5, IL-4, STAT5, beta - casein, cytokine - inducible SH2-containing protein, CIS, oncostatin M, OSM, STAT6, IL-...

865_2

Sentence: Transcriptional regulation of the beta-casein gene by cytokines: cross-talk between STAT5 and other signaling molecules. The beta-casein promoter has been widely used to monitor the activation of STAT (signal transducer and activator of transcription)5 since STAT5 was originally found as a mediator of PRL-in...

[ "O", "O", "O", "O", "B-Protein", "I-Protein", "I-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "I-Protein", "I-Protein", "B-Entity", "O", "O", "O", "O", "O", "O", "O", "O", "O", "...

Transcriptional regulation of the beta-casein gene by cytokines: cross-talk between STAT5 and other signaling molecules. The beta-casein promoter has been widely used to monitor the activation of STAT (signal transducer and activator of transcription)5 since STAT5 was originally found as a mediator of PRL-inducible be...

[ "Transcriptional", "regulation", "of", "the", "beta", "-", "casein", "gene", "by", "cytokines", ":", "cross", "-", "talk", "between", "STAT5", "and", "other", "signaling", "molecules", ".", "\n", "The", "beta", "-", "casein", "promoter", "has", "been", "wide...

[ "Protein", "Entity" ]

DDB1 is a Protein, Ubiquitin is a Protein

397_0

Sentence: Targeting protein ubiquitylation: DDB1 takes its RING off. Ubiquitin E3 ligases of the RING and HECT families are distinct not only in their catalytic mechanisms but also in targeting substrates. Now it seems that one heterodimeric complex can target substrates to both types of E3 ligase. Instru...

[ "O", "O", "O", "O", "B-Protein", "O", "O", "O", "O", "O", "O", "B-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", ...

Targeting protein ubiquitylation: DDB1 takes its RING off. Ubiquitin E3 ligases of the RING and HECT families are distinct not only in their catalytic mechanisms but also in targeting substrates. Now it seems that one heterodimeric complex can target substrates to both types of E3 ligase.

[ "Targeting", "protein", "ubiquitylation", ":", "DDB1", "takes", "its", "RING", "off", ".", "\n", "Ubiquitin", "E3", "ligases", "of", "the", "RING", "and", "HECT", "families", "are", "distinct", "not", "only", "in", "their", "catalytic", "mechanisms", "but", ...

[ "Protein" ]

DDB1 is a Protein, Ubiquitin is a Protein

397_1

Sentence: Targeting protein ubiquitylation: DDB1 takes its RING off. Ubiquitin E3 ligases of the RING and HECT families are distinct not only in their catalytic mechanisms but also in targeting substrates. Now it seems that one heterodimeric complex can target substrates to both types of E3 ligase. Instru...

[ "O", "O", "O", "O", "B-Protein", "O", "O", "O", "O", "O", "O", "B-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", ...

Targeting protein ubiquitylation: DDB1 takes its RING off. Ubiquitin E3 ligases of the RING and HECT families are distinct not only in their catalytic mechanisms but also in targeting substrates. Now it seems that one heterodimeric complex can target substrates to both types of E3 ligase.

[ "Targeting", "protein", "ubiquitylation", ":", "DDB1", "takes", "its", "RING", "off", ".", "\n", "Ubiquitin", "E3", "ligases", "of", "the", "RING", "and", "HECT", "families", "are", "distinct", "not", "only", "in", "their", "catalytic", "mechanisms", "but", ...

[ "Protein" ]

DDB1, Ubiquitin

397_2

Sentence: Targeting protein ubiquitylation: DDB1 takes its RING off. Ubiquitin E3 ligases of the RING and HECT families are distinct not only in their catalytic mechanisms but also in targeting substrates. Now it seems that one heterodimeric complex can target substrates to both types of E3 ligase. Instru...

[ "O", "O", "O", "O", "B-Protein", "O", "O", "O", "O", "O", "O", "B-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", ...

Targeting protein ubiquitylation: DDB1 takes its RING off. Ubiquitin E3 ligases of the RING and HECT families are distinct not only in their catalytic mechanisms but also in targeting substrates. Now it seems that one heterodimeric complex can target substrates to both types of E3 ligase.

[ "Targeting", "protein", "ubiquitylation", ":", "DDB1", "takes", "its", "RING", "off", ".", "\n", "Ubiquitin", "E3", "ligases", "of", "the", "RING", "and", "HECT", "families", "are", "distinct", "not", "only", "in", "their", "catalytic", "mechanisms", "but", ...

[ "Protein" ]

exercises is an umlsterm, sports is an umlsterm, physical therapy is an umlsterm, manual is an umlsterm, therapy is an umlsterm, standard is an umlsterm, treatment is an umlsterm, program is an umlsterm, techniques is an umlsterm, therapy is an umlsterm, choice is an umlsterm, treatment is an umlsterm, muscle is an uml...

DerOrthopaede.70260981.eng.abstr_0

Sentence: Static stretching exercises have become very popular over the past fifteen years both in professional and amateur sports . In the fields of physical therapy and in manual therapy , in particular , static stretching has become part of a standard and successful treatment modality . Together with an appropriate ...

[ "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "B-umlsterm", "I-umlsterm", "O", "O", "B-umlsterm", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O"...

Static stretching exercises have become very popular over the past fifteen years both in professional and amateur sports . In the fields of physical therapy and in manual therapy , in particular , static stretching has become part of a standard and successful treatment modality . Together with an appropriate strengthen...

[ "Static", "stretching", "exercises", "have", "become", "very", "popular", "over", "the", "past", "fifteen", "years", "both", "in", "professional", "and", "amateur", "sports", ".", "In", "the", "fields", "of", "physical", "therapy", "and", "in", "manual", "ther...

[ "umlsterm" ]

exercises is an umlsterm, sports is an umlsterm, physical therapy is an umlsterm, manual is an umlsterm, therapy is an umlsterm, standard is an umlsterm, treatment is an umlsterm, program is an umlsterm, techniques is an umlsterm, therapy is an umlsterm, choice is an umlsterm, treatment is an umlsterm, muscle is an uml...

DerOrthopaede.70260981.eng.abstr_1

Sentence: Static stretching exercises have become very popular over the past fifteen years both in professional and amateur sports . In the fields of physical therapy and in manual therapy , in particular , static stretching has become part of a standard and successful treatment modality . Together with an appropriate ...

[ "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "B-umlsterm", "I-umlsterm", "O", "O", "B-umlsterm", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O"...

Static stretching exercises have become very popular over the past fifteen years both in professional and amateur sports . In the fields of physical therapy and in manual therapy , in particular , static stretching has become part of a standard and successful treatment modality . Together with an appropriate strengthen...

[ "Static", "stretching", "exercises", "have", "become", "very", "popular", "over", "the", "past", "fifteen", "years", "both", "in", "professional", "and", "amateur", "sports", ".", "In", "the", "fields", "of", "physical", "therapy", "and", "in", "manual", "ther...

[ "umlsterm" ]

exercises, sports, physical therapy, manual, therapy, standard, treatment, program, techniques, therapy, choice, treatment, muscle, musculoskeletal system, muscle, testing, procedures, muscle, muscle, techniques, techniques, exercises, methods, exercise, program, muscle

DerOrthopaede.70260981.eng.abstr_2

Sentence: Static stretching exercises have become very popular over the past fifteen years both in professional and amateur sports . In the fields of physical therapy and in manual therapy , in particular , static stretching has become part of a standard and successful treatment modality . Together with an appropriate ...

[ "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "B-umlsterm", "I-umlsterm", "O", "O", "B-umlsterm", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O"...

Static stretching exercises have become very popular over the past fifteen years both in professional and amateur sports . In the fields of physical therapy and in manual therapy , in particular , static stretching has become part of a standard and successful treatment modality . Together with an appropriate strengthen...

[ "Static", "stretching", "exercises", "have", "become", "very", "popular", "over", "the", "past", "fifteen", "years", "both", "in", "professional", "and", "amateur", "sports", ".", "In", "the", "fields", "of", "physical", "therapy", "and", "in", "manual", "ther...

[ "umlsterm" ]

staurosporine is a compound, 1,25-dihydroxy vitamin D is a compound, VDR is a protein, VDR is a protein

DS.d1450_0

Sentence: In the LNCaP prostate cancer cell line, induction of apoptosis and caspase-3/7 activities by staurosporine (STS) abolished ((3)H) 1,25-dihydroxy vitamin D (3) binding and VDR protein, suggesting that the VDR may be targeted for inactivation by caspases during apoptosis. Instructions: please extrac...

[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-compound", "O", "O", "O", "O", "O", "O", "O", "O", "B-compound", "I-compound", "I-compound", "O", "O", "O", "O", "O", "B-protein", "O", "O", "O", "O", "O", "B-pro...

In the LNCaP prostate cancer cell line, induction of apoptosis and caspase-3/7 activities by staurosporine (STS) abolished ((3)H) 1,25-dihydroxy vitamin D (3) binding and VDR protein, suggesting that the VDR may be targeted for inactivation by caspases during apoptosis.

[ "In", "the", "LNCaP", "prostate", "cancer", "cell", "line", ",", "induction", "of", "apoptosis", "and", "caspase-3/7", "activities", "by", "staurosporine", "(", "STS", ")", "abolished", "(", "(", "3)H", ")", "1,25-dihydroxy", "vitamin", "D", "(", "3", ")", ...

[ "compound", "protein" ]

staurosporine is a compound, 1,25-dihydroxy vitamin D is a compound, VDR is a protein, VDR is a protein

DS.d1450_1

Sentence: In the LNCaP prostate cancer cell line, induction of apoptosis and caspase-3/7 activities by staurosporine (STS) abolished ((3)H) 1,25-dihydroxy vitamin D (3) binding and VDR protein, suggesting that the VDR may be targeted for inactivation by caspases during apoptosis. Instructions: please typing...

[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-compound", "O", "O", "O", "O", "O", "O", "O", "O", "B-compound", "I-compound", "I-compound", "O", "O", "O", "O", "O", "B-protein", "O", "O", "O", "O", "O", "B-pro...

In the LNCaP prostate cancer cell line, induction of apoptosis and caspase-3/7 activities by staurosporine (STS) abolished ((3)H) 1,25-dihydroxy vitamin D (3) binding and VDR protein, suggesting that the VDR may be targeted for inactivation by caspases during apoptosis.

[ "In", "the", "LNCaP", "prostate", "cancer", "cell", "line", ",", "induction", "of", "apoptosis", "and", "caspase-3/7", "activities", "by", "staurosporine", "(", "STS", ")", "abolished", "(", "(", "3)H", ")", "1,25-dihydroxy", "vitamin", "D", "(", "3", ")", ...

[ "compound", "protein" ]

staurosporine, 1,25-dihydroxy vitamin D, VDR, VDR

DS.d1450_2

Sentence: In the LNCaP prostate cancer cell line, induction of apoptosis and caspase-3/7 activities by staurosporine (STS) abolished ((3)H) 1,25-dihydroxy vitamin D (3) binding and VDR protein, suggesting that the VDR may be targeted for inactivation by caspases during apoptosis. Instructions: please extrac...

[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-compound", "O", "O", "O", "O", "O", "O", "O", "O", "B-compound", "I-compound", "I-compound", "O", "O", "O", "O", "O", "B-protein", "O", "O", "O", "O", "O", "B-pro...

In the LNCaP prostate cancer cell line, induction of apoptosis and caspase-3/7 activities by staurosporine (STS) abolished ((3)H) 1,25-dihydroxy vitamin D (3) binding and VDR protein, suggesting that the VDR may be targeted for inactivation by caspases during apoptosis.

[ "In", "the", "LNCaP", "prostate", "cancer", "cell", "line", ",", "induction", "of", "apoptosis", "and", "caspase-3/7", "activities", "by", "staurosporine", "(", "STS", ")", "abolished", "(", "(", "3)H", ")", "1,25-dihydroxy", "vitamin", "D", "(", "3", ")", ...

[ "compound", "protein" ]

Laparoscopic cholecystectomy is an umlsterm, patients is an umlsterm, haemodynamic is an umlsterm, June is an umlsterm, cholecystectomies is an umlsterm, patients is an umlsterm, ASA is an umlsterm, cholecystectomies is an umlsterm, patients is an umlsterm, risk is an umlsterm, ASA is an umlsterm, patients is an umlste...

DerChirurg.80690061.eng.abstr_0

Sentence: Laparoscopic cholecystectomy offers many advantages , but cardiopulmonary impaired patients may be endangered by the haemodynamic and respiratory effects of the pneumoperitoneum . Between June 1990 and December 1995 , laparoscopic cholecystectomies were performed on 19 high-risk patients ( ASA IV ) and conven...

[ "B-umlsterm", "I-umlsterm", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O"...

Laparoscopic cholecystectomy offers many advantages , but cardiopulmonary impaired patients may be endangered by the haemodynamic and respiratory effects of the pneumoperitoneum . Between June 1990 and December 1995 , laparoscopic cholecystectomies were performed on 19 high-risk patients ( ASA IV ) and conventional cho...

[ "Laparoscopic", "cholecystectomy", "offers", "many", "advantages", ",", "but", "cardiopulmonary", "impaired", "patients", "may", "be", "endangered", "by", "the", "haemodynamic", "and", "respiratory", "effects", "of", "the", "pneumoperitoneum", ".", "Between", "June", ...

[ "umlsterm" ]

Laparoscopic cholecystectomy is an umlsterm, patients is an umlsterm, haemodynamic is an umlsterm, June is an umlsterm, cholecystectomies is an umlsterm, patients is an umlsterm, ASA is an umlsterm, cholecystectomies is an umlsterm, patients is an umlsterm, risk is an umlsterm, ASA is an umlsterm, patients is an umlste...

DerChirurg.80690061.eng.abstr_1

Sentence: Laparoscopic cholecystectomy offers many advantages , but cardiopulmonary impaired patients may be endangered by the haemodynamic and respiratory effects of the pneumoperitoneum . Between June 1990 and December 1995 , laparoscopic cholecystectomies were performed on 19 high-risk patients ( ASA IV ) and conven...

[ "B-umlsterm", "I-umlsterm", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O"...

Laparoscopic cholecystectomy offers many advantages , but cardiopulmonary impaired patients may be endangered by the haemodynamic and respiratory effects of the pneumoperitoneum . Between June 1990 and December 1995 , laparoscopic cholecystectomies were performed on 19 high-risk patients ( ASA IV ) and conventional cho...

[ "Laparoscopic", "cholecystectomy", "offers", "many", "advantages", ",", "but", "cardiopulmonary", "impaired", "patients", "may", "be", "endangered", "by", "the", "haemodynamic", "and", "respiratory", "effects", "of", "the", "pneumoperitoneum", ".", "Between", "June", ...

[ "umlsterm" ]

Laparoscopic cholecystectomy, patients, haemodynamic, June, cholecystectomies, patients, ASA, cholecystectomies, patients, risk, ASA, patients, complications, cholecystectomy, open, laparotomy, postoperative complications, patients, cholcystectomy, hospital, open, cholecystectomy, laparotomy, laparoscopy, classificatio...

DerChirurg.80690061.eng.abstr_2

Sentence: Laparoscopic cholecystectomy offers many advantages , but cardiopulmonary impaired patients may be endangered by the haemodynamic and respiratory effects of the pneumoperitoneum . Between June 1990 and December 1995 , laparoscopic cholecystectomies were performed on 19 high-risk patients ( ASA IV ) and conven...

[ "B-umlsterm", "I-umlsterm", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O"...

Laparoscopic cholecystectomy offers many advantages , but cardiopulmonary impaired patients may be endangered by the haemodynamic and respiratory effects of the pneumoperitoneum . Between June 1990 and December 1995 , laparoscopic cholecystectomies were performed on 19 high-risk patients ( ASA IV ) and conventional cho...

[ "Laparoscopic", "cholecystectomy", "offers", "many", "advantages", ",", "but", "cardiopulmonary", "impaired", "patients", "may", "be", "endangered", "by", "the", "haemodynamic", "and", "respiratory", "effects", "of", "the", "pneumoperitoneum", ".", "Between", "June", ...

[ "umlsterm" ]

Hospital is an umlsterm

DerOpthalmologe.80950820.eng.abstr_0

Sentence: In the years from 1995 to 1997 in the eyeclinic of Darmstadt and the eyeclinic of the St. Josef Hospital Hagen 261 dacryoendoscopies were done in a bicentrical study . Instructions: please extract entities and their types from the input sentence, all entity types are in options Options...

[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ]

In the years from 1995 to 1997 in the eyeclinic of Darmstadt and the eyeclinic of the St. Josef Hospital Hagen 261 dacryoendoscopies were done in a bicentrical study .

[ "In", "the", "years", "from", "1995", "to", "1997", "in", "the", "eyeclinic", "of", "Darmstadt", "and", "the", "eyeclinic", "of", "the", "St", ".", "Josef", "Hospital", "Hagen", "261", "dacryoendoscopies", "were", "done", "in", "a", "bicentrical", "study", ...

[ "umlsterm" ]

Hospital is an umlsterm

DerOpthalmologe.80950820.eng.abstr_1

Sentence: In the years from 1995 to 1997 in the eyeclinic of Darmstadt and the eyeclinic of the St. Josef Hospital Hagen 261 dacryoendoscopies were done in a bicentrical study . Instructions: please typing these entity words according to sentence: Hospital Options: umlsterm

[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ]

In the years from 1995 to 1997 in the eyeclinic of Darmstadt and the eyeclinic of the St. Josef Hospital Hagen 261 dacryoendoscopies were done in a bicentrical study .

[ "In", "the", "years", "from", "1995", "to", "1997", "in", "the", "eyeclinic", "of", "Darmstadt", "and", "the", "eyeclinic", "of", "the", "St", ".", "Josef", "Hospital", "Hagen", "261", "dacryoendoscopies", "were", "done", "in", "a", "bicentrical", "study", ...

[ "umlsterm" ]

Hospital

DerOpthalmologe.80950820.eng.abstr_2

Sentence: In the years from 1995 to 1997 in the eyeclinic of Darmstadt and the eyeclinic of the St. Josef Hospital Hagen 261 dacryoendoscopies were done in a bicentrical study . Instructions: please extract entity words from the input sentence

[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ]

In the years from 1995 to 1997 in the eyeclinic of Darmstadt and the eyeclinic of the St. Josef Hospital Hagen 261 dacryoendoscopies were done in a bicentrical study .

[ "In", "the", "years", "from", "1995", "to", "1997", "in", "the", "eyeclinic", "of", "Darmstadt", "and", "the", "eyeclinic", "of", "the", "St", ".", "Josef", "Hospital", "Hagen", "261", "dacryoendoscopies", "were", "done", "in", "a", "bicentrical", "study", ...

[ "umlsterm" ]

Angiitis is an umlsterm, Mann is an umlsterm, Lungenoberlappen is an umlsterm, Thymus is an umlsterm, Perikard is an umlsterm, Thymuskarzinom is an umlsterm, Thymus is an umlsterm, Lungenoberlappens is an umlsterm, Lymphknoten is an umlsterm, Diagnose is an umlsterm, Angiitis is an umlsterm, Differentialdiagnostik is a...

ZfuerHerzThoraxGefaesschirurgie.90130083.ger.abstr_0

Sentence: In der vorliegenden Kasuistik wird ueber eine ausgedehnte mediastinale Raumforderung berichtet , als deren Ursache sich eine allergische Granulomatose mit Angiitis ( Churg-Strauss ) herausstellte . Ein 24-jaehriger Mann wurde wegen einer grossen mediastinalen Raumforderung mit Infiltration von Mittellappen , ...

[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O",...

In der vorliegenden Kasuistik wird ueber eine ausgedehnte mediastinale Raumforderung berichtet , als deren Ursache sich eine allergische Granulomatose mit Angiitis ( Churg-Strauss ) herausstellte . Ein 24-jaehriger Mann wurde wegen einer grossen mediastinalen Raumforderung mit Infiltration von Mittellappen , rechtem Lu...

[ "In", "der", "vorliegenden", "Kasuistik", "wird", "ueber", "eine", "ausgedehnte", "mediastinale", "Raumforderung", "berichtet", ",", "als", "deren", "Ursache", "sich", "eine", "allergische", "Granulomatose", "mit", "Angiitis", "(", "Churg", "-", "Strauss", ")", "h...

[ "umlsterm" ]

Angiitis is an umlsterm, Mann is an umlsterm, Lungenoberlappen is an umlsterm, Thymus is an umlsterm, Perikard is an umlsterm, Thymuskarzinom is an umlsterm, Thymus is an umlsterm, Lungenoberlappens is an umlsterm, Lymphknoten is an umlsterm, Diagnose is an umlsterm, Angiitis is an umlsterm, Differentialdiagnostik is a...

ZfuerHerzThoraxGefaesschirurgie.90130083.ger.abstr_1

Sentence: In der vorliegenden Kasuistik wird ueber eine ausgedehnte mediastinale Raumforderung berichtet , als deren Ursache sich eine allergische Granulomatose mit Angiitis ( Churg-Strauss ) herausstellte . Ein 24-jaehriger Mann wurde wegen einer grossen mediastinalen Raumforderung mit Infiltration von Mittellappen , ...

[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O",...

In der vorliegenden Kasuistik wird ueber eine ausgedehnte mediastinale Raumforderung berichtet , als deren Ursache sich eine allergische Granulomatose mit Angiitis ( Churg-Strauss ) herausstellte . Ein 24-jaehriger Mann wurde wegen einer grossen mediastinalen Raumforderung mit Infiltration von Mittellappen , rechtem Lu...

[ "In", "der", "vorliegenden", "Kasuistik", "wird", "ueber", "eine", "ausgedehnte", "mediastinale", "Raumforderung", "berichtet", ",", "als", "deren", "Ursache", "sich", "eine", "allergische", "Granulomatose", "mit", "Angiitis", "(", "Churg", "-", "Strauss", ")", "h...

[ "umlsterm" ]

Angiitis, Mann, Lungenoberlappen, Thymus, Perikard, Thymuskarzinom, Thymus, Lungenoberlappens, Lymphknoten, Diagnose, Angiitis, Differentialdiagnostik, Churg - Strauss - Syndrom, Differentialdiagnose, Spezifitaet

ZfuerHerzThoraxGefaesschirurgie.90130083.ger.abstr_2

Sentence: In der vorliegenden Kasuistik wird ueber eine ausgedehnte mediastinale Raumforderung berichtet , als deren Ursache sich eine allergische Granulomatose mit Angiitis ( Churg-Strauss ) herausstellte . Ein 24-jaehriger Mann wurde wegen einer grossen mediastinalen Raumforderung mit Infiltration von Mittellappen , ...

[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O",...

In der vorliegenden Kasuistik wird ueber eine ausgedehnte mediastinale Raumforderung berichtet , als deren Ursache sich eine allergische Granulomatose mit Angiitis ( Churg-Strauss ) herausstellte . Ein 24-jaehriger Mann wurde wegen einer grossen mediastinalen Raumforderung mit Infiltration von Mittellappen , rechtem Lu...

[ "In", "der", "vorliegenden", "Kasuistik", "wird", "ueber", "eine", "ausgedehnte", "mediastinale", "Raumforderung", "berichtet", ",", "als", "deren", "Ursache", "sich", "eine", "allergische", "Granulomatose", "mit", "Angiitis", "(", "Churg", "-", "Strauss", ")", "h...

[ "umlsterm" ]

Folic acid - based intervention is a Intervention_Pharmacological, non - ST elevation acute coronary syndromes . is a Participant_Condition, vitamins B ( 6 ) and B ( 12 ) is a Intervention_Pharmacological, homocysteine levels is a Outcome_Physical, placebo - controlled is a Intervention_Control, folic acid - based supp...

40611_0

Sentence: Folic acid-based intervention in non-ST elevation acute coronary syndromes . Homocysteinemia is a risk factor for cardiovascular diseases . Folic acid combined with vitamins B ( 6 ) and B ( 12 ) is effective in lowering homocysteine levels . This randomized placebo-controlled study was designed to determine t...

[ "B-Intervention_Pharmacological", "I-Intervention_Pharmacological", "I-Intervention_Pharmacological", "I-Intervention_Pharmacological", "I-Intervention_Pharmacological", "O", "B-Participant_Condition", "I-Participant_Condition", "I-Participant_Condition", "I-Participant_Condition", "I-Participan...

Folic acid-based intervention in non-ST elevation acute coronary syndromes . Homocysteinemia is a risk factor for cardiovascular diseases . Folic acid combined with vitamins B ( 6 ) and B ( 12 ) is effective in lowering homocysteine levels . This randomized placebo-controlled study was designed to determine the effect ...

[ "Folic", "acid", "-", "based", "intervention", "in", "non", "-", "ST", "elevation", "acute", "coronary", "syndromes", ".", "Homocysteinemia", "is", "a", "risk", "factor", "for", "cardiovascular", "diseases", ".", "Folic", "acid", "combined", "with", "vitamins", ...

[ "Participant_Condition", "Outcome_Physical", "Intervention_Pharmacological", "Outcome_Other", "Intervention_Control", "Outcome_Mortality" ]

Folic acid - based intervention is a Intervention_Pharmacological, non - ST elevation acute coronary syndromes . is a Participant_Condition, vitamins B ( 6 ) and B ( 12 ) is a Intervention_Pharmacological, homocysteine levels is a Outcome_Physical, placebo - controlled is a Intervention_Control, folic acid - based supp...

40611_1

Sentence: Folic acid-based intervention in non-ST elevation acute coronary syndromes . Homocysteinemia is a risk factor for cardiovascular diseases . Folic acid combined with vitamins B ( 6 ) and B ( 12 ) is effective in lowering homocysteine levels . This randomized placebo-controlled study was designed to determine t...

[ "B-Intervention_Pharmacological", "I-Intervention_Pharmacological", "I-Intervention_Pharmacological", "I-Intervention_Pharmacological", "I-Intervention_Pharmacological", "O", "B-Participant_Condition", "I-Participant_Condition", "I-Participant_Condition", "I-Participant_Condition", "I-Participan...

Folic acid-based intervention in non-ST elevation acute coronary syndromes . Homocysteinemia is a risk factor for cardiovascular diseases . Folic acid combined with vitamins B ( 6 ) and B ( 12 ) is effective in lowering homocysteine levels . This randomized placebo-controlled study was designed to determine the effect ...

[ "Folic", "acid", "-", "based", "intervention", "in", "non", "-", "ST", "elevation", "acute", "coronary", "syndromes", ".", "Homocysteinemia", "is", "a", "risk", "factor", "for", "cardiovascular", "diseases", ".", "Folic", "acid", "combined", "with", "vitamins", ...

[ "Participant_Condition", "Outcome_Physical", "Intervention_Pharmacological", "Outcome_Other", "Intervention_Control", "Outcome_Mortality" ]

Folic acid - based intervention, non - ST elevation acute coronary syndromes ., vitamins B ( 6 ) and B ( 12 ), homocysteine levels, placebo - controlled, folic acid - based supplement, folate, placebo group, vitamin B ( 12 ), vitamin B ( 6 ), Clinical outcomes, death, nonfatal acute coronary syndrome, serious re - hosp...

40611_2

Sentence: Folic acid-based intervention in non-ST elevation acute coronary syndromes . Homocysteinemia is a risk factor for cardiovascular diseases . Folic acid combined with vitamins B ( 6 ) and B ( 12 ) is effective in lowering homocysteine levels . This randomized placebo-controlled study was designed to determine t...

[ "B-Intervention_Pharmacological", "I-Intervention_Pharmacological", "I-Intervention_Pharmacological", "I-Intervention_Pharmacological", "I-Intervention_Pharmacological", "O", "B-Participant_Condition", "I-Participant_Condition", "I-Participant_Condition", "I-Participant_Condition", "I-Participan...

Folic acid-based intervention in non-ST elevation acute coronary syndromes . Homocysteinemia is a risk factor for cardiovascular diseases . Folic acid combined with vitamins B ( 6 ) and B ( 12 ) is effective in lowering homocysteine levels . This randomized placebo-controlled study was designed to determine the effect ...

[ "Folic", "acid", "-", "based", "intervention", "in", "non", "-", "ST", "elevation", "acute", "coronary", "syndromes", ".", "Homocysteinemia", "is", "a", "risk", "factor", "for", "cardiovascular", "diseases", ".", "Folic", "acid", "combined", "with", "vitamins", ...

[ "Participant_Condition", "Outcome_Physical", "Intervention_Pharmacological", "Outcome_Other", "Intervention_Control", "Outcome_Mortality" ]

Sp1 site is a DNA, p53 is a protein, p53 is a protein, p53 is a protein, Sp1 mutant probe is an experimental-construct

1.0alpha7.train.1170_0

Sentence: Although mutation of the Sp1 site did not block p53 binding, it affected p53 binding in a significant manner, ranging from 50% to 25% of p53 bound to the Sp1 mutant probe relative to the native probe ( Fig. 1 E, lane 3). Instructions: please extract entities and their types from the inp...

[ "O", "O", "O", "O", "O", "O", "B-DNA", "I-DNA", "O", "O", "O", "O", "B-protein", "O", "O", "O", "O", "O", "B-protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-protein", "O", "O", "O",...

Although mutation of the Sp1 site did not block p53 binding, it affected p53 binding in a significant manner, ranging from 50% to 25% of p53 bound to the Sp1 mutant probe relative to the native probe ( Fig. 1 E, lane 3).

[ "Although", "mutation", " ", "of", "the", " ", "Sp1", "site", "did", "not", "block", " ", "p53", "binding", ",", "it", "affected", " ", "p53", "binding", "in", "a", " ", "significant", "manner", ",", "ranging", "from", "50", "%", " ", "to", "25", "%"...

[ "experimental-construct", "DNA", "protein" ]

Sp1 site is a DNA, p53 is a protein, p53 is a protein, p53 is a protein, Sp1 mutant probe is an experimental-construct

1.0alpha7.train.1170_1

Sentence: Although mutation of the Sp1 site did not block p53 binding, it affected p53 binding in a significant manner, ranging from 50% to 25% of p53 bound to the Sp1 mutant probe relative to the native probe ( Fig. 1 E, lane 3). Instructions: please typing these entity words according to senten...

[ "O", "O", "O", "O", "O", "O", "B-DNA", "I-DNA", "O", "O", "O", "O", "B-protein", "O", "O", "O", "O", "O", "B-protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-protein", "O", "O", "O",...

Although mutation of the Sp1 site did not block p53 binding, it affected p53 binding in a significant manner, ranging from 50% to 25% of p53 bound to the Sp1 mutant probe relative to the native probe ( Fig. 1 E, lane 3).

[ "Although", "mutation", " ", "of", "the", " ", "Sp1", "site", "did", "not", "block", " ", "p53", "binding", ",", "it", "affected", " ", "p53", "binding", "in", "a", " ", "significant", "manner", ",", "ranging", "from", "50", "%", " ", "to", "25", "%"...

[ "experimental-construct", "DNA", "protein" ]

Sp1 site, p53, p53, p53, Sp1 mutant probe

1.0alpha7.train.1170_2

Sentence: Although mutation of the Sp1 site did not block p53 binding, it affected p53 binding in a significant manner, ranging from 50% to 25% of p53 bound to the Sp1 mutant probe relative to the native probe ( Fig. 1 E, lane 3). Instructions: please extract entity words from the input sentence ...

[ "O", "O", "O", "O", "O", "O", "B-DNA", "I-DNA", "O", "O", "O", "O", "B-protein", "O", "O", "O", "O", "O", "B-protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-protein", "O", "O", "O",...

Although mutation of the Sp1 site did not block p53 binding, it affected p53 binding in a significant manner, ranging from 50% to 25% of p53 bound to the Sp1 mutant probe relative to the native probe ( Fig. 1 E, lane 3).

[ "Although", "mutation", " ", "of", "the", " ", "Sp1", "site", "did", "not", "block", " ", "p53", "binding", ",", "it", "affected", " ", "p53", "binding", "in", "a", " ", "significant", "manner", ",", "ranging", "from", "50", "%", " ", "to", "25", "%"...

[ "experimental-construct", "DNA", "protein" ]

perfusion is an umlsterm, shock is an umlsterm, mucosa is an umlsterm, oxygen is an umlsterm, vessels is an umlsterm, mucosa is an umlsterm, tip is an umlsterm, risk is an umlsterm, ischemia is an umlsterm, dysfunction is an umlsterm, bacteria is an umlsterm, toxins is an umlsterm, leukocytes is an umlsterm, cytokine i...

DerAnaesthesist.00490446.eng.abstr_0

Sentence: The splanchnic perfusion is reduced early in the course of any shock . The mucosa of the gut suffers most as it experiences a high oxygen demand even in the steady state . The specific arrangement of the micro vessels within the villus of the mucosa exposes the tip of the villus at the highest risk for ischem...

[ "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umls...

The splanchnic perfusion is reduced early in the course of any shock . The mucosa of the gut suffers most as it experiences a high oxygen demand even in the steady state . The specific arrangement of the micro vessels within the villus of the mucosa exposes the tip of the villus at the highest risk for ischemia , parti...

[ "The", "splanchnic", "perfusion", "is", "reduced", "early", "in", "the", "course", "of", "any", "shock", ".", "The", "mucosa", "of", "the", "gut", "suffers", "most", "as", "it", "experiences", "a", "high", "oxygen", "demand", "even", "in", "the", "steady",...

[ "umlsterm" ]

perfusion is an umlsterm, shock is an umlsterm, mucosa is an umlsterm, oxygen is an umlsterm, vessels is an umlsterm, mucosa is an umlsterm, tip is an umlsterm, risk is an umlsterm, ischemia is an umlsterm, dysfunction is an umlsterm, bacteria is an umlsterm, toxins is an umlsterm, leukocytes is an umlsterm, cytokine i...

DerAnaesthesist.00490446.eng.abstr_1

Sentence: The splanchnic perfusion is reduced early in the course of any shock . The mucosa of the gut suffers most as it experiences a high oxygen demand even in the steady state . The specific arrangement of the micro vessels within the villus of the mucosa exposes the tip of the villus at the highest risk for ischem...

[ "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umls...

The splanchnic perfusion is reduced early in the course of any shock . The mucosa of the gut suffers most as it experiences a high oxygen demand even in the steady state . The specific arrangement of the micro vessels within the villus of the mucosa exposes the tip of the villus at the highest risk for ischemia , parti...

[ "The", "splanchnic", "perfusion", "is", "reduced", "early", "in", "the", "course", "of", "any", "shock", ".", "The", "mucosa", "of", "the", "gut", "suffers", "most", "as", "it", "experiences", "a", "high", "oxygen", "demand", "even", "in", "the", "steady",...

[ "umlsterm" ]

perfusion, shock, mucosa, oxygen, vessels, mucosa, tip, risk, ischemia, dysfunction, bacteria, toxins, leukocytes, cytokine, syndrome, role, shock, dysfunction

DerAnaesthesist.00490446.eng.abstr_2

Sentence: The splanchnic perfusion is reduced early in the course of any shock . The mucosa of the gut suffers most as it experiences a high oxygen demand even in the steady state . The specific arrangement of the micro vessels within the villus of the mucosa exposes the tip of the villus at the highest risk for ischem...

[ "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umls...

The splanchnic perfusion is reduced early in the course of any shock . The mucosa of the gut suffers most as it experiences a high oxygen demand even in the steady state . The specific arrangement of the micro vessels within the villus of the mucosa exposes the tip of the villus at the highest risk for ischemia , parti...

[ "The", "splanchnic", "perfusion", "is", "reduced", "early", "in", "the", "course", "of", "any", "shock", ".", "The", "mucosa", "of", "the", "gut", "suffers", "most", "as", "it", "experiences", "a", "high", "oxygen", "demand", "even", "in", "the", "steady",...

[ "umlsterm" ]

HCC70 is a cellline

2778_0

Sentence: C Correlation plot between Cisplatin IC50 (half maximal inhibitory concentration) and H2AX protein level defined by western blots in BC cell lines (MCF7, BT474, MDA361, SKBr3, MDA453, MDA231, HCC70). Correlation coefficients σ and P-value are based on Spearman's rank correlation test. Instructions...

[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-cellline", "O", "O", "O", "O", "O", "O", ...

C Correlation plot between Cisplatin IC50 (half maximal inhibitory concentration) and H2AX protein level defined by western blots in BC cell lines (MCF7, BT474, MDA361, SKBr3, MDA453, MDA231, HCC70). Correlation coefficients σ and P-value are based on Spearman's rank correlation test.

[ "C", "Correlation", "plot", "between", "Cisplatin", "IC50", "(", "half", "maximal", "inhibitory", "concentration", ")", "and", "H2AX", "protein", "level", "defined", "by", "western", "blots", "in", "BC", "cell", "lines", "(", "MCF7", ",", "BT474", ",", "MDA3...

[ "cellline" ]

HCC70 is a cellline

2778_1

Sentence: C Correlation plot between Cisplatin IC50 (half maximal inhibitory concentration) and H2AX protein level defined by western blots in BC cell lines (MCF7, BT474, MDA361, SKBr3, MDA453, MDA231, HCC70). Correlation coefficients σ and P-value are based on Spearman's rank correlation test. Instructions...

[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-cellline", "O", "O", "O", "O", "O", "O", ...

C Correlation plot between Cisplatin IC50 (half maximal inhibitory concentration) and H2AX protein level defined by western blots in BC cell lines (MCF7, BT474, MDA361, SKBr3, MDA453, MDA231, HCC70). Correlation coefficients σ and P-value are based on Spearman's rank correlation test.

[ "C", "Correlation", "plot", "between", "Cisplatin", "IC50", "(", "half", "maximal", "inhibitory", "concentration", ")", "and", "H2AX", "protein", "level", "defined", "by", "western", "blots", "in", "BC", "cell", "lines", "(", "MCF7", ",", "BT474", ",", "MDA3...

[ "cellline" ]

HCC70

2778_2

Sentence: C Correlation plot between Cisplatin IC50 (half maximal inhibitory concentration) and H2AX protein level defined by western blots in BC cell lines (MCF7, BT474, MDA361, SKBr3, MDA453, MDA231, HCC70). Correlation coefficients σ and P-value are based on Spearman's rank correlation test. Instructions...

[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-cellline", "O", "O", "O", "O", "O", "O", ...

C Correlation plot between Cisplatin IC50 (half maximal inhibitory concentration) and H2AX protein level defined by western blots in BC cell lines (MCF7, BT474, MDA361, SKBr3, MDA453, MDA231, HCC70). Correlation coefficients σ and P-value are based on Spearman's rank correlation test.

[ "C", "Correlation", "plot", "between", "Cisplatin", "IC50", "(", "half", "maximal", "inhibitory", "concentration", ")", "and", "H2AX", "protein", "level", "defined", "by", "western", "blots", "in", "BC", "cell", "lines", "(", "MCF7", ",", "BT474", ",", "MDA3...

[ "cellline" ]

ROCK is a protein

10326_0

Sentence: (d) ROCK activity is increased upon starvation. Cell lines (HeLa and EJ) grown in control (+Glu) or starved with HBSS for 1 and 3 h were lysed, extracts normalized and ROCK kinase activity was measured by performing enzyme-linked immunosorbent assay. Graphs represent ROCK activity in starved cells plotted as ...

[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "...

(d) ROCK activity is increased upon starvation. Cell lines (HeLa and EJ) grown in control (+Glu) or starved with HBSS for 1 and 3 h were lysed, extracts normalized and ROCK kinase activity was measured by performing enzyme-linked immunosorbent assay. Graphs represent ROCK activity in starved cells plotted as percent of...

[ "(", "d", ")", "ROCK", "activity", "is", "increased", "upon", "starvation", ".", "Cell", "lines", "(", "HeLa", "and", "EJ", ")", "grown", "in", "control", "(", "+", "Glu", ")", "or", "starved", "with", "HBSS", "for", "1", "and", "3", "h", "were", "...

[ "protein" ]

ROCK is a protein

10326_1

Sentence: (d) ROCK activity is increased upon starvation. Cell lines (HeLa and EJ) grown in control (+Glu) or starved with HBSS for 1 and 3 h were lysed, extracts normalized and ROCK kinase activity was measured by performing enzyme-linked immunosorbent assay. Graphs represent ROCK activity in starved cells plotted as ...

[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "...

(d) ROCK activity is increased upon starvation. Cell lines (HeLa and EJ) grown in control (+Glu) or starved with HBSS for 1 and 3 h were lysed, extracts normalized and ROCK kinase activity was measured by performing enzyme-linked immunosorbent assay. Graphs represent ROCK activity in starved cells plotted as percent of...

[ "(", "d", ")", "ROCK", "activity", "is", "increased", "upon", "starvation", ".", "Cell", "lines", "(", "HeLa", "and", "EJ", ")", "grown", "in", "control", "(", "+", "Glu", ")", "or", "starved", "with", "HBSS", "for", "1", "and", "3", "h", "were", "...

[ "protein" ]

ROCK

10326_2

Sentence: (d) ROCK activity is increased upon starvation. Cell lines (HeLa and EJ) grown in control (+Glu) or starved with HBSS for 1 and 3 h were lysed, extracts normalized and ROCK kinase activity was measured by performing enzyme-linked immunosorbent assay. Graphs represent ROCK activity in starved cells plotted as ...

[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "...

(d) ROCK activity is increased upon starvation. Cell lines (HeLa and EJ) grown in control (+Glu) or starved with HBSS for 1 and 3 h were lysed, extracts normalized and ROCK kinase activity was measured by performing enzyme-linked immunosorbent assay. Graphs represent ROCK activity in starved cells plotted as percent of...

[ "(", "d", ")", "ROCK", "activity", "is", "increased", "upon", "starvation", ".", "Cell", "lines", "(", "HeLa", "and", "EJ", ")", "grown", "in", "control", "(", "+", "Glu", ")", "or", "starved", "with", "HBSS", "for", "1", "and", "3", "h", "were", "...

[ "protein" ]

Abstract is an umlsterm, cell is an umlsterm, non - Hodgkin lymphomas is an umlsterm, cell is an umlsterm, lymphomas is an umlsterm, diagnosis is an umlsterm, treatment is an umlsterm, antibiotics is an umlsterm, malignant is an umlsterm, non - Hodgkin lymphoma is an umlsterm, tumour is an umlsterm, lymphoid cells is a...

DerHautarzt.50460028.eng.abstr_0

Sentence: Abstract . Primary cutaneous large cell anaplastic non-Hodgkin lymphomas positive for Ki-1-antigen are rarely described . There are 100 published cases worldwide . Typically large cell anaplastic lymphomas have an inflammatory appearance , which often leads to false diagnosis and unsuccessful treatment with a...

[ "B-umlsterm", "O", "O", "O", "O", "B-umlsterm", "O", "B-umlsterm", "I-umlsterm", "I-umlsterm", "I-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "B-umlsterm", "O", "O", "O", "O", "O", ...

Abstract . Primary cutaneous large cell anaplastic non-Hodgkin lymphomas positive for Ki-1-antigen are rarely described . There are 100 published cases worldwide . Typically large cell anaplastic lymphomas have an inflammatory appearance , which often leads to false diagnosis and unsuccessful treatment with antibiotics...

[ "Abstract", ".", "Primary", "cutaneous", "large", "cell", "anaplastic", "non", "-", "Hodgkin", "lymphomas", "positive", "for", "Ki-1-antigen", "are", "rarely", "described", ".", "There", "are", "100", "published", "cases", "worldwide", ".", "Typically", "large", ...

[ "umlsterm" ]

Abstract is an umlsterm, cell is an umlsterm, non - Hodgkin lymphomas is an umlsterm, cell is an umlsterm, lymphomas is an umlsterm, diagnosis is an umlsterm, treatment is an umlsterm, antibiotics is an umlsterm, malignant is an umlsterm, non - Hodgkin lymphoma is an umlsterm, tumour is an umlsterm, lymphoid cells is a...

DerHautarzt.50460028.eng.abstr_1

Sentence: Abstract . Primary cutaneous large cell anaplastic non-Hodgkin lymphomas positive for Ki-1-antigen are rarely described . There are 100 published cases worldwide . Typically large cell anaplastic lymphomas have an inflammatory appearance , which often leads to false diagnosis and unsuccessful treatment with a...

[ "B-umlsterm", "O", "O", "O", "O", "B-umlsterm", "O", "B-umlsterm", "I-umlsterm", "I-umlsterm", "I-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "B-umlsterm", "O", "O", "O", "O", "O", ...

Abstract . Primary cutaneous large cell anaplastic non-Hodgkin lymphomas positive for Ki-1-antigen are rarely described . There are 100 published cases worldwide . Typically large cell anaplastic lymphomas have an inflammatory appearance , which often leads to false diagnosis and unsuccessful treatment with antibiotics...

[ "Abstract", ".", "Primary", "cutaneous", "large", "cell", "anaplastic", "non", "-", "Hodgkin", "lymphomas", "positive", "for", "Ki-1-antigen", "are", "rarely", "described", ".", "There", "are", "100", "published", "cases", "worldwide", ".", "Typically", "large", ...

[ "umlsterm" ]

Abstract, cell, non - Hodgkin lymphomas, cell, lymphomas, diagnosis, treatment, antibiotics, malignant, non - Hodgkin lymphoma, tumour, lymphoid cells, diagnosis, CD30 antigen, tumour, cells, lymphoma, Berlin, patients, diagnosis, cutaneous lymphoma, patient, lymph node, stage, tumour, stage, adjuvant, polychemotherapy...

DerHautarzt.50460028.eng.abstr_2

Sentence: Abstract . Primary cutaneous large cell anaplastic non-Hodgkin lymphomas positive for Ki-1-antigen are rarely described . There are 100 published cases worldwide . Typically large cell anaplastic lymphomas have an inflammatory appearance , which often leads to false diagnosis and unsuccessful treatment with a...

[ "B-umlsterm", "O", "O", "O", "O", "B-umlsterm", "O", "B-umlsterm", "I-umlsterm", "I-umlsterm", "I-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "B-umlsterm", "O", "O", "O", "O", "O", ...

Abstract . Primary cutaneous large cell anaplastic non-Hodgkin lymphomas positive for Ki-1-antigen are rarely described . There are 100 published cases worldwide . Typically large cell anaplastic lymphomas have an inflammatory appearance , which often leads to false diagnosis and unsuccessful treatment with antibiotics...

[ "Abstract", ".", "Primary", "cutaneous", "large", "cell", "anaplastic", "non", "-", "Hodgkin", "lymphomas", "positive", "for", "Ki-1-antigen", "are", "rarely", "described", ".", "There", "are", "100", "published", "cases", "worldwide", ".", "Typically", "large", ...

[ "umlsterm" ]

Zinc is a CHEMICAL, MTF-1 is a GENE-Y, ZnT4 is a GENE-Y, Slc30a4 is a GENE-Y

23368743_0

Sentence: Zinc-dependent lysosomal enlargement in TRPML1-deficient cells involves MTF-1 transcription factor and ZnT4 (Slc30a4) transporter. Instructions: please extract entities and their types from the input sentence, all entity types are in options Options: CHEMICAL, GENE-Y

[ "B-CHEMICAL", "O", "O", "O", "O", "O", "O", "O", "O", "B-GENE-Y", "O", "O", "O", "B-GENE-Y", "O", "B-GENE-Y", "O", "O", "O" ]

Zinc-dependent lysosomal enlargement in TRPML1-deficient cells involves MTF-1 transcription factor and ZnT4 (Slc30a4) transporter.

[ "Zinc", "-", "dependent", "lysosomal", "enlargement", "in", "TRPML1-deficient", "cells", "involves", "MTF-1", "transcription", "factor", "and", "ZnT4", "(", "Slc30a4", ")", "transporter", "." ]

[ "GENE-Y", "GENE-N", "CHEMICAL" ]

Zinc is a CHEMICAL, MTF-1 is a GENE-Y, ZnT4 is a GENE-Y, Slc30a4 is a GENE-Y

23368743_1

Sentence: Zinc-dependent lysosomal enlargement in TRPML1-deficient cells involves MTF-1 transcription factor and ZnT4 (Slc30a4) transporter. Instructions: please typing these entity words according to sentence: Zinc, MTF-1, ZnT4, Slc30a4 Options: CHEMICAL, GENE-Y

[ "B-CHEMICAL", "O", "O", "O", "O", "O", "O", "O", "O", "B-GENE-Y", "O", "O", "O", "B-GENE-Y", "O", "B-GENE-Y", "O", "O", "O" ]

Zinc-dependent lysosomal enlargement in TRPML1-deficient cells involves MTF-1 transcription factor and ZnT4 (Slc30a4) transporter.

[ "Zinc", "-", "dependent", "lysosomal", "enlargement", "in", "TRPML1-deficient", "cells", "involves", "MTF-1", "transcription", "factor", "and", "ZnT4", "(", "Slc30a4", ")", "transporter", "." ]

[ "GENE-Y", "GENE-N", "CHEMICAL" ]

Zinc, MTF-1, ZnT4, Slc30a4

23368743_2

Sentence: Zinc-dependent lysosomal enlargement in TRPML1-deficient cells involves MTF-1 transcription factor and ZnT4 (Slc30a4) transporter. Instructions: please extract entity words from the input sentence

[ "B-CHEMICAL", "O", "O", "O", "O", "O", "O", "O", "O", "B-GENE-Y", "O", "O", "O", "B-GENE-Y", "O", "B-GENE-Y", "O", "O", "O" ]

Zinc-dependent lysosomal enlargement in TRPML1-deficient cells involves MTF-1 transcription factor and ZnT4 (Slc30a4) transporter.

[ "Zinc", "-", "dependent", "lysosomal", "enlargement", "in", "TRPML1-deficient", "cells", "involves", "MTF-1", "transcription", "factor", "and", "ZnT4", "(", "Slc30a4", ")", "transporter", "." ]

[ "GENE-Y", "GENE-N", "CHEMICAL" ]

LC3 is a protein

18532_0

Sentence: (b) Immunofluorescence for LC3 in MOBs treated with vehicle or 18α glycyrrhetinic acid. Where indicated, chloroquine (CQ) was added to block lysosomal degradation. Bottom: Quantification of the average number of LC3-positive puncta per cell (n = 3 wells, 3 independent experiments, >30 cells per experiment). ...

[ "O", "O", "O", "O", "O", "B-protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", ...

(b) Immunofluorescence for LC3 in MOBs treated with vehicle or 18α glycyrrhetinic acid. Where indicated, chloroquine (CQ) was added to block lysosomal degradation. Bottom: Quantification of the average number of LC3-positive puncta per cell (n = 3 wells, 3 independent experiments, >30 cells per experiment).

[ "(", "b", ")", "Immunofluorescence", "for", "LC3", "in", "MOBs", "treated", "with", "vehicle", "or", "18α", "glycyrrhetinic", "acid", ".", "Where", "indicated", ",", "chloroquine", "(", "CQ", ")", "was", "added", "to", "block", "lysosomal", "degradation", "....

[ "protein" ]

LC3 is a protein

18532_1

Sentence: (b) Immunofluorescence for LC3 in MOBs treated with vehicle or 18α glycyrrhetinic acid. Where indicated, chloroquine (CQ) was added to block lysosomal degradation. Bottom: Quantification of the average number of LC3-positive puncta per cell (n = 3 wells, 3 independent experiments, >30 cells per experiment). ...

[ "O", "O", "O", "O", "O", "B-protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", ...

(b) Immunofluorescence for LC3 in MOBs treated with vehicle or 18α glycyrrhetinic acid. Where indicated, chloroquine (CQ) was added to block lysosomal degradation. Bottom: Quantification of the average number of LC3-positive puncta per cell (n = 3 wells, 3 independent experiments, >30 cells per experiment).

[ "(", "b", ")", "Immunofluorescence", "for", "LC3", "in", "MOBs", "treated", "with", "vehicle", "or", "18α", "glycyrrhetinic", "acid", ".", "Where", "indicated", ",", "chloroquine", "(", "CQ", ")", "was", "added", "to", "block", "lysosomal", "degradation", "....

[ "protein" ]

LC3

18532_2

Sentence: (b) Immunofluorescence for LC3 in MOBs treated with vehicle or 18α glycyrrhetinic acid. Where indicated, chloroquine (CQ) was added to block lysosomal degradation. Bottom: Quantification of the average number of LC3-positive puncta per cell (n = 3 wells, 3 independent experiments, >30 cells per experiment). ...

[ "O", "O", "O", "O", "O", "B-protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", ...

(b) Immunofluorescence for LC3 in MOBs treated with vehicle or 18α glycyrrhetinic acid. Where indicated, chloroquine (CQ) was added to block lysosomal degradation. Bottom: Quantification of the average number of LC3-positive puncta per cell (n = 3 wells, 3 independent experiments, >30 cells per experiment).

[ "(", "b", ")", "Immunofluorescence", "for", "LC3", "in", "MOBs", "treated", "with", "vehicle", "or", "18α", "glycyrrhetinic", "acid", ".", "Where", "indicated", ",", "chloroquine", "(", "CQ", ")", "was", "added", "to", "block", "lysosomal", "degradation", "....

[ "protein" ]

myc is a protein

32459_0

Sentence: F. Co-transfection of HEK293 cells with GADD34-Flag and different myc-tagged Nox4 constructs, followed by IP with an anti-myc antibody. GADD34 binds to full-length Nox4 (FL) and the Nox4 transmembrane domain (TD) but not the C-terminal domain (CD). Instructions: please extract entities and their t...

[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", ...

F. Co-transfection of HEK293 cells with GADD34-Flag and different myc-tagged Nox4 constructs, followed by IP with an anti-myc antibody. GADD34 binds to full-length Nox4 (FL) and the Nox4 transmembrane domain (TD) but not the C-terminal domain (CD).

[ "F.", "Co", "-", "transfection", "of", "HEK293", "cells", "with", "GADD34-Flag", "and", "different", "myc", "-", "tagged", "Nox4", "constructs", ",", "followed", "by", "IP", "with", "an", "anti", "-", "myc", "antibody", ".", "GADD34", "binds", "to", "full"...

[ "protein" ]

myc is a protein

32459_1

Sentence: F. Co-transfection of HEK293 cells with GADD34-Flag and different myc-tagged Nox4 constructs, followed by IP with an anti-myc antibody. GADD34 binds to full-length Nox4 (FL) and the Nox4 transmembrane domain (TD) but not the C-terminal domain (CD). Instructions: please typing these entity words ac...

[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", ...

F. Co-transfection of HEK293 cells with GADD34-Flag and different myc-tagged Nox4 constructs, followed by IP with an anti-myc antibody. GADD34 binds to full-length Nox4 (FL) and the Nox4 transmembrane domain (TD) but not the C-terminal domain (CD).

[ "F.", "Co", "-", "transfection", "of", "HEK293", "cells", "with", "GADD34-Flag", "and", "different", "myc", "-", "tagged", "Nox4", "constructs", ",", "followed", "by", "IP", "with", "an", "anti", "-", "myc", "antibody", ".", "GADD34", "binds", "to", "full"...

[ "protein" ]

myc

32459_2

Sentence: F. Co-transfection of HEK293 cells with GADD34-Flag and different myc-tagged Nox4 constructs, followed by IP with an anti-myc antibody. GADD34 binds to full-length Nox4 (FL) and the Nox4 transmembrane domain (TD) but not the C-terminal domain (CD). Instructions: please extract entity words from th...

[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", ...

F. Co-transfection of HEK293 cells with GADD34-Flag and different myc-tagged Nox4 constructs, followed by IP with an anti-myc antibody. GADD34 binds to full-length Nox4 (FL) and the Nox4 transmembrane domain (TD) but not the C-terminal domain (CD).

[ "F.", "Co", "-", "transfection", "of", "HEK293", "cells", "with", "GADD34-Flag", "and", "different", "myc", "-", "tagged", "Nox4", "constructs", ",", "followed", "by", "IP", "with", "an", "anti", "-", "myc", "antibody", ".", "GADD34", "binds", "to", "full"...

[ "protein" ]

alpha 2B - adrenoceptors is a GENE-Y, etomidate is a CHEMICAL

14508322_0

Sentence: Activation of alpha 2B-adrenoceptors mediates the cardiovascular effects of etomidate. Instructions: please extract entities and their types from the input sentence, all entity types are in options Options: CHEMICAL, GENE-Y

[ "O", "O", "B-GENE-Y", "I-GENE-Y", "I-GENE-Y", "I-GENE-Y", "O", "O", "O", "O", "O", "B-CHEMICAL", "O" ]

Activation of alpha 2B-adrenoceptors mediates the cardiovascular effects of etomidate.

[ "Activation", "of", "alpha", "2B", "-", "adrenoceptors", "mediates", "the", "cardiovascular", "effects", "of", "etomidate", "." ]

[ "GENE-N", "GENE-Y", "CHEMICAL" ]

alpha 2B - adrenoceptors is a GENE-Y, etomidate is a CHEMICAL

14508322_1

Sentence: Activation of alpha 2B-adrenoceptors mediates the cardiovascular effects of etomidate. Instructions: please typing these entity words according to sentence: alpha 2B - adrenoceptors, etomidate Options: CHEMICAL, GENE-Y

[ "O", "O", "B-GENE-Y", "I-GENE-Y", "I-GENE-Y", "I-GENE-Y", "O", "O", "O", "O", "O", "B-CHEMICAL", "O" ]

Activation of alpha 2B-adrenoceptors mediates the cardiovascular effects of etomidate.

[ "Activation", "of", "alpha", "2B", "-", "adrenoceptors", "mediates", "the", "cardiovascular", "effects", "of", "etomidate", "." ]

[ "GENE-N", "GENE-Y", "CHEMICAL" ]

alpha 2B - adrenoceptors, etomidate

14508322_2

Sentence: Activation of alpha 2B-adrenoceptors mediates the cardiovascular effects of etomidate. Instructions: please extract entity words from the input sentence

[ "O", "O", "B-GENE-Y", "I-GENE-Y", "I-GENE-Y", "I-GENE-Y", "O", "O", "O", "O", "O", "B-CHEMICAL", "O" ]

Activation of alpha 2B-adrenoceptors mediates the cardiovascular effects of etomidate.

[ "Activation", "of", "alpha", "2B", "-", "adrenoceptors", "mediates", "the", "cardiovascular", "effects", "of", "etomidate", "." ]

[ "GENE-N", "GENE-Y", "CHEMICAL" ]

IL-2 receptor alpha - chain is a Protein, protein kinase C - independent mechanism is a Entity, IL-2 is a Protein, IL-2R alpha is a Protein, IL-2R alpha is a Protein, IL-2R alpha is a Protein, IL-2R alpha is a Protein, IL-2R alpha is a Protein, IL-2R alpha is a Protein, IL-2R alpha is a Protein, IL-2R alpha is a Protei...

393_0

Sentence: Thapsigargin induces IL-2 receptor alpha-chain in human peripheral and Jurkat T cells via a protein kinase C-independent mechanism. Thapsigargin (TG), an inhibitor of Ca(2+)-ATPase, depletes intracellular Ca2+ stores and induces a sustained Ca2+ influx without altering phosphatidyl inositol levels. TG plus p...

[ "O", "O", "B-Protein", "I-Protein", "I-Protein", "I-Protein", "I-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Entity", "I-Entity", "I-Entity", "I-Entity", "I-Entity", "I-Entity", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O"...

Thapsigargin induces IL-2 receptor alpha-chain in human peripheral and Jurkat T cells via a protein kinase C-independent mechanism. Thapsigargin (TG), an inhibitor of Ca(2+)-ATPase, depletes intracellular Ca2+ stores and induces a sustained Ca2+ influx without altering phosphatidyl inositol levels. TG plus phorbol myr...

[ "Thapsigargin", "induces", "IL-2", "receptor", "alpha", "-", "chain", "in", "human", "peripheral", "and", "Jurkat", "T", "cells", "via", "a", "protein", "kinase", "C", "-", "independent", "mechanism", ".", "\n", "Thapsigargin", "(", "TG", ")", ",", "an", "...

[ "Entity", "Protein" ]

IL-2 receptor alpha - chain is a Protein, protein kinase C - independent mechanism is a Entity, IL-2 is a Protein, IL-2R alpha is a Protein, IL-2R alpha is a Protein, IL-2R alpha is a Protein, IL-2R alpha is a Protein, IL-2R alpha is a Protein, IL-2R alpha is a Protein, IL-2R alpha is a Protein, IL-2R alpha is a Protei...

393_1

Sentence: Thapsigargin induces IL-2 receptor alpha-chain in human peripheral and Jurkat T cells via a protein kinase C-independent mechanism. Thapsigargin (TG), an inhibitor of Ca(2+)-ATPase, depletes intracellular Ca2+ stores and induces a sustained Ca2+ influx without altering phosphatidyl inositol levels. TG plus p...

[ "O", "O", "B-Protein", "I-Protein", "I-Protein", "I-Protein", "I-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Entity", "I-Entity", "I-Entity", "I-Entity", "I-Entity", "I-Entity", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O"...

Thapsigargin induces IL-2 receptor alpha-chain in human peripheral and Jurkat T cells via a protein kinase C-independent mechanism. Thapsigargin (TG), an inhibitor of Ca(2+)-ATPase, depletes intracellular Ca2+ stores and induces a sustained Ca2+ influx without altering phosphatidyl inositol levels. TG plus phorbol myr...

[ "Thapsigargin", "induces", "IL-2", "receptor", "alpha", "-", "chain", "in", "human", "peripheral", "and", "Jurkat", "T", "cells", "via", "a", "protein", "kinase", "C", "-", "independent", "mechanism", ".", "\n", "Thapsigargin", "(", "TG", ")", ",", "an", "...

[ "Entity", "Protein" ]

IL-2 receptor alpha - chain, protein kinase C - independent mechanism, IL-2, IL-2R alpha, IL-2R alpha, IL-2R alpha, IL-2R alpha, IL-2R alpha, IL-2R alpha, IL-2R alpha, IL-2R alpha

393_2

Sentence: Thapsigargin induces IL-2 receptor alpha-chain in human peripheral and Jurkat T cells via a protein kinase C-independent mechanism. Thapsigargin (TG), an inhibitor of Ca(2+)-ATPase, depletes intracellular Ca2+ stores and induces a sustained Ca2+ influx without altering phosphatidyl inositol levels. TG plus p...

[ "O", "O", "B-Protein", "I-Protein", "I-Protein", "I-Protein", "I-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Entity", "I-Entity", "I-Entity", "I-Entity", "I-Entity", "I-Entity", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O"...

Thapsigargin induces IL-2 receptor alpha-chain in human peripheral and Jurkat T cells via a protein kinase C-independent mechanism. Thapsigargin (TG), an inhibitor of Ca(2+)-ATPase, depletes intracellular Ca2+ stores and induces a sustained Ca2+ influx without altering phosphatidyl inositol levels. TG plus phorbol myr...

[ "Thapsigargin", "induces", "IL-2", "receptor", "alpha", "-", "chain", "in", "human", "peripheral", "and", "Jurkat", "T", "cells", "via", "a", "protein", "kinase", "C", "-", "independent", "mechanism", ".", "\n", "Thapsigargin", "(", "TG", ")", ",", "an", "...

[ "Entity", "Protein" ]

mice is a species

10116_0

Sentence: Following injection of 20 mg/kg of RK-33, twice a week for 7 weeks, extensive histopathological examination was carried out following necropsy. Identical patterns were observed both in the control and in the treated mice (n = 2). Samples were stained with H&E. Scale bar is 50 μm. Instructions: ple...

[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-species", "O", "O", "O", "O", "O", ...

Following injection of 20 mg/kg of RK-33, twice a week for 7 weeks, extensive histopathological examination was carried out following necropsy. Identical patterns were observed both in the control and in the treated mice (n = 2). Samples were stained with H&E. Scale bar is 50 μm.

[ "Following", "injection", "of", "20", "mg", "/", "kg", "of", "RK-33", ",", "twice", "a", "week", "for", "7", "weeks", ",", "extensive", "histopathological", "examination", "was", "carried", "out", "following", "necropsy", ".", "Identical", "patterns", "were", ...

[ "species" ]

mice is a species

10116_1

Sentence: Following injection of 20 mg/kg of RK-33, twice a week for 7 weeks, extensive histopathological examination was carried out following necropsy. Identical patterns were observed both in the control and in the treated mice (n = 2). Samples were stained with H&E. Scale bar is 50 μm. Instructions: ple...

[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-species", "O", "O", "O", "O", "O", ...

Following injection of 20 mg/kg of RK-33, twice a week for 7 weeks, extensive histopathological examination was carried out following necropsy. Identical patterns were observed both in the control and in the treated mice (n = 2). Samples were stained with H&E. Scale bar is 50 μm.

[ "Following", "injection", "of", "20", "mg", "/", "kg", "of", "RK-33", ",", "twice", "a", "week", "for", "7", "weeks", ",", "extensive", "histopathological", "examination", "was", "carried", "out", "following", "necropsy", ".", "Identical", "patterns", "were", ...

[ "species" ]

mice

10116_2

Sentence: Following injection of 20 mg/kg of RK-33, twice a week for 7 weeks, extensive histopathological examination was carried out following necropsy. Identical patterns were observed both in the control and in the treated mice (n = 2). Samples were stained with H&E. Scale bar is 50 μm. Instructions: ple...

[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-species", "O", "O", "O", "O", "O", ...

Following injection of 20 mg/kg of RK-33, twice a week for 7 weeks, extensive histopathological examination was carried out following necropsy. Identical patterns were observed both in the control and in the treated mice (n = 2). Samples were stained with H&E. Scale bar is 50 μm.

[ "Following", "injection", "of", "20", "mg", "/", "kg", "of", "RK-33", ",", "twice", "a", "week", "for", "7", "weeks", ",", "extensive", "histopathological", "examination", "was", "carried", "out", "following", "necropsy", ".", "Identical", "patterns", "were", ...

[ "species" ]

triazole is a compound, gp120 is a protein, CD4 is a protein

DS.d254_0

Sentence: In this work, we identified a high affinity and potency metallocene-containing triazole peptide conjugate that suppresses the interactions of HIV-1 envelope gp120 at both its CD4 and co-receptor binding sites. Instructions: please extract entities and their types from the input sentence, all entit...

[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-compound", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-protein", "O", "O", "O", "B-protein", "O", "O", "O", "O", "O", "O", "O" ]

In this work, we identified a high affinity and potency metallocene-containing triazole peptide conjugate that suppresses the interactions of HIV-1 envelope gp120 at both its CD4 and co-receptor binding sites.

[ "In", "this", "work", ",", "we", "identified", "a", "high", "affinity", "and", "potency", "metallocene", "-", "containing", "triazole", "peptide", "conjugate", "that", "suppresses", "the", "interactions", "of", "HIV-1", "envelope", "gp120", "at", "both", "its", ...

[ "compound", "protein" ]

triazole is a compound, gp120 is a protein, CD4 is a protein

DS.d254_1

Sentence: In this work, we identified a high affinity and potency metallocene-containing triazole peptide conjugate that suppresses the interactions of HIV-1 envelope gp120 at both its CD4 and co-receptor binding sites. Instructions: please typing these entity words according to sentence: triazole, gp120, C...

[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-compound", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-protein", "O", "O", "O", "B-protein", "O", "O", "O", "O", "O", "O", "O" ]

In this work, we identified a high affinity and potency metallocene-containing triazole peptide conjugate that suppresses the interactions of HIV-1 envelope gp120 at both its CD4 and co-receptor binding sites.

[ "In", "this", "work", ",", "we", "identified", "a", "high", "affinity", "and", "potency", "metallocene", "-", "containing", "triazole", "peptide", "conjugate", "that", "suppresses", "the", "interactions", "of", "HIV-1", "envelope", "gp120", "at", "both", "its", ...

[ "compound", "protein" ]

triazole, gp120, CD4

DS.d254_2

Sentence: In this work, we identified a high affinity and potency metallocene-containing triazole peptide conjugate that suppresses the interactions of HIV-1 envelope gp120 at both its CD4 and co-receptor binding sites. Instructions: please extract entity words from the input sentence

[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-compound", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-protein", "O", "O", "O", "B-protein", "O", "O", "O", "O", "O", "O", "O" ]

In this work, we identified a high affinity and potency metallocene-containing triazole peptide conjugate that suppresses the interactions of HIV-1 envelope gp120 at both its CD4 and co-receptor binding sites.

[ "In", "this", "work", ",", "we", "identified", "a", "high", "affinity", "and", "potency", "metallocene", "-", "containing", "triazole", "peptide", "conjugate", "that", "suppresses", "the", "interactions", "of", "HIV-1", "envelope", "gp120", "at", "both", "its", ...

[ "compound", "protein" ]

technology is an umlsterm, sonography is an umlsterm, ultrasound is an umlsterm, developments is an umlsterm, ultrasound is an umlsterm, devices is an umlsterm, imaging is an umlsterm, communication is an umlsterm, standard is an umlsterm, control is an umlsterm, maintenance is an umlsterm, ultrasound is an umlsterm, d...

DerGynaekologe.00330187.eng.abstr_0

Sentence: Due to the basic digital technology of modern sonography , a large number of new features have become available . It is easy for the sonographer to employ an ultrasound improvement such as 3D , but other developments , like the networking of ultrasound devices , are less well known . The following application...

[ "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", ...

Due to the basic digital technology of modern sonography , a large number of new features have become available . It is easy for the sonographer to employ an ultrasound improvement such as 3D , but other developments , like the networking of ultrasound devices , are less well known . The following applications demonstr...

[ "Due", "to", "the", "basic", "digital", "technology", "of", "modern", "sonography", ",", "a", "large", "number", "of", "new", "features", "have", "become", "available", ".", "It", "is", "easy", "for", "the", "sonographer", "to", "employ", "an", "ultrasound",...

[ "umlsterm" ]

technology is an umlsterm, sonography is an umlsterm, ultrasound is an umlsterm, developments is an umlsterm, ultrasound is an umlsterm, devices is an umlsterm, imaging is an umlsterm, communication is an umlsterm, standard is an umlsterm, control is an umlsterm, maintenance is an umlsterm, ultrasound is an umlsterm, d...

DerGynaekologe.00330187.eng.abstr_1

Sentence: Due to the basic digital technology of modern sonography , a large number of new features have become available . It is easy for the sonographer to employ an ultrasound improvement such as 3D , but other developments , like the networking of ultrasound devices , are less well known . The following application...

[ "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", ...

Due to the basic digital technology of modern sonography , a large number of new features have become available . It is easy for the sonographer to employ an ultrasound improvement such as 3D , but other developments , like the networking of ultrasound devices , are less well known . The following applications demonstr...

[ "Due", "to", "the", "basic", "digital", "technology", "of", "modern", "sonography", ",", "a", "large", "number", "of", "new", "features", "have", "become", "available", ".", "It", "is", "easy", "for", "the", "sonographer", "to", "employ", "an", "ultrasound",...

[ "umlsterm" ]

technology, sonography, ultrasound, developments, ultrasound, devices, imaging, communication, standard, control, maintenance, ultrasound, devices, devices, hand, devices, future, ultrasound

DerGynaekologe.00330187.eng.abstr_2

Sentence: Due to the basic digital technology of modern sonography , a large number of new features have become available . It is easy for the sonographer to employ an ultrasound improvement such as 3D , but other developments , like the networking of ultrasound devices , are less well known . The following application...

[ "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", ...

Due to the basic digital technology of modern sonography , a large number of new features have become available . It is easy for the sonographer to employ an ultrasound improvement such as 3D , but other developments , like the networking of ultrasound devices , are less well known . The following applications demonstr...

[ "Due", "to", "the", "basic", "digital", "technology", "of", "modern", "sonography", ",", "a", "large", "number", "of", "new", "features", "have", "become", "available", ".", "It", "is", "easy", "for", "the", "sonographer", "to", "employ", "an", "ultrasound",...

[ "umlsterm" ]

serine palmitoyltransferase is a GENE-N

17559874_0

Sentence: The structure of serine palmitoyltransferase; gateway to sphingolipid biosynthesis. Instructions: please extract entities and their types from the input sentence, all entity types are in options Options: GENE-N

[ "O", "O", "O", "B-GENE-N", "I-GENE-N", "O", "O", "O", "O", "O", "O" ]

The structure of serine palmitoyltransferase; gateway to sphingolipid biosynthesis.

[ "The", "structure", "of", "serine", "palmitoyltransferase", ";", "gateway", "to", "sphingolipid", "biosynthesis", "." ]

[ "GENE-N", "CHEMICAL", "GENE-Y" ]

serine palmitoyltransferase is a GENE-N

17559874_1

Sentence: The structure of serine palmitoyltransferase; gateway to sphingolipid biosynthesis. Instructions: please typing these entity words according to sentence: serine palmitoyltransferase Options: GENE-N

[ "O", "O", "O", "B-GENE-N", "I-GENE-N", "O", "O", "O", "O", "O", "O" ]

The structure of serine palmitoyltransferase; gateway to sphingolipid biosynthesis.

[ "The", "structure", "of", "serine", "palmitoyltransferase", ";", "gateway", "to", "sphingolipid", "biosynthesis", "." ]

[ "GENE-N", "CHEMICAL", "GENE-Y" ]

serine palmitoyltransferase

17559874_2

Sentence: The structure of serine palmitoyltransferase; gateway to sphingolipid biosynthesis. Instructions: please extract entity words from the input sentence

[ "O", "O", "O", "B-GENE-N", "I-GENE-N", "O", "O", "O", "O", "O", "O" ]

The structure of serine palmitoyltransferase; gateway to sphingolipid biosynthesis.

[ "The", "structure", "of", "serine", "palmitoyltransferase", ";", "gateway", "to", "sphingolipid", "biosynthesis", "." ]

[ "GENE-N", "CHEMICAL", "GENE-Y" ]

Erythropoietin is a protein_molecule, tyrosine phosphorylation is an other_name, Jak2 is a protein_molecule, STAT5A is a protein_molecule, STAT5B is a protein_molecule, primary cultured human erythroid precursors is a cell_type

78479_0

Sentence: Erythropoietin induces tyrosine phosphorylation of Jak2, STAT5A, and STAT5B in primary cultured human erythroid precursors. Instructions: please extract entities and their types from the input sentence, all entity types are in options Options: cell_type, protein_molecule, other_name ...

[ "B-protein_molecule", "O", "B-other_name", "I-other_name", "O", "B-protein_molecule", "O", "B-protein_molecule", "O", "O", "B-protein_molecule", "O", "B-cell_type", "I-cell_type", "I-cell_type", "I-cell_type", "I-cell_type", "O" ]

Erythropoietin induces tyrosine phosphorylation of Jak2, STAT5A, and STAT5B in primary cultured human erythroid precursors.

[ "Erythropoietin", "induces", "tyrosine", "phosphorylation", "of", "Jak2", ",", "STAT5A", ",", "and", "STAT5B", "in", "primary", "cultured", "human", "erythroid", "precursors", "." ]

[ "cell_type", "other_name", "protein_molecule", "DNA_domain_or_region", "cell_line", "amino_acid_monomer" ]

Erythropoietin is a protein_molecule, tyrosine phosphorylation is an other_name, Jak2 is a protein_molecule, STAT5A is a protein_molecule, STAT5B is a protein_molecule, primary cultured human erythroid precursors is a cell_type

78479_1

Sentence: Erythropoietin induces tyrosine phosphorylation of Jak2, STAT5A, and STAT5B in primary cultured human erythroid precursors. Instructions: please typing these entity words according to sentence: Erythropoietin, tyrosine phosphorylation, Jak2, STAT5A, STAT5B, primary cultured human erythroid precurs...

[ "B-protein_molecule", "O", "B-other_name", "I-other_name", "O", "B-protein_molecule", "O", "B-protein_molecule", "O", "O", "B-protein_molecule", "O", "B-cell_type", "I-cell_type", "I-cell_type", "I-cell_type", "I-cell_type", "O" ]

Erythropoietin induces tyrosine phosphorylation of Jak2, STAT5A, and STAT5B in primary cultured human erythroid precursors.

[ "Erythropoietin", "induces", "tyrosine", "phosphorylation", "of", "Jak2", ",", "STAT5A", ",", "and", "STAT5B", "in", "primary", "cultured", "human", "erythroid", "precursors", "." ]

[ "cell_type", "other_name", "protein_molecule", "DNA_domain_or_region", "cell_line", "amino_acid_monomer" ]

Erythropoietin, tyrosine phosphorylation, Jak2, STAT5A, STAT5B, primary cultured human erythroid precursors

78479_2

Sentence: Erythropoietin induces tyrosine phosphorylation of Jak2, STAT5A, and STAT5B in primary cultured human erythroid precursors. Instructions: please extract entity words from the input sentence

[ "B-protein_molecule", "O", "B-other_name", "I-other_name", "O", "B-protein_molecule", "O", "B-protein_molecule", "O", "O", "B-protein_molecule", "O", "B-cell_type", "I-cell_type", "I-cell_type", "I-cell_type", "I-cell_type", "O" ]

Erythropoietin induces tyrosine phosphorylation of Jak2, STAT5A, and STAT5B in primary cultured human erythroid precursors.

[ "Erythropoietin", "induces", "tyrosine", "phosphorylation", "of", "Jak2", ",", "STAT5A", ",", "and", "STAT5B", "in", "primary", "cultured", "human", "erythroid", "precursors", "." ]

[ "cell_type", "other_name", "protein_molecule", "DNA_domain_or_region", "cell_line", "amino_acid_monomer" ]

THP1 is a cellline

34051_0

Sentence: (A) THP1 cells were infected with HSV-1 KOS or an ICP27-deficient mutant (ΔICP27) on KOS genetic background (MOI 3). Supernatants were harvested from untreated cultures or cells infected for 12 or 18 hours for measurement of type I IFN bioactivity. Instructions: please extract entities and their t...

[ "O", "O", "O", "B-cellline", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", ...

(A) THP1 cells were infected with HSV-1 KOS or an ICP27-deficient mutant (ΔICP27) on KOS genetic background (MOI 3). Supernatants were harvested from untreated cultures or cells infected for 12 or 18 hours for measurement of type I IFN bioactivity.

[ "(", "A", ")", "THP1", "cells", "were", "infected", "with", "HSV-1", "KOS", "or", "an", "ICP27-deficient", "mutant", "(", "ΔICP27", ")", "on", "KOS", "genetic", "background", "(", "MOI", "3", ")", ".", "Supernatants", "were", "harvested", "from", "untreate...

[ "cellline" ]

THP1 is a cellline

34051_1

Sentence: (A) THP1 cells were infected with HSV-1 KOS or an ICP27-deficient mutant (ΔICP27) on KOS genetic background (MOI 3). Supernatants were harvested from untreated cultures or cells infected for 12 or 18 hours for measurement of type I IFN bioactivity. Instructions: please typing these entity words ac...

[ "O", "O", "O", "B-cellline", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", ...

(A) THP1 cells were infected with HSV-1 KOS or an ICP27-deficient mutant (ΔICP27) on KOS genetic background (MOI 3). Supernatants were harvested from untreated cultures or cells infected for 12 or 18 hours for measurement of type I IFN bioactivity.

[ "(", "A", ")", "THP1", "cells", "were", "infected", "with", "HSV-1", "KOS", "or", "an", "ICP27-deficient", "mutant", "(", "ΔICP27", ")", "on", "KOS", "genetic", "background", "(", "MOI", "3", ")", ".", "Supernatants", "were", "harvested", "from", "untreate...

[ "cellline" ]

THP1

34051_2

Sentence: (A) THP1 cells were infected with HSV-1 KOS or an ICP27-deficient mutant (ΔICP27) on KOS genetic background (MOI 3). Supernatants were harvested from untreated cultures or cells infected for 12 or 18 hours for measurement of type I IFN bioactivity. Instructions: please extract entity words from th...

[ "O", "O", "O", "B-cellline", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", ...

(A) THP1 cells were infected with HSV-1 KOS or an ICP27-deficient mutant (ΔICP27) on KOS genetic background (MOI 3). Supernatants were harvested from untreated cultures or cells infected for 12 or 18 hours for measurement of type I IFN bioactivity.

[ "(", "A", ")", "THP1", "cells", "were", "infected", "with", "HSV-1", "KOS", "or", "an", "ICP27-deficient", "mutant", "(", "ΔICP27", ")", "on", "KOS", "genetic", "background", "(", "MOI", "3", ")", ".", "Supernatants", "were", "harvested", "from", "untreate...

[ "cellline" ]

sequence - specific HMG box is a DNA_domain_or_region, lymphocyte transcriptional activator is a protein_family_or_group, Sox-4 is a protein_molecule

100643_0

Sentence: Solution structure of the sequence-specific HMG box of the lymphocyte transcriptional activator Sox-4. Instructions: please extract entities and their types from the input sentence, all entity types are in options Options: protein_family_or_group, DNA_domain_or_region, protein_molecule...

[ "O", "O", "O", "O", "B-DNA_domain_or_region", "I-DNA_domain_or_region", "I-DNA_domain_or_region", "I-DNA_domain_or_region", "I-DNA_domain_or_region", "O", "O", "B-protein_family_or_group", "I-protein_family_or_group", "I-protein_family_or_group", "B-protein_molecule", "O" ]

Solution structure of the sequence-specific HMG box of the lymphocyte transcriptional activator Sox-4.

[ "Solution", "structure", "of", "the", "sequence", "-", "specific", "HMG", "box", "of", "the", "lymphocyte", "transcriptional", "activator", "Sox-4", "." ]

[ "protein_family_or_group", "DNA_domain_or_region", "protein_domain_or_region", "other_name", "protein_substructure", "peptide", "protein_molecule", "(AND protein_substructure protein_substructure)", "DNA_family_or_group", "DNA_substructure", "polynucleotide", "" ]

sequence - specific HMG box is a DNA_domain_or_region, lymphocyte transcriptional activator is a protein_family_or_group, Sox-4 is a protein_molecule

100643_1

Sentence: Solution structure of the sequence-specific HMG box of the lymphocyte transcriptional activator Sox-4. Instructions: please typing these entity words according to sentence: sequence - specific HMG box, lymphocyte transcriptional activator, Sox-4 Options: protein_family_or_group, DNA_do...

[ "O", "O", "O", "O", "B-DNA_domain_or_region", "I-DNA_domain_or_region", "I-DNA_domain_or_region", "I-DNA_domain_or_region", "I-DNA_domain_or_region", "O", "O", "B-protein_family_or_group", "I-protein_family_or_group", "I-protein_family_or_group", "B-protein_molecule", "O" ]

Solution structure of the sequence-specific HMG box of the lymphocyte transcriptional activator Sox-4.

[ "Solution", "structure", "of", "the", "sequence", "-", "specific", "HMG", "box", "of", "the", "lymphocyte", "transcriptional", "activator", "Sox-4", "." ]

[ "protein_family_or_group", "DNA_domain_or_region", "protein_domain_or_region", "other_name", "protein_substructure", "peptide", "protein_molecule", "(AND protein_substructure protein_substructure)", "DNA_family_or_group", "DNA_substructure", "polynucleotide", "" ]

sequence - specific HMG box, lymphocyte transcriptional activator, Sox-4

100643_2

Sentence: Solution structure of the sequence-specific HMG box of the lymphocyte transcriptional activator Sox-4. Instructions: please extract entity words from the input sentence

[ "O", "O", "O", "O", "B-DNA_domain_or_region", "I-DNA_domain_or_region", "I-DNA_domain_or_region", "I-DNA_domain_or_region", "I-DNA_domain_or_region", "O", "O", "B-protein_family_or_group", "I-protein_family_or_group", "I-protein_family_or_group", "B-protein_molecule", "O" ]

Solution structure of the sequence-specific HMG box of the lymphocyte transcriptional activator Sox-4.

[ "Solution", "structure", "of", "the", "sequence", "-", "specific", "HMG", "box", "of", "the", "lymphocyte", "transcriptional", "activator", "Sox-4", "." ]

[ "protein_family_or_group", "DNA_domain_or_region", "protein_domain_or_region", "other_name", "protein_substructure", "peptide", "protein_molecule", "(AND protein_substructure protein_substructure)", "DNA_family_or_group", "DNA_substructure", "polynucleotide", "" ]

hearing is an umlsterm, conductive hearing loss is an umlsterm, sensorineural hearing loss is an umlsterm, conductive hearing loss is an umlsterm, impedance is an umlsterm, middle ear is an umlsterm, impedance is an umlsterm, use is an umlsterm, patients is an umlsterm, electronic is an umlsterm, sensorineural hearing ...

HNO.70450758.eng.abstr_0

Sentence: Active hearing implants have been developed to varying degrees for conductive hearing loss as well as for sensorineural hearing loss . Implants for conductive hearing loss match impedance transformation by the middle ear . They will be referred to as ITI ( impedance transformation implants ) . Three partial I...

[ "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "I-umlsterm", "I-umlsterm", "O", "O", "O", "O", "B-umlsterm", "I-umlsterm", "I-umlsterm", "O", "O", "O", "B-umlsterm", "I-umlsterm", "I-umlsterm", "O", "B-umlsterm", "O", "O", "O", ...

Active hearing implants have been developed to varying degrees for conductive hearing loss as well as for sensorineural hearing loss . Implants for conductive hearing loss match impedance transformation by the middle ear . They will be referred to as ITI ( impedance transformation implants ) . Three partial ITIs have b...

[ "Active", "hearing", "implants", "have", "been", "developed", "to", "varying", "degrees", "for", "conductive", "hearing", "loss", "as", "well", "as", "for", "sensorineural", "hearing", "loss", ".", "Implants", "for", "conductive", "hearing", "loss", "match", "im...

[ "umlsterm" ]

hearing is an umlsterm, conductive hearing loss is an umlsterm, sensorineural hearing loss is an umlsterm, conductive hearing loss is an umlsterm, impedance is an umlsterm, middle ear is an umlsterm, impedance is an umlsterm, use is an umlsterm, patients is an umlsterm, electronic is an umlsterm, sensorineural hearing ...

HNO.70450758.eng.abstr_1

Sentence: Active hearing implants have been developed to varying degrees for conductive hearing loss as well as for sensorineural hearing loss . Implants for conductive hearing loss match impedance transformation by the middle ear . They will be referred to as ITI ( impedance transformation implants ) . Three partial I...

[ "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "I-umlsterm", "I-umlsterm", "O", "O", "O", "O", "B-umlsterm", "I-umlsterm", "I-umlsterm", "O", "O", "O", "B-umlsterm", "I-umlsterm", "I-umlsterm", "O", "B-umlsterm", "O", "O", "O", ...

Active hearing implants have been developed to varying degrees for conductive hearing loss as well as for sensorineural hearing loss . Implants for conductive hearing loss match impedance transformation by the middle ear . They will be referred to as ITI ( impedance transformation implants ) . Three partial ITIs have b...

[ "Active", "hearing", "implants", "have", "been", "developed", "to", "varying", "degrees", "for", "conductive", "hearing", "loss", "as", "well", "as", "for", "sensorineural", "hearing", "loss", ".", "Implants", "for", "conductive", "hearing", "loss", "match", "im...

[ "umlsterm" ]

hearing, conductive hearing loss, sensorineural hearing loss, conductive hearing loss, impedance, middle ear, impedance, use, patients, electronic, sensorineural hearing loss, function, cochlea, amplifier, CA, CAI, cochlea, amplifier, CAI, transducer, control, CAI, use, transducer, use, electromagnetic, transducers, tr...

HNO.70450758.eng.abstr_2

Sentence: Active hearing implants have been developed to varying degrees for conductive hearing loss as well as for sensorineural hearing loss . Implants for conductive hearing loss match impedance transformation by the middle ear . They will be referred to as ITI ( impedance transformation implants ) . Three partial I...

[ "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "I-umlsterm", "I-umlsterm", "O", "O", "O", "O", "B-umlsterm", "I-umlsterm", "I-umlsterm", "O", "O", "O", "B-umlsterm", "I-umlsterm", "I-umlsterm", "O", "B-umlsterm", "O", "O", "O", ...

Active hearing implants have been developed to varying degrees for conductive hearing loss as well as for sensorineural hearing loss . Implants for conductive hearing loss match impedance transformation by the middle ear . They will be referred to as ITI ( impedance transformation implants ) . Three partial ITIs have b...

[ "Active", "hearing", "implants", "have", "been", "developed", "to", "varying", "degrees", "for", "conductive", "hearing", "loss", "as", "well", "as", "for", "sensorineural", "hearing", "loss", ".", "Implants", "for", "conductive", "hearing", "loss", "match", "im...

[ "umlsterm" ]

STAMP2 is a gene

3637_0

Sentence: G LNCaP cells stably expressing either control or STAMP2 vector were treated in the same way as in (D). Cell lysates were prepared and subjected to Western blot analysis with the indicated antibodies. Instructions: please extract entities and their types from the input sentence, all entity types a...

[ "O", "O", "O", "O", "O", "O", "O", "O", "B-gene", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ]

G LNCaP cells stably expressing either control or STAMP2 vector were treated in the same way as in (D). Cell lysates were prepared and subjected to Western blot analysis with the indicated antibodies.

[ "G", "LNCaP", "cells", "stably", "expressing", "either", "control", "or", "STAMP2", "vector", "were", "treated", "in", "the", "same", "way", "as", "in", "(", "D", ")", ".", "Cell", "lysates", "were", "prepared", "and", "subjected", "to", "Western", "blot",...

[ "gene" ]

STAMP2 is a gene

3637_1

Sentence: G LNCaP cells stably expressing either control or STAMP2 vector were treated in the same way as in (D). Cell lysates were prepared and subjected to Western blot analysis with the indicated antibodies. Instructions: please typing these entity words according to sentence: STAMP2 Options:...

[ "O", "O", "O", "O", "O", "O", "O", "O", "B-gene", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ]

G LNCaP cells stably expressing either control or STAMP2 vector were treated in the same way as in (D). Cell lysates were prepared and subjected to Western blot analysis with the indicated antibodies.

[ "G", "LNCaP", "cells", "stably", "expressing", "either", "control", "or", "STAMP2", "vector", "were", "treated", "in", "the", "same", "way", "as", "in", "(", "D", ")", ".", "Cell", "lysates", "were", "prepared", "and", "subjected", "to", "Western", "blot",...

[ "gene" ]

STAMP2

3637_2

Sentence: G LNCaP cells stably expressing either control or STAMP2 vector were treated in the same way as in (D). Cell lysates were prepared and subjected to Western blot analysis with the indicated antibodies. Instructions: please extract entity words from the input sentence

[ "O", "O", "O", "O", "O", "O", "O", "O", "B-gene", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ]

G LNCaP cells stably expressing either control or STAMP2 vector were treated in the same way as in (D). Cell lysates were prepared and subjected to Western blot analysis with the indicated antibodies.

[ "G", "LNCaP", "cells", "stably", "expressing", "either", "control", "or", "STAMP2", "vector", "were", "treated", "in", "the", "same", "way", "as", "in", "(", "D", ")", ".", "Cell", "lysates", "were", "prepared", "and", "subjected", "to", "Western", "blot",...

[ "gene" ]

E2 is a chemical, DES is a chemical, estrogen is a chemical, alpha - fetoprotein is a protein, AFP is a protein, E2 is a chemical, DES is a chemical

1.0alpha7.train.518_0

Sentence: Complicating such studies is the fact that, in many perinatal rodents, E2 is much less potent than DES as an estrogen due to high serum concentrations of alpha-fetoprotein (AFP), which binds E2 but not DES with high affinity [ 17]. Instructions: please extract entities and their types from...

[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-chemical", "O", "O", "O", "O", "O", "B-chemical", "O", "O", "O", "B-chemical", "O", "O", "O", "O", "O", "O", "O", "B-protein", "I-protein", "I-protein", "O", ...

Complicating such studies is the fact that, in many perinatal rodents, E2 is much less potent than DES as an estrogen due to high serum concentrations of alpha-fetoprotein (AFP), which binds E2 but not DES with high affinity [ 17].

[ " ", "Complicating", "such", "studies", "is", "the", "fact", "that", ",", "in", "many", "perinatal", " ", "rodents", ",", " ", "E2", "is", "much", "less", "potent", "than", "DES", "as", "an", " ", "estrogen", "due", "to", "high", "serum", "concentrations...

[ "protein", "chemical" ]

E2 is a chemical, DES is a chemical, estrogen is a chemical, alpha - fetoprotein is a protein, AFP is a protein, E2 is a chemical, DES is a chemical

1.0alpha7.train.518_1

Sentence: Complicating such studies is the fact that, in many perinatal rodents, E2 is much less potent than DES as an estrogen due to high serum concentrations of alpha-fetoprotein (AFP), which binds E2 but not DES with high affinity [ 17]. Instructions: please typing these entity words according t...

[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-chemical", "O", "O", "O", "O", "O", "B-chemical", "O", "O", "O", "B-chemical", "O", "O", "O", "O", "O", "O", "O", "B-protein", "I-protein", "I-protein", "O", ...

Complicating such studies is the fact that, in many perinatal rodents, E2 is much less potent than DES as an estrogen due to high serum concentrations of alpha-fetoprotein (AFP), which binds E2 but not DES with high affinity [ 17].

[ " ", "Complicating", "such", "studies", "is", "the", "fact", "that", ",", "in", "many", "perinatal", " ", "rodents", ",", " ", "E2", "is", "much", "less", "potent", "than", "DES", "as", "an", " ", "estrogen", "due", "to", "high", "serum", "concentrations...

[ "protein", "chemical" ]

E2, DES, estrogen, alpha - fetoprotein, AFP, E2, DES

1.0alpha7.train.518_2

Sentence: Complicating such studies is the fact that, in many perinatal rodents, E2 is much less potent than DES as an estrogen due to high serum concentrations of alpha-fetoprotein (AFP), which binds E2 but not DES with high affinity [ 17]. Instructions: please extract entity words from the input s...

[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-chemical", "O", "O", "O", "O", "O", "B-chemical", "O", "O", "O", "B-chemical", "O", "O", "O", "O", "O", "O", "O", "B-protein", "I-protein", "I-protein", "O", ...

Complicating such studies is the fact that, in many perinatal rodents, E2 is much less potent than DES as an estrogen due to high serum concentrations of alpha-fetoprotein (AFP), which binds E2 but not DES with high affinity [ 17].

[ " ", "Complicating", "such", "studies", "is", "the", "fact", "that", ",", "in", "many", "perinatal", " ", "rodents", ",", " ", "E2", "is", "much", "less", "potent", "than", "DES", "as", "an", " ", "estrogen", "due", "to", "high", "serum", "concentrations...

[ "protein", "chemical" ]

nucleus is a gene

10152_0

Sentence: A β-catenin (red) and DDX3 (green) expression in H1299 cells. After overexpressing β-catenin, both DDX3 and β-catenin accumulate in the nucleus. Scale bar is 10 μm. Instructions: please extract entities and their types from the input sentence, all entity types are in options Options: g...

[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-gene", "O", "O", "O", "O", "O", "O", "O" ]

A β-catenin (red) and DDX3 (green) expression in H1299 cells. After overexpressing β-catenin, both DDX3 and β-catenin accumulate in the nucleus. Scale bar is 10 μm.

[ "A", "β", "-", "catenin", "(", "red", ")", "and", "DDX3", "(", "green", ")", "expression", "in", "H1299", "cells", ".", "After", "overexpressing", "β", "-", "catenin", ",", "both", "DDX3", "and", "β", "-", "catenin", "accumulate", "in", "the", "nucleus...

[ "gene" ]

nucleus is a gene

10152_1

Sentence: A β-catenin (red) and DDX3 (green) expression in H1299 cells. After overexpressing β-catenin, both DDX3 and β-catenin accumulate in the nucleus. Scale bar is 10 μm. Instructions: please typing these entity words according to sentence: nucleus Options: gene

[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-gene", "O", "O", "O", "O", "O", "O", "O" ]

A β-catenin (red) and DDX3 (green) expression in H1299 cells. After overexpressing β-catenin, both DDX3 and β-catenin accumulate in the nucleus. Scale bar is 10 μm.

[ "A", "β", "-", "catenin", "(", "red", ")", "and", "DDX3", "(", "green", ")", "expression", "in", "H1299", "cells", ".", "After", "overexpressing", "β", "-", "catenin", ",", "both", "DDX3", "and", "β", "-", "catenin", "accumulate", "in", "the", "nucleus...

[ "gene" ]

nucleus

10152_2

Sentence: A β-catenin (red) and DDX3 (green) expression in H1299 cells. After overexpressing β-catenin, both DDX3 and β-catenin accumulate in the nucleus. Scale bar is 10 μm. Instructions: please extract entity words from the input sentence

[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-gene", "O", "O", "O", "O", "O", "O", "O" ]

A β-catenin (red) and DDX3 (green) expression in H1299 cells. After overexpressing β-catenin, both DDX3 and β-catenin accumulate in the nucleus. Scale bar is 10 μm.

[ "A", "β", "-", "catenin", "(", "red", ")", "and", "DDX3", "(", "green", ")", "expression", "in", "H1299", "cells", ".", "After", "overexpressing", "β", "-", "catenin", ",", "both", "DDX3", "and", "β", "-", "catenin", "accumulate", "in", "the", "nucleus...

[ "gene" ]

Operationstechniken is an umlsterm, Nebennierenchirurgie is an umlsterm, Methoden is an umlsterm, Adrenalektomie is an umlsterm, hormonaktive is an umlsterm, Nebennierentumoren is an umlsterm, Hyperplasien is an umlsterm, Methoden is an umlsterm, Trokarzugaenge is an umlsterm, Methoden is an umlsterm, Orientierung is a...

DerChirurg.80690613.ger.abstr_0

Sentence: Zusammenfassung . Die minimal-invasiven Operationstechniken sind heute fester Bestandteil der Nebennierenchirurgie . Inzwischen kommen vier verschiedene Methoden zur Anwendung : laparoskopisch von vorne und von der Seite sowie retroperitoneoskopisch von hinten und von der Seite . Indikationen zur endoskopisch...

[ "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B...

Zusammenfassung . Die minimal-invasiven Operationstechniken sind heute fester Bestandteil der Nebennierenchirurgie . Inzwischen kommen vier verschiedene Methoden zur Anwendung : laparoskopisch von vorne und von der Seite sowie retroperitoneoskopisch von hinten und von der Seite . Indikationen zur endoskopischen Adrenal...

[ "Zusammenfassung", ".", "Die", "minimal", "-", "invasiven", "Operationstechniken", "sind", "heute", "fester", "Bestandteil", "der", "Nebennierenchirurgie", ".", "Inzwischen", "kommen", "vier", "verschiedene", "Methoden", "zur", "Anwendung", ":", "laparoskopisch", "von",...

[ "umlsterm" ]

Operationstechniken is an umlsterm, Nebennierenchirurgie is an umlsterm, Methoden is an umlsterm, Adrenalektomie is an umlsterm, hormonaktive is an umlsterm, Nebennierentumoren is an umlsterm, Hyperplasien is an umlsterm, Methoden is an umlsterm, Trokarzugaenge is an umlsterm, Methoden is an umlsterm, Orientierung is a...

DerChirurg.80690613.ger.abstr_1

Sentence: Zusammenfassung . Die minimal-invasiven Operationstechniken sind heute fester Bestandteil der Nebennierenchirurgie . Inzwischen kommen vier verschiedene Methoden zur Anwendung : laparoskopisch von vorne und von der Seite sowie retroperitoneoskopisch von hinten und von der Seite . Indikationen zur endoskopisch...

[ "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B...

Zusammenfassung . Die minimal-invasiven Operationstechniken sind heute fester Bestandteil der Nebennierenchirurgie . Inzwischen kommen vier verschiedene Methoden zur Anwendung : laparoskopisch von vorne und von der Seite sowie retroperitoneoskopisch von hinten und von der Seite . Indikationen zur endoskopischen Adrenal...

[ "Zusammenfassung", ".", "Die", "minimal", "-", "invasiven", "Operationstechniken", "sind", "heute", "fester", "Bestandteil", "der", "Nebennierenchirurgie", ".", "Inzwischen", "kommen", "vier", "verschiedene", "Methoden", "zur", "Anwendung", ":", "laparoskopisch", "von",...

[ "umlsterm" ]

Operationstechniken, Nebennierenchirurgie, Methoden, Adrenalektomie, hormonaktive, Nebennierentumoren, Hyperplasien, Methoden, Trokarzugaenge, Methoden, Orientierung, Nebenniere, Chirurgie, Methodik

DerChirurg.80690613.ger.abstr_2

Sentence: Zusammenfassung . Die minimal-invasiven Operationstechniken sind heute fester Bestandteil der Nebennierenchirurgie . Inzwischen kommen vier verschiedene Methoden zur Anwendung : laparoskopisch von vorne und von der Seite sowie retroperitoneoskopisch von hinten und von der Seite . Indikationen zur endoskopisch...

[ "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B...

Zusammenfassung . Die minimal-invasiven Operationstechniken sind heute fester Bestandteil der Nebennierenchirurgie . Inzwischen kommen vier verschiedene Methoden zur Anwendung : laparoskopisch von vorne und von der Seite sowie retroperitoneoskopisch von hinten und von der Seite . Indikationen zur endoskopischen Adrenal...

[ "Zusammenfassung", ".", "Die", "minimal", "-", "invasiven", "Operationstechniken", "sind", "heute", "fester", "Bestandteil", "der", "Nebennierenchirurgie", ".", "Inzwischen", "kommen", "vier", "verschiedene", "Methoden", "zur", "Anwendung", ":", "laparoskopisch", "von",...

[ "umlsterm" ]

activin is a protein-complex, ActRII is a protein, ActRIIB is a protein, activin type IB receptor is a protein, ALK4 is a protein, ActRI is a protein, ALK2 is a protein

1.0alpha7.train.1362_0

Sentence: Similarly, activin binds to either ActRII or ActRIIB, with activin type IB receptor (ALK4) or possibly ActRI (ALK2) then joining the complex ( 14-19). Instructions: please extract entities and their types from the input sentence, all entity types are in options Options: protein-co...

[ "O", "O", "O", "B-protein-complex", "O", "O", "O", "O", "B-protein", "O", "O", "B-protein", "O", "O", "O", "B-protein", "I-protein", "I-protein", "I-protein", "O", "B-protein", "O", "O", "O", "O", "B-protein", "O", "B-protein", "O", "O", "O", "O", "O",...

Similarly, activin binds to either ActRII or ActRIIB, with activin type IB receptor (ALK4) or possibly ActRI (ALK2) then joining the complex ( 14-19).

[ "Similarly", ",", " ", "activin", "binds", "to", "either", " ", "ActRII", "or", " ", "ActRIIB", ",", "with", " ", "activin", "type", "IB", "receptor", "(", "ALK4", ")", "or", "possibly", " ", "ActRI", "(", "ALK2", ")", "then", "joining", "the", "comple...

[ "protein", "protein-complex" ]

activin is a protein-complex, ActRII is a protein, ActRIIB is a protein, activin type IB receptor is a protein, ALK4 is a protein, ActRI is a protein, ALK2 is a protein

1.0alpha7.train.1362_1

Sentence: Similarly, activin binds to either ActRII or ActRIIB, with activin type IB receptor (ALK4) or possibly ActRI (ALK2) then joining the complex ( 14-19). Instructions: please typing these entity words according to sentence: activin, ActRII, ActRIIB, activin type IB receptor, ALK4, ActRI, ALK2 ...

[ "O", "O", "O", "B-protein-complex", "O", "O", "O", "O", "B-protein", "O", "O", "B-protein", "O", "O", "O", "B-protein", "I-protein", "I-protein", "I-protein", "O", "B-protein", "O", "O", "O", "O", "B-protein", "O", "B-protein", "O", "O", "O", "O", "O",...

Similarly, activin binds to either ActRII or ActRIIB, with activin type IB receptor (ALK4) or possibly ActRI (ALK2) then joining the complex ( 14-19).

[ "Similarly", ",", " ", "activin", "binds", "to", "either", " ", "ActRII", "or", " ", "ActRIIB", ",", "with", " ", "activin", "type", "IB", "receptor", "(", "ALK4", ")", "or", "possibly", " ", "ActRI", "(", "ALK2", ")", "then", "joining", "the", "comple...

[ "protein", "protein-complex" ]

activin, ActRII, ActRIIB, activin type IB receptor, ALK4, ActRI, ALK2

1.0alpha7.train.1362_2

Sentence: Similarly, activin binds to either ActRII or ActRIIB, with activin type IB receptor (ALK4) or possibly ActRI (ALK2) then joining the complex ( 14-19). Instructions: please extract entity words from the input sentence

[ "O", "O", "O", "B-protein-complex", "O", "O", "O", "O", "B-protein", "O", "O", "B-protein", "O", "O", "O", "B-protein", "I-protein", "I-protein", "I-protein", "O", "B-protein", "O", "O", "O", "O", "B-protein", "O", "B-protein", "O", "O", "O", "O", "O",...

Similarly, activin binds to either ActRII or ActRIIB, with activin type IB receptor (ALK4) or possibly ActRI (ALK2) then joining the complex ( 14-19).

[ "Similarly", ",", " ", "activin", "binds", "to", "either", " ", "ActRII", "or", " ", "ActRIIB", ",", "with", " ", "activin", "type", "IB", "receptor", "(", "ALK4", ")", "or", "possibly", " ", "ActRI", "(", "ALK2", ")", "then", "joining", "the", "comple...

[ "protein", "protein-complex" ]

MCF7 is a cellline

39788_0

Sentence: e, Log2(H:L) heat map of class 1A candidates from PANC-1 and MCF7 cells. CQ, chloroquine. Instructions: please extract entities and their types from the input sentence, all entity types are in options Options: cellline

[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-cellline", "O", "O", "O", "O", "O", "O" ]

e, Log2(H:L) heat map of class 1A candidates from PANC-1 and MCF7 cells. CQ, chloroquine.

[ "e", ",", "Log2(H", ":", "L", ")", "heat", "map", "of", "class", "1A", "candidates", "from", "PANC-1", "and", "MCF7", "cells", ".", "CQ", ",", "chloroquine", "." ]

[ "cellline" ]

MCF7 is a cellline

39788_1

Sentence: e, Log2(H:L) heat map of class 1A candidates from PANC-1 and MCF7 cells. CQ, chloroquine. Instructions: please typing these entity words according to sentence: MCF7 Options: cellline

[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-cellline", "O", "O", "O", "O", "O", "O" ]

e, Log2(H:L) heat map of class 1A candidates from PANC-1 and MCF7 cells. CQ, chloroquine.

[ "e", ",", "Log2(H", ":", "L", ")", "heat", "map", "of", "class", "1A", "candidates", "from", "PANC-1", "and", "MCF7", "cells", ".", "CQ", ",", "chloroquine", "." ]

[ "cellline" ]

MCF7

39788_2

Sentence: e, Log2(H:L) heat map of class 1A candidates from PANC-1 and MCF7 cells. CQ, chloroquine. Instructions: please extract entity words from the input sentence

[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-cellline", "O", "O", "O", "O", "O", "O" ]

e, Log2(H:L) heat map of class 1A candidates from PANC-1 and MCF7 cells. CQ, chloroquine.

[ "e", ",", "Log2(H", ":", "L", ")", "heat", "map", "of", "class", "1A", "candidates", "from", "PANC-1", "and", "MCF7", "cells", ".", "CQ", ",", "chloroquine", "." ]

[ "cellline" ]